Healthcare Realty Trust (HR) 10-K 16 Feb 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2023	Feb. 12, 2024	Jun. 30, 2023
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-35568
Entity Registrant Name	HEALTHCARE REALTY TRUST INCORPORATED
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	20-4738467
Entity Address, Address Line One	3310 West End Avenue
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	615
Local Phone Number	269-8175
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	HR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction Flag	false
Entity Shell Company	false
Entity Public Float			$ 7,130,838,614
Entity Common Stock, Shares Outstanding		381,180,874
Documents Incorporated by Reference	Portions of the Registrant’s definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held on May 21, 2024, are incorporated by reference into Part III of this Report .
Entity Central Index Key	0001360604
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2023
Audit Information [Abstract]
Auditor Name	BDO USA, P.C.
Auditor Location	Nashville, TN
Auditor Firm ID	243

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Real estate properties
Land	$ 1,343,265	$ 1,439,798
Buildings and improvements	10,881,373	11,332,037
Lease intangibles	836,302	959,998
Personal property	12,718	11,907
Investment in financing receivables, net	122,602	120,236
Financing lease right-of-use assets	82,209	83,824
Construction in progress	60,727	35,560
Land held for development	59,871	74,265
Total real estate investments	13,399,067	14,057,625
Less accumulated depreciation	(2,226,853)	(1,645,271)
Total real estate investments, net	11,172,214	12,412,354
Cash and cash equivalents	25,699	60,961
Assets held for sale, net	8,834	18,893
Operating lease right-of-use assets	275,975	336,983
Investments in unconsolidated joint ventures	311,511	327,248
Goodwill	250,530	223,202
Other assets, net	592,368	469,990
Total assets	12,637,131	13,849,631
Liabilities
Notes and bonds payable	4,994,859	5,351,827
Accounts payable and accrued liabilities	211,994	244,033
Liabilities of properties held for sale	295	437
Operating lease liabilities	229,714	279,895
Financing lease liabilities	74,503	72,939
Other liabilities	202,984	218,668
Total liabilities	5,714,349	6,167,799
Commitments and contingencies (See Footnote 15)
Redeemable non-controlling interests	3,868	2,014
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 1,000,000 shares authorized; 380,964 and 380,590 shares issued and outstanding at December 31, 2023 and 2022, respectively.	3,810	3,806
Additional paid-in capital	9,602,592	9,587,637
Accumulated other comprehensive (loss) income	(10,741)	2,140
Cumulative net income attributable to common stockholders	1,028,794	1,307,055
Cumulative dividends	(3,801,793)	(3,329,562)
Total stockholders’ equity	6,822,662	7,571,076
Non-controlling interest	96,252	108,742
Total equity	6,918,914	7,679,818
Total liabilities, redeemable non-controlling interests, and stockholders' equity	$ 12,637,131	$ 13,849,631

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	380,964,000	380,590,000
Common stock, outstanding (in shares)	380,964,000	380,590,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues
Rental income	$ 1,309,184	$ 907,451	$ 520,334
Interest income	17,134	11,480	4,192
Other operating	17,451	13,706	10,291
Total Revenue	1,343,769	932,637	534,817
Expenses
Property operating	500,437	344,038	212,273
General and administrative	58,405	52,734	34,152
Acquisition and pursuit costs	2,026	3,229	3,930
Merger-related costs	(1,952)	103,380	0
Depreciation and amortization	730,709	453,082	202,714
Total expenses	1,289,625	956,463	453,069
Other income (expense)
Gain on sales of real estate properties	77,546	270,271	55,940
Interest expense	(258,584)	(146,691)	(53,124)
Gain (loss) on extinguishment of debt	62	(2,401)	0
Impairment of real estate properties and credit loss reserves	(154,912)	(54,427)	(17,101)
Equity loss from unconsolidated joint ventures	(1,682)	(687)	(795)
Interest and other income (expense), net	1,343	(1,546)	(9)
Total other income (expense)	(336,227)	64,519	(15,089)
Net (loss) income	(282,083)	40,693	66,659
Net loss attributable to non-controlling interests	3,822	204	0
Net (loss) income attributable to common stockholders	$ (278,261)	$ 40,897	$ 66,659
Basic and diluted earnings per share:
Basic earnings per common share (in dollars per share)	$ (0.74)	$ 0.15	$ 0.45
Diluted earnings per common share (in dollars per share)	$ (0.74)	$ 0.15	$ 0.45
Weighted average number of shares outstanding, basic and diluted:
Weighted average common shares outstanding - basic (in shares)	378,927,871	252,356,203	142,637,166
Weighted average common shares outstanding - diluted (in shares)	378,927,871	253,873,321	142,710,228
Revenue, Product and Service [Extensible List]	Service [Member]	Service [Member]	Service [Member]

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (282,083)	$ 40,693	$ 66,659
Interest rate swaps
Reclassification adjustment for (gains) losses included in net income (interest expense)	(14,488)	1,527	4,472
Gains arising during the period on interest rate swaps	1,463	10,630	3,379
Net current-period other comprehensive (loss) income	(13,025)	12,157	7,851
Comprehensive (loss) income	(295,108)	52,850	74,510
Less: Comprehensive loss attributable to non-controlling interests	3,966	168	0
Comprehensive (loss) income attributable to common stockholders	$ (291,142)	$ 53,018	$ 74,510

Consolidated Statements of Equi

Consolidated Statements of Equity and Redeemable Non-Controlling Interests - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Cumulative Net Income	Cumulative Dividends	Total Stockholders’ Equity	Non- controlling Interests
Beginning Balance at Dec. 31, 2020	$ 1,948,376	$ 0	$ 1,395	$ 3,635,341	$ (17,832)	$ 1,199,499	$ (2,870,027)	$ 1,948,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	331,042		109	330,933				331,042
Common stock redemption	(4,085)		(1)	(4,084)				(4,085)
Share-based compensation	10,729		2	10,727				10,729
Net (loss) income	66,659					66,659		66,659
Loss on interest rate swaps and treasury locks	7,851				7,851			7,851
Reclassification adjustments for losses (gains) included in net income (interest expense)	4,472
Gains (losses) arising during the period on interest rate swaps and treasury locks	3,379
Dividends to common stockholders	(175,456)						(175,456)	(175,456)
Ending Balance at Dec. 31, 2021	2,185,116	0	1,505	3,972,917	(9,981)	1,266,158	(3,045,483)	2,185,116	$ 0
Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2020	0
Redeemable Non-controlling Interests, ending balance at Dec. 31, 2021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	22,907		6	22,901				22,907
Merger consideration transferred	5,687,165		2,289	5,574,174				5,576,463	110,702
Common stock redemption	(2,792)		(1)	(2,791)				(2,792)
Share-based compensation	20,346		7	20,339				20,346
Redemption of non-controlling interest	0			97				97	(97)
Net (loss) income	40,693					40,897		40,897	(204)
Loss on interest rate swaps and treasury locks	12,157
Reclassification adjustments for losses (gains) included in net income (interest expense)	1,527				1,531			1,531	(4)
Gains (losses) arising during the period on interest rate swaps and treasury locks	10,630				10,590			10,590	40
Dividends to common stockholders	(285,774)						(284,079)	(284,079)	(1,695)
Ending Balance at Dec. 31, 2022	7,679,818	0	3,806	9,587,637	2,140	1,307,055	(3,329,562)	7,571,076	108,742
Redeemable Non-controlling Interests
Contributions from redeemable non-controlling interests	2,014
Redeemable Non-controlling Interests, ending balance at Dec. 31, 2022	2,014
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net of costs	130			130				130
Common stock redemption	(2,235)		(1)	(2,234)				(2,235)
Conversion of OP Units to common stock	0		2	2,774				2,776	(2,776)
Share-based compensation	14,288		3	14,285				14,288
Net (loss) income	(282,083)					(278,261)		(278,261)	(3,822)
Loss on interest rate swaps and treasury locks	(13,025)
Reclassification adjustments for losses (gains) included in net income (interest expense)	(14,488)				(14,315)			(14,315)	(173)
Gains (losses) arising during the period on interest rate swaps and treasury locks	1,463				1,434			1,434	29
Dividends to common stockholders	(477,979)						(472,231)	(472,231)	(5,748)
Ending Balance at Dec. 31, 2023	6,918,914	$ 0	$ 3,810	$ 9,602,592	$ (10,741)	$ 1,028,794	$ (3,801,793)	$ 6,822,662	$ 96,252
Redeemable Non-controlling Interests
Contributions from redeemable non-controlling interests	1,889
Adjustments to redemption value of redeemable non-controlling interests	(35)
Redeemable Non-controlling Interests, ending balance at Dec. 31, 2023	$ 3,868

Consolidated Statements of Eq_2

Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]
Dividends to common stockholders (in dollars per share)	$ 1.24	$ 1.24	$ 1.21

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES
Net (loss) income	$ (282,083)	$ 40,693	$ 66,659
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	730,709	453,082	202,714
Other amortization	45,181	24,695	3,793
Share-based compensation	14,288	20,346	10,729
Amortization of straight-line rent receivable (lessor)	(38,676)	(23,498)	(5,801)
Amortization of straight-line rent on operating leases (lessee)	6,084	3,374	1,498
Gain on sales of real estate properties	(77,546)	(270,271)	(55,940)
(Gain) loss on extinguishment of debt	(62)	2,401	0
Impairment of real estate properties and credit loss reserves	154,912	54,427	17,101
Equity loss from unconsolidated joint ventures	1,682	687	795
Distributions from unconsolidated joint ventures	17,880	1,881	0
Non-cash interest from financing and real estate notes receivable	(1,654)	(2,257)	(391)
Changes in operating assets and liabilities:
Other assets, including right-of-use-assets	(55,946)	(26,098)	(11,436)
Accounts payable and accrued liabilities	(18,775)	24,191	(839)
Other liabilities	3,826	(30,906)	3,747
Net cash provided by operating activities	499,820	272,747	232,629
INVESTING ACTIVITIES
Acquisitions of real estate	(49,171)	(402,529)	(365,943)
Development of real estate	(41,058)	(37,862)	(4,029)
Additional long-lived assets	(231,026)	(163,544)	(100,689)
Funding of mortgages and notes receivable	(26,803)	(23,325)	0
Investments in unconsolidated joint ventures	(3,824)	(99,967)	(89,600)
Investment in financing receivable	(1,801)	(1,002)	(186,433)
Proceeds from sales of real estate properties and additional long-lived assets	701,434	1,201,068	184,221
Contributions from redeemable non-controlling interests	1,389	0	0
Proceeds from notes receivable repayments	0	1,688	0
Cash assumed in Merger, including restricted cash for special dividend payment	0	1,159,837
Net cash provided by (used in) investing activities	349,140	1,634,364	(562,473)
FINANCING ACTIVITIES
Net (repayments) borrowing on unsecured credit facility	(385,000)	40,000	210,000
Borrowings on term loans	0	666,500	0
Repayment on term loan	0	(1,141,500)	0
Repayments of notes and bonds payable	(19,143)	(20,042)	(24,557)
Redemption of notes and bonds payable	0	(2,184)	0
Dividends paid	(472,242)	(283,713)	(175,456)
Special dividend paid in relation to the Merger	0	(1,123,648)	0
Net proceeds from issuance of common stock	130	22,902	331,119
Common stock redemptions	(2,298)	(3,192)	(3,803)
Distributions to non-controlling interest of limited partners	(5,123)	(1,695)	0
Debt issuance and assumption costs	(529)	(12,753)	(405)
Payments made on finance leases	(17)	0	(9,182)
Net cash (used in) provided by financing activities	(884,222)	(1,859,325)	327,716
(Decrease) increase in cash and cash equivalents	(35,262)	47,786	(2,128)
Cash and cash equivalents cash at beginning of period	60,961	13,175	15,303
Cash and cash equivalents at end of period	25,699	60,961	13,175
Supplemental Cash Flow Information
Interest paid	216,033	112,692	49,443
Mortgage notes payable assumed in connection with acquisition of real estate, net	5,284	0	11,790
Invoices accrued for construction, tenant improvements and other capitalized costs	31,469	48,292	17,655
Capitalized interest	2,961	1,410	221
Mortgage note receivables taken in connection with sale of real estate	51,000	0	0
Real estate notes receivable assumed in Merger (adjusted to fair value)	0	74,819	0
Unsecured credit facility and term loans assumed in Merger (adjusted to fair value)	0	1,758,650	0
Senior notes assumed in Merger (adjusted to fair value)	0	2,232,650	0
Consideration transferred in relation to the Merger	$ 0	$ 5,576,463	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. Except as otherwise provided in the Notes to the Company’s Consolidated Financial Statements, references herein to the "Company" mean Healthcare Realty Trust Incorporated and its consolidated subsidiaries, including Healthcare Realty Holdings, L.P. (formerly known as Healthcare Trust of America Holdings, LP) (the "OP"), after giving effect to the Merger discussed in more detail in Note 2 below. As of December 31, 2023, the Company had gross investments of approximately $13.4 billion in 655 consolidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development, corporate property and excluding held for sale assets. The Company’s real estate properties are located in 35 states and total approximately 38.5 million square feet. In addition, the Company had a weighted average ownership interest of approximately 43% in 33 real estate properties held in unconsolidated joint ventures. See Note 5 below for more details regarding the Company's joint ventures. Square footage and property count disclosures in these Notes to the Company's Consolidated Financial Statements are unaudited. Principles of Consolidation The Company’s Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). ASC Topic 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. The OP is 98.8% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2023, there were approximately 4.5 million , or 1.2%, of OP Units issued and outstanding held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP. As of December 31, 2023, the Company had four consolidated VIEs in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) DECEMBER 31, 2023 Assets: Net real estate investments $ 85,752 Cash and cash equivalents 2,144 Receivables and other assets 2,704 Total assets $ 90,600 Liabilities: Accrued expenses and other liabilities $ 17,835 Total equity 72,765 Total liabilities and equity $ 90,600 As of December 31, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture. It was determined that the Company was not the primary beneficiary of the unconsolidated VIEs because the Company does not have the power or economics to direct the activities of the VIEs on a stand-alone basis. Therefore, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs: (dollars in thousands) ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 31,150 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,796 6,000 2022 Texas 2 Equity method 61,801 61,801 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in seven properties. As of December 31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities. See Note 5 for more details regarding the Company's unconsolidated joint ventures. Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates and assumptions. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, collectability of tenant receivables, and fair value measurements, as applicable. Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment. Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under ASC Topic 805, Business Combinations . Cost or fair value at the time of acquisition is allocated among land, buildings, tenant improvements, lease and other intangibles, and personal property as applicable. During 2023 and 2022, the Company eliminated against accumulated depreciation approximately $51.7 million and $19.6 million, respectively, of fully amortized real estate intangibles that were initially recorded as a component of certain real estate acquisitions. During 2022, approximately $4.1 million of fully depreciated tenant and capital improvements that were no longer in service were eliminated against accumulated depreciation. Depreciation expense of real estate properties for the three years ended December 31, 2023, 2022 and 2021 was $518.6 million, $320.8 million and $170.0 million, respectively. Depreciation and amortization of real estate assets in place as of December 31, 2023, is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 2.0 to 39.0 years Buildings and improvements 3.3 to 49.0 years Lease intangibles (including ground lease intangibles) 1.0 to 99.0 years Personal property 3.0 to 20.0 years The Company capitalizes direct costs, including costs such as construction costs and professional services, and indirect costs, including capitalized interest and overhead costs, associated with the development and construction of real estate assets while substantive activities are ongoing to prepare the assets for their intended use. Capitalized interest cost is calculated using the weighted average interest rate of the Company's unsecured debt or the interest rate on project specific debt, if applicable. The Company continues to capitalize interest on the unoccupied portion of the properties in stabilization for up to one year after the buildings have been placed into service, at which time the capitalization of interest must cease. Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualty losses, such as tornadoes and hurricanes. A property value is considered impaired only if management's estimate of current and projected (undiscounted and unleveraged) operating cash flows of the property is less than the net carrying value of the property. These estimates of future cash flows include only those that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the property based on its estimated remaining useful life. These estimates, including the useful life determination which can be affected by any potential sale of the property, are based on management's assumptions about its use of the property. Therefore, significant judgment is involved in estimating the current and projected cash flows. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property. Acquisitions of Real Estate Properties with In-Place Leases The Company's acquisitions of real estate properties typically do not meet the definition of a business and are accounted for as asset acquisitions. Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Land fair value is estimated by using an assessment of comparable transactions and other relevant data. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the estimated market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. These assets (above- or below-market lease, tenant improvement, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various relative asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-place leases. The at-market, in-place lease intangibles are amortized to depreciation and amortization expense over the weighted average remaining term of the leases, and customer relationship assets are amortized to depreciation amortization expense over terms applicable to each acquisition. Any goodwill recorded through a business combination would be reviewed for impairment at least annually and is not amortized. See Note 9 for more details on the Company’s intangible assets. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, which are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature. Fair Value of Derivative Financial Instruments Derivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest rate swap contracts are estimated by pricing models that consider foreign trade rates and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. For derivatives designated in qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Gains and losses are reclassified from accumulated other comprehensive income (loss) into earnings once the underlying hedged transaction is recognized in earnings. As of December 31, 2023 and 2022, the Company had $10.7 million recorded in accumulated other comprehensive loss and $2.1 million recorded in accumulated other comprehensive (loss) income, respectively, related to forward starting interest rate swaps entered into and settled during 2015 and 2020 and a hedge of the Company's variable rate debt. See Note 11 for additional information. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The Company did not have any restricted cash for the years ended December 31, 2023 or 2022. Cash and cash equivalents are held in bank accounts and overnight investments. The Company maintains its bank deposits with large financial institutions in amounts that often exceed federally-insured limits. The Company has not experienced any losses in such accounts. Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present. Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and debt issuance costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Debt issuance costs are amortized over the term of the debt instrument on the effective interest method or the straight-line method when the effective interest method is not applicable. Goodwill is not amortized but is evaluated annually as of December 31 for impairment. The Company's goodwill asset increased $27.3 million to $250.5 million in 2023 compared to $223.2 million in 2022, as a result of the final purchase price allocation adjustments related to the Merger. The 2023 impairment evaluation indicated that no impairment had occurred with respect to the Company's goodwill asset. See Note 9 for more detail on the Company’s intangible assets. Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements. Share-Based Compensation The Company has various employee and director share-based awards outstanding. These awards include non-vested common stock or other stock-based awards, including units in the OP, pursuant to the Company's Amended and Restated 2006 Incentive Plan, dated April 29, 2021 ("the Incentive Plan"). The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Operations on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date. The Company recognizes the impact of forfeitures as they occur. See Note 13 for details on the Company’s share-based awards. Accumulated Other Comprehensive (Loss) Income Certain items must be included in comprehensive (loss) income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, changes in the fair value of derivative instruments and unrealized gains or losses on available-for-sale securities. As of December 31, 2023, the Company’s accumulated other comprehensive (loss) income consists of the loss for changes in the fair value of active derivatives designated as cash flow hedges and the loss on the unamortized settlement of forward starting swaps and treasury hedges. See Note 11 for more details on the Company's derivative financial instruments. Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. Revenue that is accounted for under Topic 606 is segregated on the Company’s Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category: YEAR ENDED DECEMBER 31, in thousands 2023 2022 2021 Type of Revenue Parking income $ 9,903 $ 8,513 $ 7,859 Management fee income/other 1 7,548 5,193 2,432 $ 17,451 $ 13,706 $ 10,291 1 Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement. The Company’s two major types of revenue that are accounted for under Topic 606 are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time and the Company recognizes revenue monthly based on this principle. In most cases, the revenue is due and payable on a monthly basis. The Company had a receivable balance of $1.9 million and $1.5 million, and $1.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Management fee income includes property management services provided to third parties and certain of the properties in the Company's unconsolidated joint ventures and is generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Management fee income also includes amounts paid to the Company for its asset management services for certain of its unconsolidated joint ventures. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Operations. For lessors, the standard requires a lessor to classify leases as either sales-type, direct-financing or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Nonlease components, such as common area maintenance, are generally accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. The combined component is accounted for under Accounting Standards Codification, Topic 842. The components of rental income are as follows: YEAR ENDED DECEMBER 31, in thousands 2023 2022 2021 Property operating income $ 1,270,508 $ 883,953 $ 514,533 Straight-line rent 38,676 23,498 5,801 Rental income $ 1,309,184 $ 907,451 $ 520,334 Federal Income Taxes The Company believes it has qualified to be taxed as a REIT and intends at all times to continue to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. As a REIT, the Company is generally not subject to federal income tax on net income it distributes to its stockholders, but may be subject to certain state and local taxes and fees. See Note 16 for further discussion. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income taxes on its taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which the qualification is lost unless the IRS grants it relief under certain statutory provisions. Such an event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. The Company conducts substantially all of its operations through the OP. As a partnership, the OP generally is not liable for federal income taxes. The income and loss from the operations of the OP is included in the tax returns of its partners, including the Company, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly, no provision for income tax has been made in the accompanying consolidated financial statements. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2023. Federal tax returns for the years 2020, 2021, 2022 and 2023 are currently subject to examination by taxing authorities. State Income Taxes The Company must pay certain state income taxes and the provisions for such taxes are generally included in general and administrative expenses on the Company’s Consolidated Statements of Operations. See Note 16 for further discussion. Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in rental income in the Company’s Consolidated Statements of Operations. Assets Held for Sale Long-lived assets held for sale are reported at the lower of their carrying amount or their fair value less estimated cost to sell. Further, depreciation of these assets ceases at the time the assets are classified as held for sale. Losses resulting from the sale of such properties are characterized as impairment losses in the Consolidated Statements of Operations. See Note 6 for more detail on assets held for sale. Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a pro rata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholders. Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the outstanding stock options from the Legacy HR Employee Stock Purchase Plan using the treasury stock method and the average stock price during the period. Additionally, net income (loss) allocated to OP units has been included in the numerator and common stock related to redeemable OP units have been included in the denominator for the purpose of computing diluted earnings per share. See Note 14 for the calculations of earnings per share. Redeemable Non-Controlling Interests The Company accounts for redeemable equity securities in accordance with Accounting Standards Update ("ASU") 2009-04 Liabilities (Topic 480): Accounting for Redeemable Equity Instruments, which requires that equity securities contingently redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Consolidated Balance Sheet. Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest’s share of net income or loss and distributions) or the redemption value. We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest. As of December 31, 2023, the Company had redeemable non-controlling interests of $3.9 million. Investments in Leases - Financing Receivables, Net In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale-leaseback transaction), control of the asset is not considered to have tran

Merger with HTA

Merger with HTA	12 Months Ended
	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Merger with HTA	Merger with HTA On July 20, 2022 (the “Closing Date”), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the “Merger Agreement”), by and among Healthcare Realty Trust Incorporated (now known as HRTI, LLC,) (“Legacy HR”), Healthcare Trust of America, Inc. (now known as Healthcare Realty Trust Incorporated) (“Legacy HTA”), the OP, and HR Acquisition 2, LLC (“Merger Sub”), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the “Merger”). On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the “Legacy HR Common Stock”), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the “Special Dividend”) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the “Legacy HTA Common Stock”), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to “Healthcare Realty Trust Incorporated”. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP. The Company operates under the name “Healthcare Realty Trust Incorporated” and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol “HR”. For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022. (c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. Final Purchase Price Allocation The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 18,359 $ 1,004,285 Buildings and improvements 6,960,418 (119,135) 6,841,283 Lease intangible assets (a) 831,920 1,839 833,759 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (102,535) $ 8,742,212 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 16,370 214,631 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (87,795) $ 11,089,391 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (8,909) 194,301 Total liabilities assumed $ 5,635,425 $ 13,844 $ 5,649,269 Net identifiable assets acquired $ 5,541,761 $ (101,639) $ 5,440,122 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 101,639 $ 247,043 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The cumulative measurement period adjustments recorded through June 30, 2023 are final and primarily resulted from updated valuations related to the Company’s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $101.6 million. Based on the final purchase price allocation of fair value, approximately $247.0 million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger. None of the goodwill recognized is expected to be deductible for tax purposes. Merger-related Costs The Company incurred Merger-related costs of $(2.0) million and $103.4 million, respectively, for the years ended December 31, 2023 and 2022, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consisted of legal, consulting, severance, and banking services and for the year ended December 31, 2023, including a refund of $17.8 million for transfer taxes paid during the year ended December 31, 2022.

Property Investments

Property Investments	12 Months Ended
	Dec. 31, 2023
Real Estate Investment Property, Net [Abstract]
Property Investments	Property Investments The Company invests in healthcare-related properties located throughout the United States. The Company provides management, leasing, development and redevelopment services, and capital for the construction of new facilities as well as for the acquisition of existing properties. The following table summarizes the Company’s consolidated investments at December 31, 2023. Dollars in thousands NUMBER OF PROPERTIES LAND BUILDINGS AND IMPROVEMENTS LEASE INTANGIBLES PERSONAL PROPERTY TOTAL ACCUMULATED DEPRECIATION Dallas, TX 43 $ 90,168 $ 1,004,810 $ 68,139 $ 550 $ 1,163,667 $ (221,375) Houston, TX 31 76,959 614,531 60,651 57 752,198 (97,793) Seattle, WA 29 64,295 631,438 9,921 715 706,369 (186,903) Denver, CO 33 76,698 501,994 43,268 610 622,570 (94,906) Charlotte, NC 32 35,465 463,461 26,971 110 526,007 (116,578) Phoenix, AZ 35 20,262 437,804 36,384 425 494,875 (59,449) Atlanta, GA 27 49,095 417,112 28,204 100 494,511 (79,569) Boston, MA 17 127,447 299,742 41,183 14 468,386 (37,569) Raleigh, NC 28 56,620 371,932 36,411 9 464,972 (38,879) Nashville, TN 13 43,347 397,192 10,206 7,427 458,172 (115,979) Los Angeles, CA 20 72,086 360,330 16,481 453 449,350 (145,875) Miami, FL 19 53,994 326,343 35,014 178 415,529 (74,470) Tampa, FL 19 31,121 351,879 27,438 33 410,471 (36,726) Indianapolis, IN 36 54,899 285,806 32,780 13 373,498 (42,273) Austin, TX 13 27,063 274,229 18,568 142 320,002 (55,891) New York, NY 14 64,402 170,304 26,430 — 261,136 (15,887) Chicago, IL 6 13,804 216,473 13,011 81 243,369 (39,671) Memphis, TN 11 13,901 189,941 4,211 322 208,375 (71,813) Honolulu, HI 6 9,527 188,772 6,319 169 204,787 (61,575) Hartford, CT 30 29,381 138,713 21,848 — 189,942 (15,883) Other (49 markets) 193 332,731 3,238,567 272,864 1,310 3,845,472 (617,789) 655 1,343,265 10,881,373 836,302 12,718 13,073,658 (2,226,853) Investment in financing receivables, net — — — — 122,602 — Financing lease right-of-use assets — — — — — 82,209 — Construction in progress — — — — — 60,727 — Land held for development — — — — — 59,871 — Total real estate investments 655 $ 1,343,265 $ 10,881,373 $ 836,302 $ 12,718 $ 13,399,067 $ (2,226,853)

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Leases	Leases Lessor Accounting Under ASC 842 The Company’s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the CPI. In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the years ended December 31, 2023 and 2022 was $1.3 billion and $907.5 million, respectively. Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2023 were as follows: In thousands 2024 $ 894,442 2025 801,973 2026 701,615 2027 582,028 2028 469,549 2029 and thereafter 1,579,010 $ 5,028,617 Revenue Concentrations The Company’s real estate portfolio is leased to a diverse tenant base. The Company did not have any customers that account for 10% or more of the Company's revenues for the years ended December 31, 2023, 2022 and 2021. Purchase Option Provisions Certain of the Company’s leases include purchase option provisions. The provisions vary by agreement but generally allow the lessee to purchase the property covered by the agreement at fair market value or an amount equal to the Company’s gross investment. The Company expects that the purchase price from its purchase options will be greater than its net investment in the properties at the time of potential exercise by the lessee. The Company had investments of approximately $111.1 million in six real estate properties as of December 31, 2023 that were subject to purchase options that were exercisable. Lessee Accounting Under ASC 842 As of December 31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. Contracts evaluated and treated as leases are those that convey the right to control the use of identified assets for a period of time in exchange for consideration. ASC 842 requires the recording of these leases based on the aggregate future cash flows, discounted utilizing the implicit rate in the lease, or, if not readily determinable, based upon the lessee's incremental borrowing rate, to which the Company utilizes market inputs that are both similar to the Company's credit profile and corresponding term of the leases. As of December 31, 2023, the Company had 232 properties totaling 16.9 million square feet that were held under ground leases. Some of the ground leases include fixed rent renewal terms and others have market rent renewal terms. The ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on the CPI. The Company had 75 prepaid ground leases as of December 31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $1.3 million, $1.1 million and $0.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. The Company’s future lease payments (primarily for its 157 non-prepaid ground leases) as of December 31, 2023 were as follows: In thousands OPERATING FINANCING 2024 $ 12,263 $ 2,182 2025 12,428 2,218 2026 12,516 2,254 2027 12,703 2,294 2028 12,822 2,326 2029 and thereafter 698,905 394,072 Total undiscounted lease payments $ 761,637 $ 405,346 Discount (531,923) (330,843) Lease liabilities $ 229,714 $ 74,503 The following table provides details of the Company's total lease expense for the years ended December 31, 2023 and 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 20,623 $ 12,699 Variable lease expense 8,979 4,529 Finance lease cost Amortization of right-of-use assets 1,564 1,288 Interest on lease liabilities 3,718 2,876 Total lease expense $ 34,884 $ 21,392 Other information Operating cash flows outflows related to operating leases $ 19,222 $ 12,816 Operating cash flows outflows related to financing leases $ 2,122 $ 1,838 Financing cash flows outflows related to financing leases $ 17 $ — Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ 53,765 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,758 $ 216,047 Weighted-average remaining lease term (excluding renewal options) - operating leases 45.8 47.5 Weighted-average remaining lease term (excluding renewal options) - finance leases 57.9 58.9 Weighted-average discount rate - operating leases 5.7 % 5.8 % Weighted-average discount rate - finance leases 5.0 % 5.0 %
Leases	Leases Lessor Accounting Under ASC 842 The Company’s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the CPI. In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the years ended December 31, 2023 and 2022 was $1.3 billion and $907.5 million, respectively. Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2023 were as follows: In thousands 2024 $ 894,442 2025 801,973 2026 701,615 2027 582,028 2028 469,549 2029 and thereafter 1,579,010 $ 5,028,617 Revenue Concentrations The Company’s real estate portfolio is leased to a diverse tenant base. The Company did not have any customers that account for 10% or more of the Company's revenues for the years ended December 31, 2023, 2022 and 2021. Purchase Option Provisions Certain of the Company’s leases include purchase option provisions. The provisions vary by agreement but generally allow the lessee to purchase the property covered by the agreement at fair market value or an amount equal to the Company’s gross investment. The Company expects that the purchase price from its purchase options will be greater than its net investment in the properties at the time of potential exercise by the lessee. The Company had investments of approximately $111.1 million in six real estate properties as of December 31, 2023 that were subject to purchase options that were exercisable. Lessee Accounting Under ASC 842 As of December 31, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. Contracts evaluated and treated as leases are those that convey the right to control the use of identified assets for a period of time in exchange for consideration. ASC 842 requires the recording of these leases based on the aggregate future cash flows, discounted utilizing the implicit rate in the lease, or, if not readily determinable, based upon the lessee's incremental borrowing rate, to which the Company utilizes market inputs that are both similar to the Company's credit profile and corresponding term of the leases. As of December 31, 2023, the Company had 232 properties totaling 16.9 million square feet that were held under ground leases. Some of the ground leases include fixed rent renewal terms and others have market rent renewal terms. The ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on the CPI. The Company had 75 prepaid ground leases as of December 31, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $1.3 million, $1.1 million and $0.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. The Company’s future lease payments (primarily for its 157 non-prepaid ground leases) as of December 31, 2023 were as follows: In thousands OPERATING FINANCING 2024 $ 12,263 $ 2,182 2025 12,428 2,218 2026 12,516 2,254 2027 12,703 2,294 2028 12,822 2,326 2029 and thereafter 698,905 394,072 Total undiscounted lease payments $ 761,637 $ 405,346 Discount (531,923) (330,843) Lease liabilities $ 229,714 $ 74,503 The following table provides details of the Company's total lease expense for the years ended December 31, 2023 and 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 20,623 $ 12,699 Variable lease expense 8,979 4,529 Finance lease cost Amortization of right-of-use assets 1,564 1,288 Interest on lease liabilities 3,718 2,876 Total lease expense $ 34,884 $ 21,392 Other information Operating cash flows outflows related to operating leases $ 19,222 $ 12,816 Operating cash flows outflows related to financing leases $ 2,122 $ 1,838 Financing cash flows outflows related to financing leases $ 17 $ — Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ 53,765 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,758 $ 216,047 Weighted-average remaining lease term (excluding renewal options) - operating leases 45.8 47.5 Weighted-average remaining lease term (excluding renewal options) - finance leases 57.9 58.9 Weighted-average discount rate - operating leases 5.7 % 5.8 % Weighted-average discount rate - finance leases 5.0 % 5.0 %

Acquisitions, Dispositions and

Acquisitions, Dispositions and Mortgage Repayments	12 Months Ended
	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions, Dispositions and Mortgage Repayments	Acquisitions, Dispositions and Mortgage Repayments 2023 Acquisition Activity The following table details the Company's real estate acquisition activity for the year ended December 31, 2023: Dollars in thousands DATE ACQUIRED PURCHASE PRICE MORTGAGE NOTES PAYABLE, NET CASH 1 REAL OTHER 2 SQUARE FOOTAGE Tampa, FL 3/10/23 $ 31,500 $ — $ 30,499 $ 30,596 $ (97) 115,867 Colorado Springs, CO 7/28/23 11,450 (5,284) 6,024 11,416 (108) 42,770 Total real estate acquisitions $ 42,950 $ (5,284) $ 36,523 $ 42,012 $ (205) 158,637 1. Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2. Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. In the second quarter of 2023, the Company entered into a joint venture agreement for the development of a medical office building in Scottsdale, Arizona. The Company holds a 90% interest in the joint venture and determined the arrangement meets the criteria to be consolidated. The joint venture acquired an $8.8 million land parcel to be developed with the Company contributing cash of $8.3 million. In the third quarter of 2023, the Company acquired the fee interest in a parcel of land previously held under a ground lease for $0.8 million and an additional interest in an operating property for $0.6 million. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2023 as of the acquisition date: ESTIMATED ESTIMATED Building $ 27.5 17.0 - 30.0 Tenant Improvements 3.4 5.1 - 5.9 Land 5.5 — Land Improvements 1.1 6.0 - 10.0 Intangibles At-market lease intangibles 4.5 5.1 - 5.9 Above-market lease intangibles (lessor) 0.2 1.8 - 4.9 Below-market lease intangibles (lessor) (0.2) 6.4 - 13.9 Mortgage notes payable assumed, including fair value adjustments (5.3) Other assets acquired 0.1 Accounts payable, accrued liabilities and other liabilities assumed (0.3) Total cash paid $ 36.5 Unconsolidated Joint Ventures As of December 31, 2023, the Company had a weighted average ownership interest of approximately 43% in 33 real estate properties held in unconsolidated joint ventures. The Company recognizes distributions from unconsolidated joint ventures utilizing the nature of distribution approach and classifies the distributions based on the nature of the underlying activity that generated the distribution. The distributions from unconsolidated joint ventures for the years ended December 31, 2023 and 2022 were classified as operating activities. The Company's investment in and loss recognized for the years ended December 31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: DECEMBER 31, Dollars in millions 2023 2022 Investments in unconsolidated joint ventures, beginning of period $ 327.2 $ 161.9 New investments during the period 3.8 167.9 Equity loss recognized during the period (1.7) (0.7) Owner distributions (17.8) (1.9) Investments in unconsolidated joint ventures, end of period $ 311.5 $ 327.2 2022 Acquisitions The following table details the Company's acquisitions, exclusive of the Merger, for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Dallas, TX 4 MOB 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 5 MOB 3/7/22 114,000 112,986 108,687 4,299 166,396 Atlanta, GA MOB 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO MOB 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 6 MOB 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA MOB 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX MOB 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA MOB 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK MOB 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 5 MOB 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa, FL 6 MOB 6/9/22 18,650 18,619 18,212 407 55,788 Seattle, WA MOB 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC MOB 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL MOB 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA MOB 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO MOB 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC MOB 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN MOB 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX MOB 9/29/22 5,450 5,449 5,572 (123) 15,000 Jacksonville, FL 4 MOB 10/12/22 3,600 3,530 3,609 (79) 6,200 Houston, TX MOB 11/21/22 5,500 5,469 5,513 (44) 28,369 Austin, TX 7 MOB 12/28/22 888 890 889 1 2,219 Denver, CO MOB 12/28/22 16,400 16,170 16,467 (297) 39,692 $ 403,578 $ 399,189 $ 386,818 $ 12,371 863,184 1 MOB = medical outpatient building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Represents a single-tenant property. 5 Includes three properties. 6 Includes two properties. 7 The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 71.4%. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Tenant Improvements 20.7 1.5 - 13.4 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 28.1 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2 Unconsolidated Joint Ventures The following table details the joint venture acquisitions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE San Francisco, CA 4 MOB 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 Los Angeles, CA 5 MOB 3/7/22 33,800 32,384 32,390 (6) 103,259 $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 MOB = medical outpatient building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties. 2023 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2023: Dollars in thousands Type 1 DATE DISPOSED SALE PRICE CLOSING ADJ COMPANY-FINANCED NOTES NET PROCEEDS NET REAL ESTATE OTHER (INCLUDING RECEIVABLES) 2 GAIN/(IMPAIR-MENT) SQUARE FOOTAGE Tampa/Miami, FL 3 MOB 1/12/23 $ 93,250 $ (5,875) $ — $ 87,375 $ 87,302 $ (888) $ 961 224,037 Dallas, TX 4 MOB 1/30/23 19,210 (141) — 19,069 18,986 43 40 36,691 St. Louis, MO MOB 2/10/23 350 (18) — 332 398 — (66) 6,500 Los Angeles, CA MOB 3/23/23 21,000 (526) — 20,474 20,610 52 (188) 37,165 Los Angeles, CA 5 MOB 3/30/23 75,000 (8,079) (45,000) 21,921 88,624 (803) (20,900) 147,078 Los Angeles, CA 6 LAND 5/12/23 3,300 (334) — 2,966 3,268 — (302) — Albany, NY MOB 6/30/23 10,000 (1,229) — 8,771 2,613 (1,040) 7,198 40,870 Houston, TX MOB 8/2/23 8,320 (285) — 8,035 4,567 194 3,274 57,170 Atlanta, GA MOB 8/22/23 25,140 (66) — 25,074 23,226 (536) 2,386 55,195 Dallas, TX INPATIENT 9/15/23 115,000 (1,504) — 113,496 64,183 6,094 43,219 161,264 Houston, TX MOB 9/18/23 250 (24) — 226 1,998 — (1,772) 52,040 Chicago, IL MOB 9/27/23 59,950 (870) — 59,080 74,710 (380) (15,250) 104,912 Evansville, IN 7 MOB 11/13/23 18,500 (63) — 18,437 17,807 (149) 779 260,520 Houston, TX HOSPITAL 12/1/23 4,100 (6) — 4,094 3,486 — 608 83,223 Charleston, SC 8 OFFICE 12/15/23 6,200 (401) — 5,799 3,415 — 2,384 15,014 Dallas, TX MOB 12/20/23 43,295 (764) — 42,531 33,882 (3,782) 12,431 77,827 Los Angeles, CA OFFICE 12/21/23 19,000 (1,311) — 17,689 17,787 — (98) 104,377 Tucson, AZ 9,10 MOB 12/22/23 43,230 (3,770) (6,000) 33,460 39,786 (26) (300) 215,471 Miami, FL MOB 12/22/23 18,250 (756) — 17,494 17,354 643 (503) 48,000 Sebring, FL MOB 12/27/23 9,500 (81) — 9,419 10,438 (512) (507) 38,949 Boston, MA MOB 12/28/23 117,197 (2,079) — 115,118 107,803 9,828 (2,513) 161,254 Jacksonville/Orlando/Miami, FL 11 SNF 12/29/23 77,000 (8,678) (7,700) 60,622 65,839 (294) 2,777 354,500 Total dispositions $ 787,042 $ (36,860) $ (58,700) $ 691,482 $ 708,082 $ 8,444 $ 33,658 2,282,057 1. MOB = medical outpatient building; SNF = skilled nursing facility. 2. Includes straight-line rent receivables, leasing commissions and lease inducements. 3. Includes two properties sold in two separate transactions to the same buyer on the same date. 4. The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property. 5. The Company entered into a mortgage loan agreement with the buyer for $45.0 million. 6. The Company sold a land parcel totaling 0.34 acres. 7. Includes five properties sold in three separate transactions to the same buyer on the same date. 8. The Company sold a corporate office in Charleston, SC that was 100% occupied by the Company. 9. Includes 12 properties sold in one transaction to the same buyer. 10. The Company entered into a mezzanine loan with the buyer for $6.0 million. 11. Includes three properties sold in one transaction to the same buyer. The Company entered into a separate note receivable for $7.7 million related to this sale. 2022 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Loveland, CO 3, 4 MOB 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 3 MOB 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 5, 11 MOB 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 7, 11 MOB 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 5, 9, 11 MOB 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 7, 10, 11 MOB 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 6, 12 MOB 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Dallas, TX 3 MOB 10/4/22 104,025 (5,883) 98,142 38,872 6,436 52,834 291,328 Houston, TX MOB 10/21/22 32,000 (280) 31,720 10,762 744 20,214 134,910 College Station, TX MOB 11/10/22 49,177 (3,755) 45,422 44,918 475 28 122,942 El Paso, TX MOB 12/22/22 55,326 (4,002) 51,324 56,427 (1,897) (3,205) 110,465 Atlanta, GA 8 MOB 12/22/22 91,243 (4,326) 86,917 109,051 235 (22,369) 348,416 St. Louis, MO MOB 12/28/22 18,000 (1,471) 16,529 18,340 4 (1,815) 69,394 $ 1,242,218 $ (45,666) $ 1,196,552 $ 939,363 $ 14,225 $ 242,964 3,069,124 1 MOB = medical outpatient building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties. 4 The Company deferred the tax gain through a 1031 exchange and reinvested the proceeds. 5 Includes four properties. 6 Includes five properties. 7 Includes six properties. 8 Includes nine properties. 9 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture with an unrelated third party that purchased these properties. 10 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture with an unrelated third party that purchased these properties. 11 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 12

Held for Sale

Held for Sale	12 Months Ended
	Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale	Held for Sale The Company had one property classified as assets held for sale as of December 31, 2023. The net real estate assets held for sale includes the impact of $5.9 million of impairment charges for the year ended December 31, 2023. The Company had one property classified as assets held for sale as of December 31, 2022, which was sold in the first quarter of 2023. The table below reflects the assets and liabilities classified as held for sale as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Balance Sheet data Land $ 1,850 $ 1,700 Buildings and improvements 6,779 15,164 Lease intangibles 1,017 1,986 9,646 18,850 Accumulated depreciation (913) — Real estate assets held for sale, net 8,733 18,850 Other assets, net 101 43 Assets held for sale, net $ 8,834 $ 18,893 Accounts payable and accrued liabilities $ 23 $ 282 Other liabilities 272 155 Liabilities of properties held for sale $ 295 $ 437

Impairment Charges

Impairment Charges	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Impairment Charges	Impairment Charges An asset is impaired when undiscounted cash flows expected to be generated by the asset are less than the carrying value of the asset. The Company must assess the potential for impairment of its long-lived assets, including real estate properties, whenever events occur or there is a change in circumstances, such as the sale of a property or the decision to sell a property, which indicate that the recorded value might not be fully recoverable. The Company recorded impairment charges on 31 properties sold and six additional properties associated with planned disposition activity for the year ended December 31, 2023, totaling $149.7 million. The Company recorded impairment charges on 12 properties sold and three additional properties associated with planned disposition activity for the year ended December 31, 2022, totaling $54.4 million. Both level 1 and level 3 fair value techniques were used to derive these impairment charges.

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022 are detailed in the table below: Dollars in thousands December 31, 2023 December 31, 2022 Real estate notes receivable, net $ 173,614 $ 99,643 Straight-line rent receivables 116,866 88,868 Prepaid assets 116,455 81,900 Above-market intangible assets, net 66,695 80,720 Accounts receivable, net 1 63,203 54,667 Additional long-lived assets, net 20,717 21,446 Interest rate swap assets 4,634 14,512 Investment in securities 2 6,011 6,011 Debt issuance costs, net 3,867 5,977 Project costs 6,187 4,337 Net investment in lease 2,112 1,828 Customer relationship intangible assets, net 1,066 1,120 Other 10,941 8,961 $ 592,368 $ 469,990 1 The amounts for December 31, 2023 and 2022 are net of allowance for doubtful accounts of $8.4 million and $4.0 million, respectively. The amount for December 31, 2022 includes $7,169 of other receivables, net. 2 This amount represents the value of the Company's preferred stock investment in a data analytics platform.

Intangible Assets and Liabiliti

Intangible Assets and Liabilities	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Liabilities	Intangible Assets and Liabilities The Company has several types of intangible assets and liabilities included in its Consolidated Balance Sheets, including goodwill, debt issuance costs, above-, below-, and at-market lease intangibles, and customer relationship intangibles. For additional details on the Company's debt issuance costs, see Note 10 to the Consolidated Financial Statements. The Company’s intangible assets and liabilities, including assets held for sale and certain debt issuance costs, as of December 31, 2023 and 2022 consisted of the following: GROSS BALANCE ACCUMULATED AMORTIZATION WEIGHTED AVG. BALANCE SHEET CLASSIFICATION Dollars in millions 2023 2022 2023 2022 Goodwill $ 250.5 $ 223.2 $ — $ — N/A Goodwill Credit facility debt issuance costs 6.9 6.9 3.1 0.9 1.9 Other assets, net Above-market lease intangibles (lessor) 98.0 91.5 31.3 10.7 5.3 Other assets, net Customer relationship intangibles (lessor) 2.1 2.1 1.1 1.0 19.6 Other assets, net Below-market lease intangibles (lessor) (112.5) (112.5) (35.7) (14.6) 5.8 Other liabilities At-market lease intangibles 837.3 1,067.4 301.7 188.3 4.0 Real estate properties $ 1,082.3 $ 1,278.6 $ 301.5 $ 186.3 4.3 For the years ended December 31, 2023 and 2022, the Company recognized approximately $214.8 million and $133.6 million of intangible amortization, respectively. The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2023: Dollars in millions FUTURE AMORTIZATION OF INTANGIBLES, NET 2024 $ 206.7 2025 109.1 2026 84.3 2027 53.0 2028 31.9

Notes and Bonds Payable

Notes and Bonds Payable	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Notes and Bonds Payable	Notes and Bonds Payable DECEMBER 31, MATURITY DATES CONTRACTUAL INTEREST RATES EFFECTIVE INTEREST RATES PRINCIPAL PAYMENTS INTEREST PAYMENTS Dollars in thousands 2023 2022 $1.5B Unsecured Credit Facility — 385,000 10/25 SOFR + 0.95% 6.24 % At maturity Monthly $350M Unsecured Term Loan 1 349,798 349,114 7/24 SOFR + 1.05% 6.30 % At maturity Monthly $200M Unsecured Term Loan 1 199,903 199,670 5/24 SOFR + 1.05% 6.30 % At maturity Monthly $150M Unsecured Term Loan 1 149,643 149,495 6/26 SOFR + 1.05% 6.30 % At maturity Monthly $300M Unsecured Term Loan 1 299,958 299,936 10/25 SOFR + 1.05% 6.30 % At maturity Monthly $200M Unsecured Term Loan 1 199,502 199,362 7/27 SOFR + 1.05% 6.30 % At maturity Monthly $300M Unsecured Term Loan 1 298,288 297,869 1/28 SOFR + 1.05% 6.30 % At maturity Monthly Senior Notes due 2025 1 249,484 249,115 5/25 3.88 % 4.12 % At maturity Semi-annual Senior Notes due 2026 1 579,017 571,587 8/26 3.50 % 4.94 % At maturity Semi-annual Senior Notes due 2027 1 483,727 479,553 7/27 3.75 % 4.76 % At maturity Semi-annual Senior Notes due 2028 1 297,429 296,852 1/28 3.63 % 3.85 % At maturity Semi-annual Senior Notes due 2030 1 575,443 565,402 2/30 3.10 % 5.30 % At maturity Semi-annual Senior Notes due 2030 1 296,780 296,385 3/30 2.40 % 2.72 % At maturity Semi-annual Senior Notes due 2031 1 295,832 295,547 3/31 2.05 % 2.25 % At maturity Semi-annual Senior Notes due 2031 1 649,521 632,693 3/31 2.00 % 5.13 % At maturity Semi-annual Mortgage notes payable 2 70,534 84,247 1/24-12/26 3.6%-4.77% 3.57%-6.88% Monthly Monthly $ 4,994,859 $ 5,351,827 1 Balances are shown net of discounts and unamortized issuance costs. 2 Balances are shown net of discounts and unamortized issuance costs and include premiums. The Company’s various debt agreements contain certain representations, warranties, and financial and other covenants customary in such loan agreements. Among other things, these provisions require the Company to maintain certain financial ratios and impose certain limits on the Company’s ability to incur indebtedness and create liens or encumbrances. As of December 31, 2023, the Company was in compliance with its financial covenant provisions under its various debt instruments. Senior Notes The following table reconciles the Company’s aggregate Senior notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Senior notes principal balance $ 3,699,285 $ 3,699,500 Unaccreted discount (265,852) (304,919) Debt issuance costs (6,200) (7,447) Senior notes carrying amount $ 3,427,233 $ 3,387,134 Term Loans The following table reconciles the Company’s aggregate term loan principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Term loan principal balances $ 1,500,000 $ 1,500,000 Debt issuance costs (2,908) (4,554) Term Loans carrying amount $ 1,497,092 $ 1,495,446 Mortgage Notes Payable The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Mortgage notes payable principal balance $ 70,752 $ 84,122 Unamortized premium 285 486 Unaccreted discount (237) (38) Debt issuance costs (266) (323) Mortgage notes payable carrying amount $ 70,534 $ 84,247 Mortgage Activity On July 28, 2023, the Company assumed a mortgage note payable of $5.6 million in connection with the acquisition of a 42,770 square foot property in Colorado Springs, Colorado. The note bears interest at a rate of 4.5% per annum and matures on April 1, 2026. On August 1, 2023, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 3.31% per annum with an outstanding principal of $9.8 million. The mortgage note encumbered a 66,984 square foot property in Marietta, Georgia. On December 1, 2023, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.51% per annum with an outstanding principal of $6.6 million. The mortgage note encumbered a 93,992 square foot property in Lakewood, Colorado. Subsequent Changes in Debt Structure On January 6, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.77% per annum with an outstanding principal of $11.3 million. The mortgage note encumbered a 63,012 square foot property in California . On February 1, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.12% per annum with an outstanding principal of $5.6 million. T he mortgage note encumbered a 40,324 squ are foot property in Georgia . The following table details the Company’s mortgage notes payable, with related collateral. ORIGINAL BALANCE EFFECTIVE INTEREST RATE 9 MATURITY COLLATERAL 10 PRINCIPAL AND INTEREST PAYMENTS 8 INVESTMENT IN COLLATERAL BALANCE Dollars in millions 2023 2023 2022 Life Insurance Co. 1 12.3 3.86 % 8/23 MOB Monthly/7-yr amort. — — 10.0 Life Insurance Co. 2 9.0 4.84 % 12/23 MOB,OFC Monthly/10-yr amort. — — 6.8 Life Insurance Co. 3 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 24.4 11.3 11.7 Life Insurance Co. 4 6.8 3.96 % 2/24 MOB Monthly/7-yr amort. 12.6 5.6 5.8 Financial Services 5 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.9 7.2 7.5 Life Insurance Co. 6 16.5 3.43 % 12/25 MOB,OFC Monthly/7-yr amort. 49.2 15.9 16.2 Financial Services 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 41.7 7.8 8.3 Life Insurance Co. 7 6.0 6.88 % 4/26 MOB Monthly/7-yr amort. 11.6 5.2 — Life Insurance Co. 19.2 4.08 % 12/26 MOB Monthly/10-yr amort. 45.7 17.5 17.9 $ 202.1 $ 70.5 $ 84.2 1 The Company repaid this loan in August 2023. The Company's unencumbered gross investment was $26.0 million at December 31, 2023. 2 The Company repaid this loan in December 2023. The Company's unencumbered gross investment was $24.5 million at December 31, 2023. 3 The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. 4 The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. 5 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 6 The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. 7 The unaccreted portion of the $0.3 million discount recorded on this note upon acquisition is included in the balance above. 8 Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). 9 The contractual interest rates for the seven outstanding mortgage notes ranged from 3.6% to 4.8% as of December 31, 2023. 10 MOB-Medical office building; OFC-Office Other Long-Term Debt Information Future maturities of the Company’s notes and bonds payable as of December 31, 2023, were as follows: Dollars in thousands PRINCIPAL MATURITIES NET ACCRETION/ AMORTIZATION 1 DEBT ISSUANCE COSTS 2 NOTES AND % 2024 $ 575,473 $ (41,050) $ (2,438) $ 531,985 10.7 % 2025 566,375 (43,163) (1,916) 521,296 10.4 % 2026 778,904 (41,837) (1,650) 735,417 14.7 % 2027 700,000 (36,192) (1,519) 662,289 13.3 % 2028 600,000 (35,179) (707) 564,114 11.3 % 2029 and thereafter 2,049,285 (68,382) (1,145) 1,979,758 39.6 % $ 5,270,037 $ (265,803) $ (9,375) $ 4,994,859 100.0 % 1 Includes discount accretion and premium amortization related to the Company’s Senior Notes and four mortgage notes payable. 2 Excludes approximate ly $3.9 million in debt issuance costs related to the Company's Unsecured Credit Facility included in other assets, net.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2023, 2022, and 2021, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income (loss) and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. On February 16, 2023, the Company entered into a swap transaction with a notional amount of $50.0 million and a fixed rate of 4.16%. The swap agreement has an effective date of March 1, 2023 and a termination date of June 1, 2026. On March 28, 2023, the Company entered into a swap transaction with a notional amount of $100.0 million and a fixed rate of 3.67%. The swap agreement has an effective date of April 3, 2023 and a termination date of June 1, 2026. On October 19, 2023, the Company entered into two swap transactions totaling $100.0 million. The notional amounts were $50.0 million each with fixed rates of 4.71% and 4.67%. The swap agreements have effective dates of November 1, 2023 and termination dates of June 1, 2027 and December 1, 2027, respectively. On October 23, 2023, the Company entered into two swap transactions totaling $100.0 million with an aggregate fixed rate of 4.73%. The swap agreements have effective dates of November 1, 2023 and termination dates of May 31, 2026. On November 9, 2023, the Company entered into a swap transaction totaling $75.0 million with a fixed rate of 4.54%. The swap agreement has an effective date of December 1, 2023 and a termination date of May 31, 2026. As of December 31, 2023, the Company had interest rate derivatives that were designated as cash flow hedges of interest rate risk. The table below presents the notional value and weighted average rates of the Company's derivative financial instruments as of December 31, 2023 and 2022: NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE EXPIRATION DECEMBER 31, 2023 EXPIRATION DECEMBER 31, 2022 January 2024 $ 200,000 1.21 % January 2023 $ 300,000 1.42 % May 2026 275,000 3.74 % January 2024 200,000 1.21 % June 2026 150,000 3.83 % May 2026 100,000 2.15 % December 2026 150,000 3.84 % December 2026 150,000 3.84 % June 2027 200,000 4.27 % June 2027 150,000 4.13 % December 2027 300,000 3.93 % December 2027 250,000 3.79 % $ 1,275,000 3.49 % $ 1,150,000 2.63 % Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheets as of December 31, 2023 and 2022. AS OF DECEMBER 31, 2023 AS OF DECEMBER 31, 2022 Dollars in thousands BALANCE SHEET LOCATION FAIR BALANCE SHEET LOCATION FAIR Interest rate swaps 2019 Other Assets $ 4,214 Other Assets $ 13,603 Interest rate swaps 2022 Other Assets 909 Interest rate swaps 2022 Other Liabilities (5,067) Other Liabilities (4,269) Interest rate swaps 2023 Other Assets 411 Interest rate swaps 2023 Other Liabilities (7,357) Total derivatives designated as hedging instruments $ (7,799) $ 10,243 Tabular Disclosure of the Effect of Fair Value and Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on Accumulated other comprehensive income (loss) as of December 31, 2023 and 2022 related to the Company's outstanding interest rate swaps. AMOUNT OF GAIN/(LOSS) RECOGNIZED AMOUNT OF (GAIN)/LOSS RECLASSIFIED Dollars in thousands 2023 2022 2023 2022 Interest rate swaps 2017 $ — $ 302 Interest expense $ — $ 118 Interest rate swaps 2018 — 616 Interest expense — 361 Interest rate swaps 2019 1,995 12,964 Interest expense (6,964) 563 Interest rate swaps 2022 4,583 (3,252) Interest expense (6,289) (109) Interest rate swaps 2023 (5,115) — Interest expense (1,829) — Settled treasury hedges — — Interest expense 426 426 Settled interest rate swaps — — Interest expense 168 168 $ 1,463 $ 10,630 Total interest expense $ (14,488) $ 1,527 The Company estimates that an additional $7.3 million will be reclassified from accumulated other comprehensive loss as a net decrease to interest expense over the next 12 months. Tabular Disclosure Offsetting Derivatives The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2023. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 4,625 $ — $ 4,625 $ (4,625) $ — $ — Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (12,424) $ — $ (12,424) $ 4,625 $ — $ (7,799) Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision where the Company could be declared in default on its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness. The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2023, 2022, and 2021 as follows: YEAR ENDED DECEMBER 31, 2023 2022 2021 Balance, beginning of year 380,589,894 150,457,433 139,487,375 Issuance of common stock 8,627 229,618,304 10,899,301 Conversion of OP units to common stock 190,544 — — Non-vested share-based awards, net of withheld shares and forfeitures 175,368 514,157 70,757 Balance, end of year 380,964,433 380,589,894 150,457,433 At-The-Market Equity Offering Program The Company has in place an ATM equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. The Company has equity distribution agreements with various sales agents with respect to the ATM offering program of common stock with an aggregate sales amount of up to $750.0 million. As of December 31, 2023, $750.0 million remained available for issuance under the current ATM offering program. Dividends Declared During 2023, the Company declared and paid common stock dividends aggregating $1.24 per share ($0.31 per share per quarter). On February 13, 2024, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on March 14, 2024, to stockholders of record on February 26 , 2024. Authorization to Repurchase Common Stock On May 31, 2023, the Company’s Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company’s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. The Company is not obligated under this authorization to repurchase any specific number of shares. This authorization supersedes all previous stock repurchase authorizations. As of the date of these Consolidated Financial Statements, the Company has not repurchased any shares of its common stock under this authorization. Accumulated Other Comprehensive (Loss) Income The following table represents the changes in accumulated other comprehensive income (loss) during the years ended December 31, 2023 and 2022: INTEREST RATE SWAPS Dollars in thousands 2023 2022 Beginning balance $ 2,140 $ (9,981) Other comprehensive income (loss) before reclassifications 1,434 1,531 Amounts reclassified from accumulated other comprehensive (loss) income (14,315) 10,590 Net current-period other comprehensive (loss) income (12,881) 12,121 Ending balance $ (10,741) $ 2,140 The following table represents the details regarding the reclassifications from accumulated other comprehensive income (loss) during the year ended December 31, 2023 (dollars in thousands): DETAILS ABOUT ACCUMULATED OTHER COMPREHENSIVE AMOUNT RECLASSIFIED AFFECTED LINE ITEM Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 594 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps (15,082) Interest Expense $ (14,488)

Stock and Other Incentive Plans

Stock and Other Incentive Plans	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock and Other Incentive Plans	Stock and Other Incentive Plans Stock Incentive Plan The Company's Incentive Plan permits the grant of incentive awards to its employees and directors in any of the following forms: options, stock appreciation rights, restricted stock, restricted or deferred stock units, performance awards, dividend equivalents, or other stock-based awards, including units in the OP. The Incentive Plan replaced the Legacy HR Incentive Plan as of the merger date. Unvested awards under the Legacy HR Incentive Plan were assumed according to their existing terms by the Company in connection with the Merger. As of the Merger date, 9,647,839 share-based awards were available for grant under the Incentive Plan. As of December 31, 2023 and 2022, the Company had share-based awards available for grant under the Incentive Plan of 8,102,861 and 9,432,388 shares, respectively. Non-vested shares issued to employees under the Incentive Plan are generally subject to fixed vesting periods varying from three $14.6 million , $13.9 million and $10.4 million, respectively. The following table represents expected amortization of the Company's non-vested shares issued as of December 31, 2023: Dollars in millions FUTURE AMORTIZATION 2024 $ 12.2 2025 9.7 2026 6.9 2027 2.1 2028 and thereafter 0.5 Total $ 31.4 Executive Incentive Plan The Compensation Committee has adopted an executive incentive plan pursuant to the Incentive Plan (the "Executive Incentive Plan") to provide specific award criteria with respect to incentive awards made under the Incentive Plan subject to the discretion of the Compensation Committee. Under the terms of the Executive Incentive Plan, the Company's named executive officers and certain other members of senior management may earn incentive awards in the form of cash, non-vested stock, restricted stock units ("RSUs"), and units in the OP ("OP Units"). For 2023, 2022 and 2021, compensation expense, included in general and administrative expense, resulting from the amortization of the Executive Incentive Plan non-vested share, RSU, and OP Unit grants to officers was approximately $9.0 million , $9.8 million, and $6.6 million, respectively. Details of equity awards that have been issued under this plan are as follows: • On January 4, 2023, the Company granted non-vested stock awards to its named executive officers, senior vice presidents, and first vice presidents with a grant date fair value of $4.1 million , which consisted of an aggregate of 205,264 shares with a ratable five-year vesting period, which will result in an annual compensation expense of $0.8 million for 2024, 2025, 2026 and 2027. • On January 4, 2023, the Company granted 165,174 RSUs to certain of its non-executive senior officers. These award are subject to a three-year performance period and if the performance criteria is met, the awards are then subject to two additional years with ratable vesting of 50% in year four and 50% in year five. The expense will be recognized on the straight-line basis over the five-year vesting period. ◦ Approximately 43% of the RSU awards are subject to two market performance conditions: relative and absolute total shareholder return ("TSR"). These components were valued using independent specialists utilizing a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions: Volatility 34.0 % Dividend Assumption Accrued Expected term in years 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 ◦ The remaining 57% of the RSU awards are subject to certain operating performance conditions. With respect to the operating performance conditions of these awards, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period. ◦ The combined weighted average grant date fair value of the January 2023 RSUs was $22.55 per share. LTIP Series C Units In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units were granted with three-year forward-looking performance targets, with a grant date fair value of $7.1 million, which consisted of an aggregate 627,547 LTIP-C units with a five-year vesting period. LTIP-C units are granted notionally at the maximum value of the award. • Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumption: Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 • The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions. With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period. • The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share. For 2023, compensation expense resulting from the amortization of LTIP-C units awarded to officers was approximately $1.2 million. Officer Incentive Program In the first quarter of 2023 the Company granted a performance-based award to certain non-executive officers totaling approximately $0.7 million, which was granted in the form of 33,438 non-vested shares. The shares have vesting periods ranging from three For 2023, 2022 and 2021, compensation expense resulting from the amortization of these non-vested share grants awarded to officers was approximately $0.6 million, $0.9 million, and $1.0 million, respectively. Salary Deferral Plan The Company's salary deferral plan allows certain of its officers to elect to defer up to 50% of their base salary in the form of non-vested shares subject to long-term vesting. The number of shares will be increased through a Company match depending on the length of the vesting period selected by the officer. The officer's vesting period choices are: three years for a 30% match; five years for a 50% match; and eight years for a 100% match. During 2023, 2022 and 2021, the Company issued 31,792 shares, 17,381 shares and 21,396 shares, respectively, to its officers through the salary deferral plan. For 2023, 2022 and 2021, compensation expense resulting from the amortization of non-vested share grants to officers was approximately $0.9 million for each year , respectively. Non-employee Directors Incentive Plan The Company grants non-vested share-based awards to its non-employee directors under the Incentive Plan. The directors’ awards typically have a one-year vesting period and are subject to forfeiture prior to such date upon termination of the director’s service, at no cost to the Company. For each of the years 2023, 2022 and 2021, compensation expense resulting from the amortization of non-vested share-based grants to directors was approximately $2.1 million , $1.5 million, and $1.2 million, respectively. • On June 5, 2023, the Company granted a non-vested stock award to six of its directors, with a grant date fair value of $0.7 million, which consisted of an aggregate of 42,768 non-vested shares, with a one-year vesting period. • On June 5, 2023, the Company also granted LTIP-D units in the OP to six of its directors, with a grant fair value of $1.1 million, which consisted of an aggregate of 57,868 non-vested units, with a one-year vesting period. The following table represents the summary of non-vested share-based awards (including restricted stock, RSUs, LTIP-C units and LTIP-D units) under the Incentive Plans and related information for the three years ended December 31, 2023: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Share-based awards, beginning of year 2,090,060 1,562,028 1,766,061 Granted 1 1,164,359 952,407 203,701 Vested (403,266) (418,949) (404,777) Change in awards based on performance assessment 2 (205,668) — — Forfeited (29,923) (5,426) (2,957) Share-based awards, end of year 2,615,562 2,090,060 1,562,028 Weighted-average grant date fair value of Share-based awards, beginning of year $ 30.35 $ 31.10 $ 30.51 Share-based awards granted during the year $ 18.70 $ 29.64 $ 30.86 Share-based awards vested during the year $ 28.38 $ 31.52 $ 28.38 Share-based awards change in performance assessment during the year $ 29.05 $ — $ — Stock-based awards forfeited during the year $ 31.16 $ 31.48 $ 33.04 Share-based awards, end of year $ 25.56 $ 30.35 $ 31.10 Grant date fair value of shares granted during the year $ 22,171 $ 28,225 $ 6,286 1 LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance period has been satisfied and the exact number of awards are determinable. 2 The Company's RSUs that are based on operating performance metrics are evaluated on the probability of those performance metrics being achieved. During 2023, the Company determined that the operating performance goals related to the RSUs issued in 2022 are not probable of being achieved and reversed all of the outstanding amortization expense for that grant. In addition, the Company lowered the probability of achieving the operating performance goals related to the RSUs issued in 2023. The vesting periods for the non-vested shares granted during 2023 ranged from one with a weighted-average amortization period remaining as of December 31, 2023 of approximately 4.8 years . During 2023, 2022 and 2021, the Company withheld 126,085 s hares, 137,892 shares and 129,987 shares, respectively, of common stock from its officers to pay estimated withholding taxes related to the vesting of shares. 401(k) Plan The Company maintains a 401(k) plan that allows eligible employees to defer salary, subject to certain limitations imposed by the Internal Revenue Code. The Company provides a matching contribution up to $2,800 per employee, subject to certain limitations. The Company’s matching contributions were approximately $1.5 million for the year ended December 31, 2023, $1.2 million for 2022 and $0.7 million for 2021. Employee Stock Purchase Plan The outstanding options relate only to the Legacy HR Employee Stock Purchase Plan, which was terminated in November 2022. No new options will be issued under the Legacy HR Employee Stock Purchase Plan and existing options will expire in March 2024. During the years ended December 31, 2022 and 2021, the Company recognized in general and administrative expenses approximately $0.4 million, and $0.4 million, respectively, of compensation expense related to the annual grant of options to its employees to purchase shares under the Legacy HR Employee Stock Purchase Plan. Cash received from employees upon exercising options under the Legacy HR Employee Stock Purchase Plan was approximately $0.2 million for the year ended December 31, 2023, $0.4 million for the year ended December 31, 2022, and $0.8 million for the year ended December 31, 2021. A summary of the Legacy HR Employee Stock Purchase Plan activity and related information for the three years ended December 31, 2023 is as follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Options outstanding, beginning of year 340,976 348,514 341,647 Granted — 255,960 253,200 Exercised (8,627) (20,246) (30,281) Forfeited (43,737) (102,619) (71,630) Expired (132,999) (140,633) (144,422) Options outstanding and exercisable, end of year 155,613 340,976 348,514 Weighted-average exercise price of Options outstanding, beginning of year $ 16.38 $ 25.38 $ 24.70 Options granted during the year $ — $ 26.89 $ 25.16 Options exercised during the year $ 15.07 $ 20.97 $ 25.03 Options forfeited during the year $ 15.50 $ 21.88 $ 25.45 Options expired during the year $ 16.43 $ 23.36 $ 24.17 Options outstanding, end of year $ 12.98 $ 16.38 $ 25.38 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ — $ 9.91 $ 9.05 Intrinsic value of options exercised during the year $ 23 $ 75 $ 165 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 401 $ 985 $ 1,997 Exercise prices of options outstanding (calculated as of December 31) $ 14.65 $ 16.38 $ 25.91 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.3 0.8 0.8 The fair values for these options were estimated at the date of grant using a Black-Scholes options pricing model with the weighted-average assumptions for the options granted during the period noted in the following table. The risk- free interest rate was based on the U.S. Treasury constant maturity-nominal two-year rate whose maturity is nearest to the date of the expiration of the latest option outstanding and exercisable; the expected dividend yield was based on the expected dividends of the current year as a percentage of the average stock price of the prior year; the expected life of each option was estimated using the historical exercise behavior of employees; expected volatility was based on historical volatility of the Company’s common stock; and expected forfeitures were based on historical forfeiture rates within the look-back period. 2023 2022 2021 Risk-free interest rates — % 0.73 % 0.13 % Expected dividend yields — % 3.97 % 4.11 % Expected life (in years) 0 1.44 1.43 Expected volatility — % 49.0 % 48.2 % Expected forfeiture rates — % 85 % 85 %

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. The Company used the treasury method to determine the dilution from the forward equity agreements during the period of time prior to settlement. The number of weighted-average shares outstanding used in the computation of earnings per common share for the year ended December 31, 2021 included the effect from the assumed issuance of 0.7 million shares of common stock pursuant to the settlement of the forward equity agreements at the contractual price, less the assumed repurchase of the common stock at the average market price using the proceeds of approximately $23.1 million, adjusted for costs to borrow. For the year ended December 31, 2021, 1,682 weighted-average incremental shares of common stock were excluded from the computation of weighted-average common shares outstanding - diluted, as the impact was anti-dilutive. As of and for the year ended December 31, 2022, these forward equity agreements settled and consequently, the Company did not have any remaining shares subject to unsettled forward sale agreements. The table below sets forth the computation of basic and diluted earnings per common share for the three years ended December 31, 2023. YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Weighted average common shares outstanding Weighted average common shares outstanding 380,850,967 254,296,810 144,411,835 Non-vested shares (1,923,096) (1,940,607) (1,774,669) Weighted average common shares outstanding - basic 378,927,871 252,356,203 142,637,166 Weighted average common shares outstanding - basic 378,927,871 252,356,203 142,637,166 Dilutive effect of forward equity shares — — — Dilutive effect of OP Units — 1,451,599 — Dilutive effect of employee stock purchase plan — 65,519 73,062 Weighted average common shares outstanding - diluted 378,927,871 253,873,321 142,710,228 Net (loss) income $ (282,083) $ 40,693 $ 66,659 Net loss attributable to non-controlling interest 3,822 204 — Net (loss) income attributable to common stockholders $ (278,261) $ 40,897 $ 66,659 Income allocated to participating securities (2,504) (2,437) (2,154) Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units (851) — — Net (loss) income applicable to common stockholders - basic $ (281,616) $ 38,460 $ 64,505 Net income attributable to OP Units — 81 — Net income applicable to common stockholders - diluted $ (281,616) $ 38,541 $ 64,505 Basic earnings per common share - net income $ (0.74) $ 0.15 $ 0.45 Diluted earnings per common share - net income $ (0.74) $ 0.15 $ 0.45 The effect of OP units convertible into shares totaling 4,023,679 shares and options to purchase 31,997 shares under the Company's Employee Stock Purchase Plan for the year ended December 31, 2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during the year.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Re/development Activity During the year ended December 31, 2023, the Company invested $69.1 million and $20.5 million toward active development and redevelopment of properties, respectively, and $22.6 million toward recently completed development and redevelopment projects. Tenant Improvements The Company may provide a tenant improvement allowance in new or renewal leases for the purpose of refurbishing or renovating tenant space. As of December 31, 2023, the Company had commitments of approximately $222.4 million that are expected to be spent on tenant improvements throughout the portfolio, excluding development properties currently under construction. Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company's land held for development included 17 parcels as of December 31, 2023 and 20 parcels as of December 31, 2022. The Company’s investments in land held for development totaled approximately $59.9 million as of December 31, 2023 and $74.3 million as of December 31, 2022. The current land held for development is located adjacent to certain of the Company's existing medical office buildings in Colorado, Connecticut, Florida, Georgia, Massachusetts, New York, Tennessee, Texas, and Washington. Security Deposits and Letters of Credit As of December 31, 2023, the Company held approximately $38.5 million in letters of credit and security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon these instruments if there are any defaults under the leases.

Other Data

Other Data	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Other Data	Other Data Taxable Income (unaudited) The Company has elected to be taxed as a REIT, as defined under the Internal Revenue Code. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders. As a REIT, the Company generally will not be subject to federal income tax on taxable income it distributes currently to its stockholders. Accordingly, no provision for federal income taxes has been made in the accompanying Consolidated Financial Statements. If the Company fails to qualify as a REIT for any taxable year, then it will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax, and may not be able to qualify as a REIT for four subsequent taxable years. Even if the Company qualifies as a REIT, it may be subject to certain state and local taxes on its income and property and to federal income and excise tax on its undistributed taxable income. Earnings and profits (as defined under the Internal Revenue Code), the current and accumulated amounts of which determine the taxability of distributions to stockholders, vary from net income attributable to common stockholders and taxable income because of different depreciation recovery periods, depreciation methods, and other items. While Legacy HR was considered the accounting acquirer in the Merger for GAAP purposes, Legacy HR’s separate tax existence ceased with the Merger and Legacy HTA continues as the tax successor. On a tax basis, the Company’s gross real estate assets totaled approximately $12.6 billion and $13.0 billion as of December 31, 2023 and 2022, respectively. As of December 31, 2021, gross real estate assets on a tax basis were $5.0 billion for Legacy HR and $8.2 billion for Legacy HTA, respectively. Characterization of Distributions (unaudited) Distributions in excess of earnings and profits generally constitute a return of capital. The following table gives the characterization of the distributions of the Company’s common stock for the three years ended December 31, 2023. For the three years ended December 31, 2023, there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. YEAR ENDED DECEMBER 31, 2023 2022 2021 PER SHARE PER SHARE PER SHARE Tax Treatment of Dividends Pre-Merger Healthcare Trust of America Ordinary income 1 $ — $ 0.5862 $ 0.7920 Return of capital — 4.0162 0.4930 Capital gain — 1.2216 — Common stock distributions $ — $ 5.8240 $ 1.2850 Tax Treatment of Dividends Pre-Merger Healthcare Realty Ordinary income 1 $ — $ 0.2655 $ 0.7500 Return of capital — 0.5555 0.3600 Capital gain — — 0.0964 Common stock distributions $ — $ 0.8210 $ 1.2064 Tax Treatment of Dividends Post-Merger Healthcare Realty Ordinary income 1 $ 0.5482 $ 0.0422 $ — Return of capital 0.5031 0.2889 — Capital gain 0.1887 0.0879 — Common stock distributions $ 1.2400 $ 0.4190 $ — 1 Reporting year ordinary income is also Code Section 199A eligible per the The Tax Cut and Jobs Act of 2017. State Income Taxes The Company must pay certain state income taxes, which are typically included in general and administrative expense on the Company’s Consolidated Statements of Operations. The State of Texas gross margins tax on gross receipts from operations is disclosed in the table below as an income tax. State income tax expense and state income tax payments for the three years ended December 31, 2023 are detailed in the table below: YEAR ENDED DECEMBER 31, Dollars in thousands 2023 2022 2021 State income tax expense Texas gross margins tax $ 1,206 $ 1,693 $ 564 Other 133 151 8 Total state income tax expense $ 1,339 $ 1,844 $ 572 State income tax payments, net of refunds and collections $ 1,324 $ 1,834 $ 560

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value. • Cash, cash equivalents and restricted cash - The carrying amount approximates fair value. • Borrowings under the Unsecured Credit Facility, Unsecured Term Loan due 2024 and Unsecured Term Loan due 2026 - The carrying amount approximates fair value because the borrowings are based on variable market interest rates. • Senior unsecured notes payable - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Mortgage notes payable - The fair value is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Interest rate swap agreements - Interest rate swap agreements are recorded in other assets on the Company's Consolidated Balance Sheets at fair value. Fair value, using level 2 inputs, is estimated by utilizing pricing models that consider forward yield curves and discount rates. The table below details the fair value and carrying values for our other financial instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1, 2 $ 4,994.9 $ 4,872.7 $ 5,351.8 $ 5,149.6 Real estate notes receivable 1 $ 173.6 $ 172.5 $ 99.6 $ 99.6 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. 2 Fair value for senior notes includes accrued interest as of December 31, 2023.

Related-Party Transactions

Related-Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related-Party Transactions	Related-Party Transactions In the ordinary course of conducting its business, the Company enters into agreements with affiliates in relation to the management and leasing of its real estate assets, including real estate assets owned through joint ventures.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	Schedule II – Valuation and Qualifying Accounts for the years ended December 31, 2023, 2022 and 2021 Dollars in thousands ADDITIONS AND DEDUCTIONS DESCRIPTION BALANCE CHARGED/(CREDITED) TO COSTS AND EXPENSES CHARGED UNCOLLECTIBLE ACCOUNTS WRITTEN-OFF BALANCE 2023 Accounts receivable allowance $ 3,954 $ 5,119 $ — $ 669 $ 8,404 2022 Accounts receivable allowance $ 654 $ 3,306 $ — $ 6 $ 3,954 2021 Accounts receivable allowance $ 604 $ 72 $ — $ 22 $ 654

Schedule III - Real Estate and

Schedule III - Real Estate and Accumulated Depreciation	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
Real Estate and Accumulated Depreciation	Schedule III – Real Estate and Accumulated Depreciation as of December 31, 2023 Dollars in thousands LAND 1 BUILDINGS, IMPROVEMENTS, LEASE INTANGIBLES AND CIP 1 MARKET NUMBER OF PROP. INITIAL INVESTMENT COST CAPITALIZED subsequent to acquisition TOTAL INITIAL INVESTMENT COST CAPITALIZED subsequent to acquisition TOTAL PERSONAL PROPERTY 2, 3, 5 1, 3 ACCUMULATED DEPRECIATION 4 ENCUMBRANCES 5 DATE CONST. Dallas, TX 43 $ 72,772 $ 17,396 $ 90,168 $ 925,170 $ 147,779 $ 1,072,949 $ 550 $ 1,163,667 $ 221,375 $ — 2003-2022 1974-2021 Houston, TX 31 63,942 13,018 76,960 642,626 32,557 675,183 57 752,200 97,793 — 2007-2022 1974-2018 Seattle, WA 29 59,412 4,883 64,295 551,328 90,031 641,359 715 706,369 186,903 — 2008-2022 1977-2018 Denver, CO 33 62,172 14,526 76,698 488,764 56,499 545,263 610 622,571 94,906 — 2007-2022 1942-2022 Charlotte, NC 32 28,119 7,345 35,464 451,251 39,182 490,433 110 526,007 116,578 — 2008-2020 1961-2018 Phoenix, AZ 35 12,205 8,057 20,262 447,753 26,436 474,189 425 494,876 59,449 — 2007-2017 1971-2008 Atlanta, GA 27 40,227 8,868 49,095 429,729 15,587 445,316 100 494,511 79,569 5,572 2007-2022 1974-2014 Boston, MA 17 117,857 9,590 127,447 336,670 4,255 340,925 14 468,386 37,569 — 2012-2016 1860-2011 Raleigh, NC 28 44,530 12,090 56,620 393,245 15,098 408,343 9 464,972 38,879 — 2010-2022 1977-2020 Nashville, TN 13 40,673 2,674 43,347 309,400 97,997 407,397 7,427 458,171 115,979 7,841 2004-2022 1976-2022 Los Angeles, CA 20 68,225 3,861 72,086 305,221 71,590 376,811 453 449,350 145,875 28,870 1994-2022 1964-2008 Miami, FL 19 47,092 6,902 53,994 325,814 35,543 361,357 178 415,529 74,470 — 1994-2021 1954-2021 Tampa, FL 19 23,491 7,631 31,122 363,588 15,729 379,317 33 410,472 36,726 — 1994-2023 1975-2015 Indianapolis, IN 36 45,914 8,985 54,899 308,044 10,542 318,586 13 373,498 42,273 — 2007-2019 1988-2013 Austin, TX 13 22,178 4,885 27,063 261,585 31,211 292,796 142 320,001 55,891 — 2007-2022 1972-2015 New York, NY 14 58,719 5,683 64,402 192,029 4,705 196,734 — 261,136 15,887 — 2014-2019 1920-2014 Chicago, IL 6 11,250 2,554 13,804 212,170 17,314 229,484 81 243,369 39,671 — 2004-2019 1970-2017 Memphis, TN 11 12,253 1,648 13,901 118,427 75,725 194,152 322 208,375 71,813 — 1999-2020 1982-2014 Honolulu, HI 6 8,314 1,213 9,527 147,422 47,669 195,091 169 204,787 61,575 — 2003-2014 1975-2010 Hartford, CT 30 24,167 5,214 29,381 159,178 1,383 160,561 — 189,942 15,883 — 2016-2019 1955-2017 Other (49 markets) 194 272,785 61,795 334,580 3,308,020 211,205 3,519,225 1,310 3,855,115 618,702 28,251 1993-2023 Total real estate 656 1,136,297 208,818 1,345,115 10,677,434 1,048,037 11,725,471 12,718 13,083,304 2,227,766 70,534 Land held for develop. — 59,871 — 59,871 — — — — 59,871 — Construction in Progress — — — — 60,727 — 60,727 — 60,727 — — Financing lease right-of-use assets — — — — — — — — 82,209 — — Investment in financing receivables, net — — — — — — — — 122,602 — — Total properties 656 1,196,168 $ 208,818 $ 1,404,986 $ 10,738,161 $ 1,048,037 $ 11,786,198 $ 12,718 $ 13,408,713 $ 2,227,766 $ 70,534 1 Includes one asset held for sale as of December 31, 2023 with gross real estate investments of approximately $9.6 million. 2 Total properties as of December 31, 2023 have an estimated aggregate total cost of $12.6 billion for federal income tax purposes. 3 Depreciation is provided for on a straight-line basis on buildings and improvements over 3.3 to 49.0 years, lease intangibles over 1.0 to 99.0 years, personal property over 3.0 to 20.0 years, and land improvements over 2.0 to 39.0 years. 4 Includes unamortized premium of $0.3 million and unaccreted discount of $0.2 million and debt issuance costs of $0.3 million as of December 31, 2023. 5 Includes merger of Healthcare Trust of America, Inc. buildings, acquired in 2022. 6 Rollforward of Total Property and Accumulated Depreciation, including assets held for sale, for the year ended December 31, 2023, 2022 and 2021 follows: YEAR ENDED DEC. 31, 2023 YEAR ENDED DEC. 31, 2022 YEAR ENDED DEC. 31, 2021 Dollars in thousands TOTAL PROPERTY ACCUMULATED DEPRECIATION TOTAL PROPERTY ACCUMULATED DEPRECIATION TOTAL PROPERTY ACCUMULATED DEPRECIATION Beginning balance $ 14,076,475 $ 1,645,271 $ 5,104,942 $ 1,338,743 $ 4,670,226 $ 1,249,679 Additions during the period Real estate acquired 54,024 2,322 9,780,070 241,285 374,912 7,668 Other improvements 28,521 668,069 219,783 205,703 103,035 191,875 Land held for development — 49,416 — 2,021 — Construction in progress 49,901 — 31,586 — 3,974 — Investment in financing receivable, net 2,366 — (66,509) — 186,745 — Financing lease right-of-use assets, net (1,616) — 52,249 — 11,909 — Corporate Properties — — 3,640 236 — — Retirement/dispositions Real estate (800,958) (87,896) (1,098,702) (140,696) (247,880) (110,479) Ending balance $ 13,408,713 $ 2,227,766 $ 14,076,475 $ 1,645,271 $ 5,104,942 $ 1,338,743

Schedule IV - Mortgage Loans on

Schedule IV - Mortgage Loans on Real Estate Assets	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
Schedule IV - Mortgage Loans on Real Estate Assets	Schedule IV – Mortgage Loans on Real Estate Assets as of December 31, 2023 Dollars in thousands Final Maturity Date Payment Terms Prior Liens Face Amount Carrying Amount Principal Amount of Loans Subject to Delinquent Principal or Interest Mortgage loan on real estate located in: Texas 7.00 % 7/1/2024 (1) $ — $ 31,150 $ 31,150 $ — North Carolina 8.00 % 12/22/2024 (2) — 6,000 5,796 Florida 6.00 % 2/27/2026 (3) — 32,156 32,112 — California 6.00 % 3/29/2026 (4) — 45,000 45,000 — Florida 9.00 % 12/28/2026 (5) — 7,700 7,700 — Mezzanine loans on real estate located in: Texas 8.00 % 6/24/2024 (6) — 54,119 45,856 54,119 Arizona 9.00 % 12/20/2026 (4) — 6,000 6,000 — Total real estate notes receivable $ — $ 182,125 $ 173,614 $ 54,119 1 Twelve-month prefunded interest reserve, with principal sum and interest on unpaid principal due on the maturity date. 2 Capitalized interest through maturity, with outstanding principal and accrued interest due on the maturity date. 3 Construction loan up to $65 million with periodic disbursements. Interest only payments due with principal and any unpaid interest due on the maturity date. 4 Interest only payments due with principal and any unpaid interest due on the maturity date. 5 Monthly installment payments of principal and interest in the amount of $152,069. 6 Interest only payments due with principal and any unpaid interest due on the maturity date. Loan on non-accrual status as of December 31, 2023. The following shows changes in the carrying amounts of mortgage loans on real estate assets during the years ended December 31, 2023, 2022 and 2021: Year Ended December 31, 2023 2022 2021 Balance as of the beginning of the year $ 99,643 $ — $ — Additions: Fair value real estate notes assumed — 74,819 — New real estate notes 58,700 23,325 — Draws on existing real estate notes 19,103 Capitalized interest — 1,499 — Accretion of fees and other items 1,364 — — Deductions: Collection of real estate loans — — — Deferred fees and other items — — — Allowance for credit loss $ (5,196) Balance as of the end of the year $ 173,614 $ 99,643 $ — All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are omitted because they are not required under the related instructions or are not applicable, or because the required information is shown in the consolidated financial statements or notes thereto.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss)	$ (278,261)	$ 40,897	$ 66,659

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Business Overview	Business Overview
Principles of Consolidation	Principles of Consolidation The Company’s Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). ASC Topic 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. The OP is 98.8% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2023, there were approximately 4.5 million , or 1.2%,
Variable Interest Entities	As of December 31, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.
Use of Estimates in the Consolidated Financial Statements	Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates and assumptions. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, collectability of tenant receivables, and fair value measurements, as applicable.
Segment Reporting	Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment.
Real Estate Properties	Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under ASC Topic 805, Business Combinations
Asset Impairment	Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualty losses, such as tornadoes and hurricanes. A property value is considered impaired only if management's estimate of current and projected (undiscounted and unleveraged) operating cash flows of the property is less than the net carrying value of the property. These estimates of future cash flows include only those that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the property based on its estimated remaining useful life. These estimates, including the useful life determination which can be affected by any potential sale of the property, are based on management's assumptions about its use of the property. Therefore, significant judgment is involved in estimating the current and projected cash flows. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.
Acquisitions of Real Estate Properties with In-Place Leases	Acquisitions of Real Estate Properties with In-Place Leases The Company's acquisitions of real estate properties typically do not meet the definition of a business and are accounted for as asset acquisitions. Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Land fair value is estimated by using an assessment of comparable transactions and other relevant data. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the estimated market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. These assets (above- or below-market lease, tenant improvement, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various relative asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-place leases. The at-market, in-place lease intangibles are amortized to depreciation and amortization expense over the weighted average remaining term of the leases, and customer relationship assets are amortized to depreciation amortization expense over terms applicable to each acquisition. Any goodwill recorded through a business combination would be reviewed for impairment at least annually and is not amortized.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, which are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature.
Fair Value of Derivative Financial Instruments	Fair Value of Derivative Financial Instruments Derivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The Company did not have any restricted cash for the years ended December 31, 2023 or 2022. Cash and cash equivalents are held in bank accounts and overnight investments. The Company maintains its bank deposits with large financial institutions in amounts that often exceed federally-insured limits. The Company has not experienced any losses in such accounts.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.
Contingent Liabilities	Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements.
Stock-based Compensation	Share-Based Compensation The Company has various employee and director share-based awards outstanding. These awards include non-vested common stock or other stock-based awards, including units in the OP, pursuant to the Company's Amended and Restated 2006 Incentive Plan, dated April 29, 2021 ("the Incentive Plan"). The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Operations on a straight-line basis over the
Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income
Revenue from Contracts with Customers (Topic 606)	Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. The Company’s two major types of revenue that are accounted for under Topic 606 are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time and the Company recognizes revenue monthly based on this principle. In most cases, the revenue is due and payable on a monthly basis. The Company had a receivable balance of $1.9 million and $1.5 million, and $1.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Management fee income includes property management services provided to third parties and certain of the properties in the Company's unconsolidated joint ventures and is generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Management fee income also includes amounts paid to the Company for its asset management services for certain of its unconsolidated joint ventures. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Operations. For lessors, the standard requires a lessor to classify leases as either sales-type, direct-financing or operating. A lease will be treated as a sale if it is considered to transfer control of the underlying asset to the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control. Otherwise, the lease is treated as an operating lease. Nonlease components, such as common area maintenance, are generally accounted for under Topic 606 and separated from the lease payments. However, the Company elected the lessor practical expedient allowing the Company to not separate these components when certain conditions are met. The combined component is accounted for under Accounting Standards Codification, Topic 842.
Federal Income Taxes	Federal Income Taxes The Company believes it has qualified to be taxed as a REIT and intends at all times to continue to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. As a REIT, the Company is generally not subject to federal income tax on net income it distributes to its stockholders, but may be subject to certain state and local taxes and fees. See Note 16 for further discussion. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income taxes on its taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which the qualification is lost unless the IRS grants it relief under certain statutory provisions. Such an event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. The Company conducts substantially all of its operations through the OP. As a partnership, the OP generally is not liable for federal income taxes. The income and loss from the operations of the OP is included in the tax returns of its partners, including the Company, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly, no provision for income tax has been made in the accompanying consolidated financial statements. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2023. Federal tax returns for the years 2020, 2021, 2022 and 2023 are currently subject to examination by taxing authorities.
State Income Taxes	State Income Taxes
Sales and Use Taxes	Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in rental income in the Company’s Consolidated Statements of Operations.
Assets Held for Sale	Assets Held for Sale
Earnings Per Share	Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a pro rata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholders.
Redeemable Non-Controlling Interests	Redeemable Non-Controlling Interests
Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income	Investments in Leases - Financing Receivables, Net Real Estate Notes Receivable Allowance for Credit Losses Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company’s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are Interest Income Income from Lease Finance Receivables The Company recognized the related income from two financing receivables totaling $8.3 million and $8.1 million, respectively, for the years ended December 31, 2023 and 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.
New Accounting Pronouncements	New Accounting Pronouncements On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting ( Topic 280) . Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of consolidated balance sheets	Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) DECEMBER 31, 2023 Assets: Net real estate investments $ 85,752 Cash and cash equivalents 2,144 Receivables and other assets 2,704 Total assets $ 90,600 Liabilities: Accrued expenses and other liabilities $ 17,835 Total equity 72,765 Total liabilities and equity $ 90,600
Schedule of variable interest entity	Therefore, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs: (dollars in thousands) ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 31,150 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,796 6,000 2022 Texas 2 Equity method 61,801 61,801 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in seven properties.
Schedule of assets' estimated useful life	Depreciation and amortization of real estate assets in place as of December 31, 2023, is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 2.0 to 39.0 years Buildings and improvements 3.3 to 49.0 years Lease intangibles (including ground lease intangibles) 1.0 to 99.0 years Personal property 3.0 to 20.0 years
Schedule of disaggregation of revenue	Below is a detail of the amounts by category: YEAR ENDED DECEMBER 31, in thousands 2023 2022 2021 Type of Revenue Parking income $ 9,903 $ 8,513 $ 7,859 Management fee income/other 1 7,548 5,193 2,432 $ 17,451 $ 13,706 $ 10,291
Schedule of rental income	The components of rental income are as follows: YEAR ENDED DECEMBER 31, in thousands 2023 2022 2021 Property operating income $ 1,270,508 $ 883,953 $ 514,533 Straight-line rent 38,676 23,498 5,801 Rental income $ 1,309,184 $ 907,451 $ 520,334
Schedule of notes receivable	See below for additional information regarding the Company's financing receivables as of December 31, 2023. (dollars in thousands) ORIGINATION DATE LOCATION INTEREST RATE CARRYING VALUE as of DECEMBER 31, 2023 May 2021 Poway, CA 5.71% $ 115,239 November 2021 Columbus, OH 6.48% 7,363 $ 122,602 (dollars in thousands) ORIGINATION MATURITY STATED INTEREST RATE MAXIMUM LOAN COMMITMENT OUTSTANDING as of ALLOWANCE FOR CREDIT LOSSES FAIR VALUE DISCOUNT AND FEES CARRYING VALUE as of DEC 31, 2023 Mezzanine loans Texas 6/24/2021 6/24/2024 8.00 % $ 54,119 $ 54,119 $ (5,196) $ (3,067) $ 45,856 Arizona 12/21/2023 12/20/2026 9.00 % 6,000 6,000 — — 6,000 60,119 60,119 (5,196) (3,067) 51,856 Mortgage loans Texas 6/30/2021 7/01/2024 7.00 % 31,150 31,150 — — 31,150 North Carolina 12/22/2021 12/22/2024 8.00 % 6,000 6,000 — (204) 5,796 Florida 5/17/2022 2/27/2026 6.00 % 65,000 32,156 — (44) 32,112 California 3/30/2023 3/29/2026 6.00 % 45,000 45,000 — — 45,000 Florida 12/28/2023 12/28/2026 9.00 % 7,700 7,700 — — 7,700 154,850 122,006 — (248) 121,758 $ 214,969 $ 182,125 $ (5,196) $ (3,315) $ 173,614
Schedule of company's allowance for credit losses	The following table summarizes the Company's allowance for credit losses on real estate notes receivable: Dollars in thousands TWELVE MONTHS ENDED DECEMBER 31, 2023 TWELVE MONTHS ENDED DECEMBER 31, 2022 Allowance for credit losses, beginning of period $ — $ — Credit loss reserves 5,196 — Allowance for credit losses, end of period $ 5,196 $ —

Merger with HTA (Tables)

Merger with HTA (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of consideration transferred	The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.
Schedule of fair values of the assets acquired and liabilities assumed	The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 18,359 $ 1,004,285 Buildings and improvements 6,960,418 (119,135) 6,841,283 Lease intangible assets (a) 831,920 1,839 833,759 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (102,535) $ 8,742,212 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 16,370 214,631 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (87,795) $ 11,089,391 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (8,909) 194,301 Total liabilities assumed $ 5,635,425 $ 13,844 $ 5,649,269 Net identifiable assets acquired $ 5,541,761 $ (101,639) $ 5,440,122 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 101,639 $ 247,043 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2023 as of the acquisition date: ESTIMATED ESTIMATED Building $ 27.5 17.0 - 30.0 Tenant Improvements 3.4 5.1 - 5.9 Land 5.5 — Land Improvements 1.1 6.0 - 10.0 Intangibles At-market lease intangibles 4.5 5.1 - 5.9 Above-market lease intangibles (lessor) 0.2 1.8 - 4.9 Below-market lease intangibles (lessor) (0.2) 6.4 - 13.9 Mortgage notes payable assumed, including fair value adjustments (5.3) Other assets acquired 0.1 Accounts payable, accrued liabilities and other liabilities assumed (0.3) Total cash paid $ 36.5 The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Tenant Improvements 20.7 1.5 - 13.4 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 28.1 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2

Property Investments (Tables)

Property Investments (Tables)	12 Months Ended
	Dec. 31, 2023
Real Estate Investment Property, Net [Abstract]
Schedule of property investment	The following table summarizes the Company’s consolidated investments at December 31, 2023. Dollars in thousands NUMBER OF PROPERTIES LAND BUILDINGS AND IMPROVEMENTS LEASE INTANGIBLES PERSONAL PROPERTY TOTAL ACCUMULATED DEPRECIATION Dallas, TX 43 $ 90,168 $ 1,004,810 $ 68,139 $ 550 $ 1,163,667 $ (221,375) Houston, TX 31 76,959 614,531 60,651 57 752,198 (97,793) Seattle, WA 29 64,295 631,438 9,921 715 706,369 (186,903) Denver, CO 33 76,698 501,994 43,268 610 622,570 (94,906) Charlotte, NC 32 35,465 463,461 26,971 110 526,007 (116,578) Phoenix, AZ 35 20,262 437,804 36,384 425 494,875 (59,449) Atlanta, GA 27 49,095 417,112 28,204 100 494,511 (79,569) Boston, MA 17 127,447 299,742 41,183 14 468,386 (37,569) Raleigh, NC 28 56,620 371,932 36,411 9 464,972 (38,879) Nashville, TN 13 43,347 397,192 10,206 7,427 458,172 (115,979) Los Angeles, CA 20 72,086 360,330 16,481 453 449,350 (145,875) Miami, FL 19 53,994 326,343 35,014 178 415,529 (74,470) Tampa, FL 19 31,121 351,879 27,438 33 410,471 (36,726) Indianapolis, IN 36 54,899 285,806 32,780 13 373,498 (42,273) Austin, TX 13 27,063 274,229 18,568 142 320,002 (55,891) New York, NY 14 64,402 170,304 26,430 — 261,136 (15,887) Chicago, IL 6 13,804 216,473 13,011 81 243,369 (39,671) Memphis, TN 11 13,901 189,941 4,211 322 208,375 (71,813) Honolulu, HI 6 9,527 188,772 6,319 169 204,787 (61,575) Hartford, CT 30 29,381 138,713 21,848 — 189,942 (15,883) Other (49 markets) 193 332,731 3,238,567 272,864 1,310 3,845,472 (617,789) 655 1,343,265 10,881,373 836,302 12,718 13,073,658 (2,226,853) Investment in financing receivables, net — — — — 122,602 — Financing lease right-of-use assets — — — — — 82,209 — Construction in progress — — — — — 60,727 — Land held for development — — — — — 59,871 — Total real estate investments 655 $ 1,343,265 $ 10,881,373 $ 836,302 $ 12,718 $ 13,399,067 $ (2,226,853)

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Schedule of future minimum lease payments due to the Company under property operating agreements	Future minimum lease payments under the non-cancelable operating leases, excluding any reimbursements, as of December 31, 2023 were as follows: In thousands 2024 $ 894,442 2025 801,973 2026 701,615 2027 582,028 2028 469,549 2029 and thereafter 1,579,010 $ 5,028,617
Schedule of future minimum operating lease payments	The Company’s future lease payments (primarily for its 157 non-prepaid ground leases) as of December 31, 2023 were as follows: In thousands OPERATING FINANCING 2024 $ 12,263 $ 2,182 2025 12,428 2,218 2026 12,516 2,254 2027 12,703 2,294 2028 12,822 2,326 2029 and thereafter 698,905 394,072 Total undiscounted lease payments $ 761,637 $ 405,346 Discount (531,923) (330,843) Lease liabilities $ 229,714 $ 74,503
Schedule of future minimum finance lease payments	The Company’s future lease payments (primarily for its 157 non-prepaid ground leases) as of December 31, 2023 were as follows: In thousands OPERATING FINANCING 2024 $ 12,263 $ 2,182 2025 12,428 2,218 2026 12,516 2,254 2027 12,703 2,294 2028 12,822 2,326 2029 and thereafter 698,905 394,072 Total undiscounted lease payments $ 761,637 $ 405,346 Discount (531,923) (330,843) Lease liabilities $ 229,714 $ 74,503
Schedule of lease cost	The following table provides details of the Company's total lease expense for the years ended December 31, 2023 and 2022: In thousands YEAR ENDED YEAR ENDED Operating lease cost Operating lease expense $ 20,623 $ 12,699 Variable lease expense 8,979 4,529 Finance lease cost Amortization of right-of-use assets 1,564 1,288 Interest on lease liabilities 3,718 2,876 Total lease expense $ 34,884 $ 21,392 Other information Operating cash flows outflows related to operating leases $ 19,222 $ 12,816 Operating cash flows outflows related to financing leases $ 2,122 $ 1,838 Financing cash flows outflows related to financing leases $ 17 $ — Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ 53,765 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,758 $ 216,047 Weighted-average remaining lease term (excluding renewal options) - operating leases 45.8 47.5 Weighted-average remaining lease term (excluding renewal options) - finance leases 57.9 58.9 Weighted-average discount rate - operating leases 5.7 % 5.8 % Weighted-average discount rate - finance leases 5.0 % 5.0 %

Acquisitions, Dispositions an_2

Acquisitions, Dispositions and Mortgage Repayments (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of acquisitions	The following table details the Company's real estate acquisition activity for the year ended December 31, 2023: Dollars in thousands DATE ACQUIRED PURCHASE PRICE MORTGAGE NOTES PAYABLE, NET CASH 1 REAL OTHER 2 SQUARE FOOTAGE Tampa, FL 3/10/23 $ 31,500 $ — $ 30,499 $ 30,596 $ (97) 115,867 Colorado Springs, CO 7/28/23 11,450 (5,284) 6,024 11,416 (108) 42,770 Total real estate acquisitions $ 42,950 $ (5,284) $ 36,523 $ 42,012 $ (205) 158,637 1. Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2. Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. The following table details the Company's acquisitions, exclusive of the Merger, for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE Dallas, TX 4 MOB 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 5 MOB 3/7/22 114,000 112,986 108,687 4,299 166,396 Atlanta, GA MOB 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO MOB 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 6 MOB 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA MOB 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX MOB 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA MOB 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK MOB 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 5 MOB 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa, FL 6 MOB 6/9/22 18,650 18,619 18,212 407 55,788 Seattle, WA MOB 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC MOB 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL MOB 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA MOB 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO MOB 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC MOB 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN MOB 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX MOB 9/29/22 5,450 5,449 5,572 (123) 15,000 Jacksonville, FL 4 MOB 10/12/22 3,600 3,530 3,609 (79) 6,200 Houston, TX MOB 11/21/22 5,500 5,469 5,513 (44) 28,369 Austin, TX 7 MOB 12/28/22 888 890 889 1 2,219 Denver, CO MOB 12/28/22 16,400 16,170 16,467 (297) 39,692 $ 403,578 $ 399,189 $ 386,818 $ 12,371 863,184 1 MOB = medical outpatient building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Represents a single-tenant property. 5 Includes three properties. 6 Includes two properties. 7 The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 71.4%.
Schedule of assets acquired and liabilities assumed	The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 18,359 $ 1,004,285 Buildings and improvements 6,960,418 (119,135) 6,841,283 Lease intangible assets (a) 831,920 1,839 833,759 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (102,535) $ 8,742,212 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 16,370 214,631 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (87,795) $ 11,089,391 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (8,909) 194,301 Total liabilities assumed $ 5,635,425 $ 13,844 $ 5,649,269 Net identifiable assets acquired $ 5,541,761 $ (101,639) $ 5,440,122 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 101,639 $ 247,043 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2023 as of the acquisition date: ESTIMATED ESTIMATED Building $ 27.5 17.0 - 30.0 Tenant Improvements 3.4 5.1 - 5.9 Land 5.5 — Land Improvements 1.1 6.0 - 10.0 Intangibles At-market lease intangibles 4.5 5.1 - 5.9 Above-market lease intangibles (lessor) 0.2 1.8 - 4.9 Below-market lease intangibles (lessor) (0.2) 6.4 - 13.9 Mortgage notes payable assumed, including fair value adjustments (5.3) Other assets acquired 0.1 Accounts payable, accrued liabilities and other liabilities assumed (0.3) Total cash paid $ 36.5 The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2022 as of the acquisition date: ESTIMATED ESTIMATED Building $ 250.7 14.0 - 38.0 Tenant Improvements 20.7 1.5 - 13.4 Land 76.1 — Land Improvements 11.2 5.0 - 14.0 Intangibles At-market lease intangibles 28.1 1.5 - 13.4 Above-market lease intangibles (lessor) 15.9 1.3 - 15.6 Below-market lease intangibles (lessor) (2.2) 1.3 - 19.3 Below-market lease intangibles (lessee) 1.2 13.1 Other assets acquired 0.4 Accounts payable, accrued liabilities and other liabilities assumed (2.9) Total cash paid $ 399.2
Schedule of equity method investments	The Company's investment in and loss recognized for the years ended December 31, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: DECEMBER 31, Dollars in millions 2023 2022 Investments in unconsolidated joint ventures, beginning of period $ 327.2 $ 161.9 New investments during the period 3.8 167.9 Equity loss recognized during the period (1.7) (0.7) Owner distributions (17.8) (1.9) Investments in unconsolidated joint ventures, end of period $ 311.5 $ 327.2
Schedule of Joint Venture Transactions	The following table details the joint venture acquisitions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE ACQUIRED PURCHASE PRICE CASH 2 REAL OTHER 3 SQUARE FOOTAGE San Francisco, CA 4 MOB 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 Los Angeles, CA 5 MOB 3/7/22 33,800 32,384 32,390 (6) 103,259 $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 MOB = medical outpatient building. 2 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties.
Schedule of dispositions	The following table details the Company's dispositions for the year ended December 31, 2023: Dollars in thousands Type 1 DATE DISPOSED SALE PRICE CLOSING ADJ COMPANY-FINANCED NOTES NET PROCEEDS NET REAL ESTATE OTHER (INCLUDING RECEIVABLES) 2 GAIN/(IMPAIR-MENT) SQUARE FOOTAGE Tampa/Miami, FL 3 MOB 1/12/23 $ 93,250 $ (5,875) $ — $ 87,375 $ 87,302 $ (888) $ 961 224,037 Dallas, TX 4 MOB 1/30/23 19,210 (141) — 19,069 18,986 43 40 36,691 St. Louis, MO MOB 2/10/23 350 (18) — 332 398 — (66) 6,500 Los Angeles, CA MOB 3/23/23 21,000 (526) — 20,474 20,610 52 (188) 37,165 Los Angeles, CA 5 MOB 3/30/23 75,000 (8,079) (45,000) 21,921 88,624 (803) (20,900) 147,078 Los Angeles, CA 6 LAND 5/12/23 3,300 (334) — 2,966 3,268 — (302) — Albany, NY MOB 6/30/23 10,000 (1,229) — 8,771 2,613 (1,040) 7,198 40,870 Houston, TX MOB 8/2/23 8,320 (285) — 8,035 4,567 194 3,274 57,170 Atlanta, GA MOB 8/22/23 25,140 (66) — 25,074 23,226 (536) 2,386 55,195 Dallas, TX INPATIENT 9/15/23 115,000 (1,504) — 113,496 64,183 6,094 43,219 161,264 Houston, TX MOB 9/18/23 250 (24) — 226 1,998 — (1,772) 52,040 Chicago, IL MOB 9/27/23 59,950 (870) — 59,080 74,710 (380) (15,250) 104,912 Evansville, IN 7 MOB 11/13/23 18,500 (63) — 18,437 17,807 (149) 779 260,520 Houston, TX HOSPITAL 12/1/23 4,100 (6) — 4,094 3,486 — 608 83,223 Charleston, SC 8 OFFICE 12/15/23 6,200 (401) — 5,799 3,415 — 2,384 15,014 Dallas, TX MOB 12/20/23 43,295 (764) — 42,531 33,882 (3,782) 12,431 77,827 Los Angeles, CA OFFICE 12/21/23 19,000 (1,311) — 17,689 17,787 — (98) 104,377 Tucson, AZ 9,10 MOB 12/22/23 43,230 (3,770) (6,000) 33,460 39,786 (26) (300) 215,471 Miami, FL MOB 12/22/23 18,250 (756) — 17,494 17,354 643 (503) 48,000 Sebring, FL MOB 12/27/23 9,500 (81) — 9,419 10,438 (512) (507) 38,949 Boston, MA MOB 12/28/23 117,197 (2,079) — 115,118 107,803 9,828 (2,513) 161,254 Jacksonville/Orlando/Miami, FL 11 SNF 12/29/23 77,000 (8,678) (7,700) 60,622 65,839 (294) 2,777 354,500 Total dispositions $ 787,042 $ (36,860) $ (58,700) $ 691,482 $ 708,082 $ 8,444 $ 33,658 2,282,057 1. MOB = medical outpatient building; SNF = skilled nursing facility. 2. Includes straight-line rent receivables, leasing commissions and lease inducements. 3. Includes two properties sold in two separate transactions to the same buyer on the same date. 4. The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property. 5. The Company entered into a mortgage loan agreement with the buyer for $45.0 million. 6. The Company sold a land parcel totaling 0.34 acres. 7. Includes five properties sold in three separate transactions to the same buyer on the same date. 8. The Company sold a corporate office in Charleston, SC that was 100% occupied by the Company. 9. Includes 12 properties sold in one transaction to the same buyer. 10. The Company entered into a mezzanine loan with the buyer for $6.0 million. 11. Includes three properties sold in one transaction to the same buyer. The Company entered into a separate note receivable for $7.7 million related to this sale. The following table details the Company's dispositions for the year ended December 31, 2022: Dollars in thousands TYPE 1 DATE DISPOSED SALES PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER 2 GAIN/ SQUARE FOOTAGE Loveland, CO 3, 4 MOB 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 3 MOB 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 5, 11 MOB 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 7, 11 MOB 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 5, 9, 11 MOB 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 7, 10, 11 MOB 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 6, 12 MOB 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Dallas, TX 3 MOB 10/4/22 104,025 (5,883) 98,142 38,872 6,436 52,834 291,328 Houston, TX MOB 10/21/22 32,000 (280) 31,720 10,762 744 20,214 134,910 College Station, TX MOB 11/10/22 49,177 (3,755) 45,422 44,918 475 28 122,942 El Paso, TX MOB 12/22/22 55,326 (4,002) 51,324 56,427 (1,897) (3,205) 110,465 Atlanta, GA 8 MOB 12/22/22 91,243 (4,326) 86,917 109,051 235 (22,369) 348,416 St. Louis, MO MOB 12/28/22 18,000 (1,471) 16,529 18,340 4 (1,815) 69,394 $ 1,242,218 $ (45,666) $ 1,196,552 $ 939,363 $ 14,225 $ 242,964 3,069,124 1 MOB = medical outpatient building 2 Includes straight-line rent receivables, leasing commissions and lease inducements. 3 Includes two properties. 4 The Company deferred the tax gain through a 1031 exchange and reinvested the proceeds. 5 Includes four properties. 6 Includes five properties. 7 Includes six properties. 8 Includes nine properties. 9 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture with an unrelated third party that purchased these properties. 10 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture with an unrelated third party that purchased these properties. 11 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 12

Held for Sale (Tables)

Held for Sale (Tables)	12 Months Ended
	Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Schedule of disposal groups, including discontinued operations, income statement, balance sheet and additional disclosures	The table below reflects the assets and liabilities classified as held for sale as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Balance Sheet data Land $ 1,850 $ 1,700 Buildings and improvements 6,779 15,164 Lease intangibles 1,017 1,986 9,646 18,850 Accumulated depreciation (913) — Real estate assets held for sale, net 8,733 18,850 Other assets, net 101 43 Assets held for sale, net $ 8,834 $ 18,893 Accounts payable and accrued liabilities $ 23 $ 282 Other liabilities 272 155 Liabilities of properties held for sale $ 295 $ 437

Other Assets (Tables)

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other assets	Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022 are detailed in the table below: Dollars in thousands December 31, 2023 December 31, 2022 Real estate notes receivable, net $ 173,614 $ 99,643 Straight-line rent receivables 116,866 88,868 Prepaid assets 116,455 81,900 Above-market intangible assets, net 66,695 80,720 Accounts receivable, net 1 63,203 54,667 Additional long-lived assets, net 20,717 21,446 Interest rate swap assets 4,634 14,512 Investment in securities 2 6,011 6,011 Debt issuance costs, net 3,867 5,977 Project costs 6,187 4,337 Net investment in lease 2,112 1,828 Customer relationship intangible assets, net 1,066 1,120 Other 10,941 8,961 $ 592,368 $ 469,990 1 The amounts for December 31, 2023 and 2022 are net of allowance for doubtful accounts of $8.4 million and $4.0 million, respectively. The amount for December 31, 2022 includes $7,169 of other receivables, net. 2 This amount represents the value of the Company's preferred stock investment in a data analytics platform.

Intangible Assets and Liabili_2

Intangible Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of finite lived intangible assets and liabilities	The Company’s intangible assets and liabilities, including assets held for sale and certain debt issuance costs, as of December 31, 2023 and 2022 consisted of the following: GROSS BALANCE ACCUMULATED AMORTIZATION WEIGHTED AVG. BALANCE SHEET CLASSIFICATION Dollars in millions 2023 2022 2023 2022 Goodwill $ 250.5 $ 223.2 $ — $ — N/A Goodwill Credit facility debt issuance costs 6.9 6.9 3.1 0.9 1.9 Other assets, net Above-market lease intangibles (lessor) 98.0 91.5 31.3 10.7 5.3 Other assets, net Customer relationship intangibles (lessor) 2.1 2.1 1.1 1.0 19.6 Other assets, net Below-market lease intangibles (lessor) (112.5) (112.5) (35.7) (14.6) 5.8 Other liabilities At-market lease intangibles 837.3 1,067.4 301.7 188.3 4.0 Real estate properties $ 1,082.3 $ 1,278.6 $ 301.5 $ 186.3 4.3
Schedule of expected net future amortization expense	The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2023: Dollars in millions FUTURE AMORTIZATION OF INTANGIBLES, NET 2024 $ 206.7 2025 109.1 2026 84.3 2027 53.0 2028 31.9

Notes and Bonds Payable (Tables

Notes and Bonds Payable (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Instrument [Line Items]
Schedule of debt	DECEMBER 31, MATURITY DATES CONTRACTUAL INTEREST RATES EFFECTIVE INTEREST RATES PRINCIPAL PAYMENTS INTEREST PAYMENTS Dollars in thousands 2023 2022 $1.5B Unsecured Credit Facility — 385,000 10/25 SOFR + 0.95% 6.24 % At maturity Monthly $350M Unsecured Term Loan 1 349,798 349,114 7/24 SOFR + 1.05% 6.30 % At maturity Monthly $200M Unsecured Term Loan 1 199,903 199,670 5/24 SOFR + 1.05% 6.30 % At maturity Monthly $150M Unsecured Term Loan 1 149,643 149,495 6/26 SOFR + 1.05% 6.30 % At maturity Monthly $300M Unsecured Term Loan 1 299,958 299,936 10/25 SOFR + 1.05% 6.30 % At maturity Monthly $200M Unsecured Term Loan 1 199,502 199,362 7/27 SOFR + 1.05% 6.30 % At maturity Monthly $300M Unsecured Term Loan 1 298,288 297,869 1/28 SOFR + 1.05% 6.30 % At maturity Monthly Senior Notes due 2025 1 249,484 249,115 5/25 3.88 % 4.12 % At maturity Semi-annual Senior Notes due 2026 1 579,017 571,587 8/26 3.50 % 4.94 % At maturity Semi-annual Senior Notes due 2027 1 483,727 479,553 7/27 3.75 % 4.76 % At maturity Semi-annual Senior Notes due 2028 1 297,429 296,852 1/28 3.63 % 3.85 % At maturity Semi-annual Senior Notes due 2030 1 575,443 565,402 2/30 3.10 % 5.30 % At maturity Semi-annual Senior Notes due 2030 1 296,780 296,385 3/30 2.40 % 2.72 % At maturity Semi-annual Senior Notes due 2031 1 295,832 295,547 3/31 2.05 % 2.25 % At maturity Semi-annual Senior Notes due 2031 1 649,521 632,693 3/31 2.00 % 5.13 % At maturity Semi-annual Mortgage notes payable 2 70,534 84,247 1/24-12/26 3.6%-4.77% 3.57%-6.88% Monthly Monthly $ 4,994,859 $ 5,351,827 1 Balances are shown net of discounts and unamortized issuance costs. 2 Balances are shown net of discounts and unamortized issuance costs and include premiums.
Schedule of mortgage notes payable	The following table details the Company’s mortgage notes payable, with related collateral. ORIGINAL BALANCE EFFECTIVE INTEREST RATE 9 MATURITY COLLATERAL 10 PRINCIPAL AND INTEREST PAYMENTS 8 INVESTMENT IN COLLATERAL BALANCE Dollars in millions 2023 2023 2022 Life Insurance Co. 1 12.3 3.86 % 8/23 MOB Monthly/7-yr amort. — — 10.0 Life Insurance Co. 2 9.0 4.84 % 12/23 MOB,OFC Monthly/10-yr amort. — — 6.8 Life Insurance Co. 3 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 24.4 11.3 11.7 Life Insurance Co. 4 6.8 3.96 % 2/24 MOB Monthly/7-yr amort. 12.6 5.6 5.8 Financial Services 5 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.9 7.2 7.5 Life Insurance Co. 6 16.5 3.43 % 12/25 MOB,OFC Monthly/7-yr amort. 49.2 15.9 16.2 Financial Services 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 41.7 7.8 8.3 Life Insurance Co. 7 6.0 6.88 % 4/26 MOB Monthly/7-yr amort. 11.6 5.2 — Life Insurance Co. 19.2 4.08 % 12/26 MOB Monthly/10-yr amort. 45.7 17.5 17.9 $ 202.1 $ 70.5 $ 84.2 1 The Company repaid this loan in August 2023. The Company's unencumbered gross investment was $26.0 million at December 31, 2023. 2 The Company repaid this loan in December 2023. The Company's unencumbered gross investment was $24.5 million at December 31, 2023. 3 The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. 4 The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. 5 The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. 6 The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. 7 The unaccreted portion of the $0.3 million discount recorded on this note upon acquisition is included in the balance above. 8 Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). 9 The contractual interest rates for the seven outstanding mortgage notes ranged from 3.6% to 4.8% as of December 31, 2023. 10 MOB-Medical office building; OFC-Office
Schedule of future contractual maturities of the company's notes and bonds payable	Future maturities of the Company’s notes and bonds payable as of December 31, 2023, were as follows: Dollars in thousands PRINCIPAL MATURITIES NET ACCRETION/ AMORTIZATION 1 DEBT ISSUANCE COSTS 2 NOTES AND % 2024 $ 575,473 $ (41,050) $ (2,438) $ 531,985 10.7 % 2025 566,375 (43,163) (1,916) 521,296 10.4 % 2026 778,904 (41,837) (1,650) 735,417 14.7 % 2027 700,000 (36,192) (1,519) 662,289 13.3 % 2028 600,000 (35,179) (707) 564,114 11.3 % 2029 and thereafter 2,049,285 (68,382) (1,145) 1,979,758 39.6 % $ 5,270,037 $ (265,803) $ (9,375) $ 4,994,859 100.0 % 1 Includes discount accretion and premium amortization related to the Company’s Senior Notes and four mortgage notes payable. 2 Excludes approximate ly $3.9 million in debt issuance costs related to the Company's Unsecured Credit Facility included in other assets, net.
Senior Notes
Debt Instrument [Line Items]
Schedule of senior notes assumed with the merger	The following table reconciles the Company’s aggregate Senior notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Senior notes principal balance $ 3,699,285 $ 3,699,500 Unaccreted discount (265,852) (304,919) Debt issuance costs (6,200) (7,447) Senior notes carrying amount $ 3,427,233 $ 3,387,134
Term Loan Net | Term Loan
Debt Instrument [Line Items]
Schedule of debt	The following table reconciles the Company’s aggregate term loan principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Term loan principal balances $ 1,500,000 $ 1,500,000 Debt issuance costs (2,908) (4,554) Term Loans carrying amount $ 1,497,092 $ 1,495,446
Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Schedule of debt	The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. DECEMBER 31, Dollars in thousands 2023 2022 Mortgage notes payable principal balance $ 70,752 $ 84,122 Unamortized premium 285 486 Unaccreted discount (237) (38) Debt issuance costs (266) (323) Mortgage notes payable carrying amount $ 70,534 $ 84,247

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of cash flow hedges included in accumulated other comprehensive income (loss)	As of December 31, 2023, the Company had interest rate derivatives that were designated as cash flow hedges of interest rate risk. The table below presents the notional value and weighted average rates of the Company's derivative financial instruments as of December 31, 2023 and 2022: NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE NOTIONAL VALUE AS OF WEIGHTED AVERAGE RATE EXPIRATION DECEMBER 31, 2023 EXPIRATION DECEMBER 31, 2022 January 2024 $ 200,000 1.21 % January 2023 $ 300,000 1.42 % May 2026 275,000 3.74 % January 2024 200,000 1.21 % June 2026 150,000 3.83 % May 2026 100,000 2.15 % December 2026 150,000 3.84 % December 2026 150,000 3.84 % June 2027 200,000 4.27 % June 2027 150,000 4.13 % December 2027 300,000 3.93 % December 2027 250,000 3.79 % $ 1,275,000 3.49 % $ 1,150,000 2.63 % Tabular Disclosure of the Effect of Fair Value and Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on Accumulated other comprehensive income (loss) as of December 31, 2023 and 2022 related to the Company's outstanding interest rate swaps. AMOUNT OF GAIN/(LOSS) RECOGNIZED AMOUNT OF (GAIN)/LOSS RECLASSIFIED Dollars in thousands 2023 2022 2023 2022 Interest rate swaps 2017 $ — $ 302 Interest expense $ — $ 118 Interest rate swaps 2018 — 616 Interest expense — 361 Interest rate swaps 2019 1,995 12,964 Interest expense (6,964) 563 Interest rate swaps 2022 4,583 (3,252) Interest expense (6,289) (109) Interest rate swaps 2023 (5,115) — Interest expense (1,829) — Settled treasury hedges — — Interest expense 426 426 Settled interest rate swaps — — Interest expense 168 168 $ 1,463 $ 10,630 Total interest expense $ (14,488) $ 1,527
Schedule of derivative instruments in statement of financial position, fair value	The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheets as of December 31, 2023 and 2022. AS OF DECEMBER 31, 2023 AS OF DECEMBER 31, 2022 Dollars in thousands BALANCE SHEET LOCATION FAIR BALANCE SHEET LOCATION FAIR Interest rate swaps 2019 Other Assets $ 4,214 Other Assets $ 13,603 Interest rate swaps 2022 Other Assets 909 Interest rate swaps 2022 Other Liabilities (5,067) Other Liabilities (4,269) Interest rate swaps 2023 Other Assets 411 Interest rate swaps 2023 Other Liabilities (7,357) Total derivatives designated as hedging instruments $ (7,799) $ 10,243
Schedule of offsetting assets	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2023. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 4,625 $ — $ 4,625 $ (4,625) $ — $ — Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (12,424) $ — $ (12,424) $ 4,625 $ — $ (7,799)
Schedule of offsetting liabilities	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of December 31, 2023. The net amounts of derivative liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative liabilities are presented on the Company's Consolidated Balance Sheets Offsetting of Derivative Assets GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF ASSETS GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ 4,625 $ — $ 4,625 $ (4,625) $ — $ — Offsetting of Derivative Liabilities GROSS AMOUNTS GROSS AMOUNTS OFFSET NET AMOUNTS OF LIABILITIES GROSS AMOUNTS NOT OFFSET FINANCIAL INSTRUMENTS CASH NET Derivatives $ (12,424) $ — $ (12,424) $ 4,625 $ — $ (7,799)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Schedule of reconciliation of the beginning and ending common stock outstanding	The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2023, 2022, and 2021 as follows: YEAR ENDED DECEMBER 31, 2023 2022 2021 Balance, beginning of year 380,589,894 150,457,433 139,487,375 Issuance of common stock 8,627 229,618,304 10,899,301 Conversion of OP units to common stock 190,544 — — Non-vested share-based awards, net of withheld shares and forfeitures 175,368 514,157 70,757 Balance, end of year 380,964,433 380,589,894 150,457,433
Schedule of reconciliation of beginning and ending balances of accumulated other comprehensive income (loss)	The following table represents the changes in accumulated other comprehensive income (loss) during the years ended December 31, 2023 and 2022: INTEREST RATE SWAPS Dollars in thousands 2023 2022 Beginning balance $ 2,140 $ (9,981) Other comprehensive income (loss) before reclassifications 1,434 1,531 Amounts reclassified from accumulated other comprehensive (loss) income (14,315) 10,590 Net current-period other comprehensive (loss) income (12,881) 12,121 Ending balance $ (10,741) $ 2,140
Schedule of reclassifications out of accumulated other comprehensive income (loss)	The following table represents the details regarding the reclassifications from accumulated other comprehensive income (loss) during the year ended December 31, 2023 (dollars in thousands): DETAILS ABOUT ACCUMULATED OTHER COMPREHENSIVE AMOUNT RECLASSIFIED AFFECTED LINE ITEM Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 594 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps (15,082) Interest Expense $ (14,488)

Stock and Other Incentive Pla_2

Stock and Other Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of unrecognized compensation cost, nonvested awards	The following table represents expected amortization of the Company's non-vested shares issued as of December 31, 2023: Dollars in millions FUTURE AMORTIZATION 2024 $ 12.2 2025 9.7 2026 6.9 2027 2.1 2028 and thereafter 0.5 Total $ 31.4
Schedule of other than stock options, valuation assumptions	a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions: Volatility 34.0 % Dividend Assumption Accrued Expected term in years 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21
Schedule of the activity under the incentive plans the previous directors' plan	The following table represents the summary of non-vested share-based awards (including restricted stock, RSUs, LTIP-C units and LTIP-D units) under the Incentive Plans and related information for the three years ended December 31, 2023: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Share-based awards, beginning of year 2,090,060 1,562,028 1,766,061 Granted 1 1,164,359 952,407 203,701 Vested (403,266) (418,949) (404,777) Change in awards based on performance assessment 2 (205,668) — — Forfeited (29,923) (5,426) (2,957) Share-based awards, end of year 2,615,562 2,090,060 1,562,028 Weighted-average grant date fair value of Share-based awards, beginning of year $ 30.35 $ 31.10 $ 30.51 Share-based awards granted during the year $ 18.70 $ 29.64 $ 30.86 Share-based awards vested during the year $ 28.38 $ 31.52 $ 28.38 Share-based awards change in performance assessment during the year $ 29.05 $ — $ — Stock-based awards forfeited during the year $ 31.16 $ 31.48 $ 33.04 Share-based awards, end of year $ 25.56 $ 30.35 $ 31.10 Grant date fair value of shares granted during the year $ 22,171 $ 28,225 $ 6,286 1 LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance period has been satisfied and the exact number of awards are determinable. 2 The Company's RSUs that are based on operating performance metrics are evaluated on the probability of those performance metrics being achieved. During 2023, the Company determined that the operating performance goals related to the RSUs issued in 2022 are not probable of being achieved and reversed all of the outstanding amortization expense for that grant. In addition, the Company lowered the probability of achieving the operating performance goals related to the RSUs issued in 2023.
Schedule of the employee stock purchase plan activity	A summary of the Legacy HR Employee Stock Purchase Plan activity and related information for the three years ended December 31, 2023 is as follows: YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Options outstanding, beginning of year 340,976 348,514 341,647 Granted — 255,960 253,200 Exercised (8,627) (20,246) (30,281) Forfeited (43,737) (102,619) (71,630) Expired (132,999) (140,633) (144,422) Options outstanding and exercisable, end of year 155,613 340,976 348,514 Weighted-average exercise price of Options outstanding, beginning of year $ 16.38 $ 25.38 $ 24.70 Options granted during the year $ — $ 26.89 $ 25.16 Options exercised during the year $ 15.07 $ 20.97 $ 25.03 Options forfeited during the year $ 15.50 $ 21.88 $ 25.45 Options expired during the year $ 16.43 $ 23.36 $ 24.17 Options outstanding, end of year $ 12.98 $ 16.38 $ 25.38 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ — $ 9.91 $ 9.05 Intrinsic value of options exercised during the year $ 23 $ 75 $ 165 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 401 $ 985 $ 1,997 Exercise prices of options outstanding (calculated as of December 31) $ 14.65 $ 16.38 $ 25.91 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.3 0.8 0.8
Schedule of stock options, valuation assumptions	2023 2022 2021 Risk-free interest rates — % 0.73 % 0.13 % Expected dividend yields — % 3.97 % 4.11 % Expected life (in years) 0 1.44 1.43 Expected volatility — % 49.0 % 48.2 % Expected forfeiture rates — % 85 % 85 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings per Common Share	The table below sets forth the computation of basic and diluted earnings per common share for the three years ended December 31, 2023. YEAR ENDED DECEMBER 31, Dollars in thousands, except per share data 2023 2022 2021 Weighted average common shares outstanding Weighted average common shares outstanding 380,850,967 254,296,810 144,411,835 Non-vested shares (1,923,096) (1,940,607) (1,774,669) Weighted average common shares outstanding - basic 378,927,871 252,356,203 142,637,166 Weighted average common shares outstanding - basic 378,927,871 252,356,203 142,637,166 Dilutive effect of forward equity shares — — — Dilutive effect of OP Units — 1,451,599 — Dilutive effect of employee stock purchase plan — 65,519 73,062 Weighted average common shares outstanding - diluted 378,927,871 253,873,321 142,710,228 Net (loss) income $ (282,083) $ 40,693 $ 66,659 Net loss attributable to non-controlling interest 3,822 204 — Net (loss) income attributable to common stockholders $ (278,261) $ 40,897 $ 66,659 Income allocated to participating securities (2,504) (2,437) (2,154) Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units (851) — — Net (loss) income applicable to common stockholders - basic $ (281,616) $ 38,460 $ 64,505 Net income attributable to OP Units — 81 — Net income applicable to common stockholders - diluted $ (281,616) $ 38,541 $ 64,505 Basic earnings per common share - net income $ (0.74) $ 0.15 $ 0.45 Diluted earnings per common share - net income $ (0.74) $ 0.15 $ 0.45

Other Data (Tables)

Other Data (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of characterization of distributions on common stock	For the three years ended December 31, 2023, there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. YEAR ENDED DECEMBER 31, 2023 2022 2021 PER SHARE PER SHARE PER SHARE Tax Treatment of Dividends Pre-Merger Healthcare Trust of America Ordinary income 1 $ — $ 0.5862 $ 0.7920 Return of capital — 4.0162 0.4930 Capital gain — 1.2216 — Common stock distributions $ — $ 5.8240 $ 1.2850 Tax Treatment of Dividends Pre-Merger Healthcare Realty Ordinary income 1 $ — $ 0.2655 $ 0.7500 Return of capital — 0.5555 0.3600 Capital gain — — 0.0964 Common stock distributions $ — $ 0.8210 $ 1.2064 Tax Treatment of Dividends Post-Merger Healthcare Realty Ordinary income 1 $ 0.5482 $ 0.0422 $ — Return of capital 0.5031 0.2889 — Capital gain 0.1887 0.0879 — Common stock distributions $ 1.2400 $ 0.4190 $ — 1
Schedule of state income taxes	State income tax expense and state income tax payments for the three years ended December 31, 2023 are detailed in the table below: YEAR ENDED DECEMBER 31, Dollars in thousands 2023 2022 2021 State income tax expense Texas gross margins tax $ 1,206 $ 1,693 $ 564 Other 133 151 8 Total state income tax expense $ 1,339 $ 1,844 $ 572 State income tax payments, net of refunds and collections $ 1,324 $ 1,834 $ 560

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of fair value and carrying values for notes and bonds payable, mortgage notes receivable and notes receivable	The table below details the fair value and carrying values for our other financial instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1, 2 $ 4,994.9 $ 4,872.7 $ 5,351.8 $ 5,149.6 Real estate notes receivable 1 $ 173.6 $ 172.5 $ 99.6 $ 99.6 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. 2 Fair value for senior notes includes accrued interest as of December 31, 2023.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) shares in Millions, ft² in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) ft² reporting_unit financing_receivable property note_receivable variable_interest_entity state joint_venture shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jan. 01, 2023 USD ($)	Jul. 20, 2022 USD ($)	Dec. 31, 2020 USD ($)
Business Overview:
Gross investment, amount, total		$ 13,400,000,000
Number of owned real estate properties | property		655
Number of states that the Company owns real estate in | state		35
Approximate square feet invested in by company | ft²		38.5
Number of properties | property		33
Principles of Consolidation:
Equity ownership for consolidation (percent)		100%
Number of entities | variable_interest_entity		4
Segment Reporting:
Number of reporting units | reporting_unit		1
Real Estate Properties:
Elimination of real estate lease intangibles against accumulated depreciation		$ 214,800,000	$ 133,600,000
Depreciation		$ 518,600,000	320,800,000	$ 170,000,000
Maximum period up to which interest capitalize on properties in stabilization		1 year
Goodwill and Other Intangible Assets:
Goodwill		$ 250,530,000	223,202,000			$ 247,043,000
Revenue from Contracts with Customers (Topic 606):
Revenue Received		$ 1,900,000	1,500,000	1,400,000
Federal Income Taxes:
Percentage of distribution of taxable income for qualify as REIT		90%
Unrecognized tax benefits, income tax penalties and interest expense		$ 0	0	0
Redeemable Non-Controlling Interests:
Redeemable non-controlling interests		3,868,000	2,014,000	0			$ 0
Real Estate Notes Receivable:
Real estate notes receivable, net		173,614,000	99,643,000
Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:
Carrying value		173,614,000
Credit loss reserves	$ 5,200,000	$ 5,196,000	0
Number of recognized lease financial receivables | financing_receivable		2
Income from financing receivables		$ 8,300,000	8,100,000
Financing receivable, nonaccrual					$ 48,900,000
Notes Receivable
Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:
Interest income		$ 8,800,000	3,400,000	$ 0
Variable Interest Entity
Principles of Consolidation:
Number of entities | variable_interest_entity		3
Number of notes receivable | note_receivable		2
Number of joint ventures | joint_venture		1
Healthcare Trustof America Holdings L P | Non-Controlling Interest Holders
Principles of Consolidation:
Limited partners capital account outstanding (in units) | shares		4.5
Limited partners ownership interest (in percent)		1.20%
Property Entities Not Determined to be VIEs
Principles of Consolidation:
Equity interest owned (percent)		100%
Healthcare Trustof America Holdings L P
Principles of Consolidation:
Equity interest owned (percent)		98.80%
Minimum
Goodwill and Other Intangible Assets:
Goodwill, purchase accounting adjustments		$ 27,300,000
Maximum
Goodwill and Other Intangible Assets:
Goodwill		250,500,000	223,200,000
Interest Rate Swap
Fair Value of Derivative Financial Instruments:
Accumulated other comprehensive income (loss), net of tax		(10,700,000)	2,100,000
Tenant and Capital Improvements
Real Estate Properties:
Fully depreciated tenant and capital improvements eliminated against accumulated depreciation			4,100,000
At Market Lease Intangibles
Real Estate Properties:
Elimination of real estate lease intangibles against accumulated depreciation		$ 51,700,000	$ 19,600,000
Real Estate Properties Held In Joint Ventures Member
Business Overview:
Weighted average ownership interest (percent)		43%
Number of properties | property		33

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets:
Net real estate investments	$ 11,172,214	$ 12,412,354
Cash and cash equivalents	25,699	60,961
Total assets	12,637,131	13,849,631
Liabilities:
Total equity	6,822,662	7,571,076
Total liabilities, redeemable non-controlling interests, and stockholders' equity	12,637,131	$ 13,849,631
Variable interest entity
Assets:
Net real estate investments	85,752
Cash and cash equivalents	2,144
Receivables and other assets	2,704
Total assets	90,600
Liabilities:
Accrued expenses and other liabilities	17,835
Total equity	72,765
Total liabilities, redeemable non-controlling interests, and stockholders' equity	$ 90,600

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Variable interest entity (Details) $ in Thousands	Dec. 31, 2023 USD ($) note_receivable property
Variable Interest Entity [Line Items]
Number of owned real estate properties | property	655
Variable Interest Entity
Variable Interest Entity [Line Items]
Number of notes receivable | note_receivable	2
Houston, TX | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	$ 31,150
MAXIMUM EXPOSURE TO LOSS	31,150
Charlotte, NC | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	5,796
MAXIMUM EXPOSURE TO LOSS	6,000
Texas | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Joint venture, carrying amount	61,801
MAXIMUM EXPOSURE TO LOSS	$ 61,801
Number of owned real estate properties | property	7

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Useful lives of real estate assets and liabilities (Details)	Dec. 31, 2023
Land improvements | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	2 years
Land improvements | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	39 years
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	3 years 3 months 18 days
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	49 years
Lease intangibles (including ground lease intangibles) | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	1 year
Intangible asset useful life	1 year
Lease intangibles (including ground lease intangibles) | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	99 years
Intangible asset useful life	99 years
Personal property | Minimum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	3 years
Personal property | Maximum
Property, Plant and Equipment [Line Items]
Asset estimated useful life	20 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Other operating	$ 17,451	$ 13,706	$ 10,291
Parking income
Disaggregation of Revenue [Line Items]
Other operating	9,903	8,513	7,859
Management fee income
Disaggregation of Revenue [Line Items]
Other operating	$ 7,548	$ 5,193	$ 2,432

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Components of rental income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Property operating income	$ 1,270,508	$ 883,953	$ 514,533
Straight-line rent	38,676	23,498	5,801
Rental income	$ 1,309,184	$ 907,451	$ 520,334

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, carrying value	$ 122,602
MAXIMUM LOAN COMMITMENT	214,969
REAL ESTATE NOTES RECEIVABLE, GROSS	182,125
ALLOWANCE FOR CREDIT LOSSES	(5,196)	$ 0	$ 0
FAIR VALUE DISCOUNT AND FEES	(3,315)
CARRYING VALUE	173,614
Mezzanine loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
MAXIMUM LOAN COMMITMENT	60,119
REAL ESTATE NOTES RECEIVABLE, GROSS	60,119
ALLOWANCE FOR CREDIT LOSSES	(5,196)
FAIR VALUE DISCOUNT AND FEES	(3,067)
CARRYING VALUE	51,856
Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
MAXIMUM LOAN COMMITMENT	154,850
REAL ESTATE NOTES RECEIVABLE, GROSS	122,006
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(248)
CARRYING VALUE	$ 121,758
Poway, CA
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	5.71%
Financing receivable, carrying value	$ 115,239
Columbus, OH
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6.48%
Financing receivable, carrying value	$ 7,363
Texas | Mezzanine loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 54,119
REAL ESTATE NOTES RECEIVABLE, GROSS	54,119
ALLOWANCE FOR CREDIT LOSSES	(5,196)
FAIR VALUE DISCOUNT AND FEES	(3,067)
CARRYING VALUE	$ 45,856
Texas | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	7%
MAXIMUM LOAN COMMITMENT	$ 31,150
REAL ESTATE NOTES RECEIVABLE, GROSS	31,150
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	0
CARRYING VALUE	$ 31,150
Arizona | Mezzanine loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	9%
MAXIMUM LOAN COMMITMENT	$ 6,000
REAL ESTATE NOTES RECEIVABLE, GROSS	6,000
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	0
CARRYING VALUE	$ 6,000
North Carolina | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 6,000
REAL ESTATE NOTES RECEIVABLE, GROSS	6,000
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(204)
CARRYING VALUE	$ 5,796
Florida | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6%
MAXIMUM LOAN COMMITMENT	$ 65,000
REAL ESTATE NOTES RECEIVABLE, GROSS	32,156
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(44)
CARRYING VALUE	$ 32,112
California | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6%
MAXIMUM LOAN COMMITMENT	$ 45,000
REAL ESTATE NOTES RECEIVABLE, GROSS	45,000
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	0
CARRYING VALUE	$ 45,000
Florida | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	9%
MAXIMUM LOAN COMMITMENT	$ 7,700
REAL ESTATE NOTES RECEIVABLE, GROSS	7,700
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	0
CARRYING VALUE	$ 7,700

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses, beginning of period	$ 0	$ 0	$ 0
Credit loss reserves	$ 5,200	5,196	0
Allowance for credit losses, end of period		$ 5,196	$ 0

Merger with HTA - Narrative (De

Merger with HTA - Narrative (Details) - USD ($)		12 Months Ended
	Jul. 20, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01
Goodwill	$ 247,043,000	$ 250,530,000	$ 223,202,000
Goodwill expected to be tax deductible	0
Merger-related costs		(1,952,000)	$ 103,380,000	$ 0
Refund of transfer taxes paid		$ 17,800,000
Revision of Prior Period, Adjustment
Business Acquisition [Line Items]
Goodwill adjustment incomplete	$ 101,600,000
HealthCare Realty Trust Incorporated | Common Class A
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.01
HealthCare Realty Trust, Inc.
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	0.01
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.01
Conversion ratio	1
Dividends per share to common stockholders, declared (in USD per share)	$ 4.82

Merger with HTA - Schedule of C

Merger with HTA - Schedule of Consideration Transferred (Details)		12 Months Ended
	Jul. 20, 2022 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 shares
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,857,717	380,964,000	380,590,000
Implied shares of Legacy HR Common Stock issued (in shares)	228,520,990
Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares	$ 24.37
Value of implied Legacy HR Common Stock issued | $	$ 5,569,057,000
Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $		$ 7,406,000
Consideration transferred | $		$ 5,576,463,000
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,520,990
Exchange ratio	1
Common Stock, fractional (in shares)	192
Healthcare Trust Of America, Inc | Restricted Stock
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	336,535
Common Stock, withheld (in shares)	215,764

Merger with HTA - Schedule of F

Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands	Jul. 20, 2022	Dec. 31, 2023	Dec. 31, 2022
Real estate investments
Land	$ 1,004,285
Buildings and improvements	6,841,283
Lease intangible assets	833,759
Financing lease right-of-use assets	13,020
Construction in progress	3,327
Land held for development	46,538
Total real estate investments	8,742,212
Assets held for sale, net	699,496
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	37,437
Restricted cash	1,122,400
Operating lease right-of-use assets	214,631
Other assets, net	205,323	$ 100	$ 400
Total assets acquired	11,089,391
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,244,944
Liabilities of assets held for sale	24,738
Operating lease liabilities	184,121
Financing lease liabilities	9,865
Other liabilities	194,301
Total liabilities assumed	5,649,269
Net identifiable assets acquired	5,440,122	36,500	399,200
Non-controlling interest	110,702
Goodwill	247,043	$ 250,530	$ 223,202
Weighted average amortization period for the acquired lease intangible assets		6 years
Gross contractual accounts receivable	15,900
Gross contractual real estate notes receivable	78,700
Gross contractual real estate notes receivable at fair value	74,800
CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS
Land	18,359
Buildings and improvements	(119,135)
Lease intangible assets	1,839
Financing lease right-of-use assets	3,146
Construction in progress	(6,744)
Total real estate investments	(102,535)
Assets held for sale, net	(7,946)
Cash and cash equivalents	11,403
Restricted cash	(1,247)
Operating lease right-of-use assets	16,370
Other assets, net	(3,840)
Total assets acquired	(87,795)
Accounts payable and accrued liabilities	17,374
Liabilities of assets held for sale	(3,939)
Operating lease liabilities	10,173
Financing lease liabilities	(855)
Other liabilities	(8,909)
Total liabilities assumed	13,844
Net identifiable assets acquired	(101,639)
Goodwill	101,639
Previously Reported
Real estate investments
Land	985,926
Buildings and improvements	6,960,418
Lease intangible assets	831,920
Financing lease right-of-use assets	9,874
Construction in progress	10,071
Land held for development	46,538
Total real estate investments	8,844,747
Assets held for sale, net	707,442
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	26,034
Restricted cash	1,123,647
Operating lease right-of-use assets	198,261
Other assets, net	209,163
Total assets acquired	11,177,186
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,227,570
Liabilities of assets held for sale	28,677
Operating lease liabilities	173,948
Financing lease liabilities	10,720
Other liabilities	203,210
Total liabilities assumed	5,635,425
Net identifiable assets acquired	5,541,761
Non-controlling interest	110,702
Goodwill	$ 145,404

Property Investments (Details)

Property Investments (Details) $ in Thousands	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($)
Summary of Company's investment
NUMBER OF PROPERTIES | property	655
LAND	$ 1,343,265
BUILDINGS AND IMPROVEMENTS	10,881,373	$ 11,332,037
LEASE INTANGIBLES	836,302
PERSONAL PROPERTY	12,718	11,907
Total real estate investments	13,399,067	14,057,625
ACCUMULATED DEPRECIATION	$ (2,226,853)	$ (1,645,271)
Investment in financing receivables, net
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES
PERSONAL PROPERTY	0
Total real estate investments	122,602
ACCUMULATED DEPRECIATION	$ 0
Financing lease right-of-use assets
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
PERSONAL PROPERTY	0
Total real estate investments	82,209
ACCUMULATED DEPRECIATION	$ 0
Construction in progress
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
PERSONAL PROPERTY	0
Total real estate investments	60,727
ACCUMULATED DEPRECIATION	$ 0
Land held for development
Summary of Company's investment
NUMBER OF PROPERTIES | property	0
LAND	$ 0
BUILDINGS AND IMPROVEMENTS	0
LEASE INTANGIBLES	0
PERSONAL PROPERTY	0
Total real estate investments	59,871
ACCUMULATED DEPRECIATION	$ 0
Medical office/outpatient
Summary of Company's investment
NUMBER OF PROPERTIES | property	655
LAND	$ 1,343,265
BUILDINGS AND IMPROVEMENTS	10,881,373
LEASE INTANGIBLES	836,302
PERSONAL PROPERTY	12,718
Total real estate investments	13,073,658
ACCUMULATED DEPRECIATION	$ (2,226,853)
Medical office/outpatient | Dallas, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	43
LAND	$ 90,168
BUILDINGS AND IMPROVEMENTS	1,004,810
LEASE INTANGIBLES	68,139
PERSONAL PROPERTY	550
Total real estate investments	1,163,667
ACCUMULATED DEPRECIATION	$ (221,375)
Medical office/outpatient | Houston, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	31
LAND	$ 76,959
BUILDINGS AND IMPROVEMENTS	614,531
LEASE INTANGIBLES	60,651
PERSONAL PROPERTY	57
Total real estate investments	752,198
ACCUMULATED DEPRECIATION	$ (97,793)
Medical office/outpatient | Seattle, WA
Summary of Company's investment
NUMBER OF PROPERTIES | property	29
LAND	$ 64,295
BUILDINGS AND IMPROVEMENTS	631,438
LEASE INTANGIBLES	9,921
PERSONAL PROPERTY	715
Total real estate investments	706,369
ACCUMULATED DEPRECIATION	$ (186,903)
Medical office/outpatient | Denver, CO
Summary of Company's investment
NUMBER OF PROPERTIES | property	33
LAND	$ 76,698
BUILDINGS AND IMPROVEMENTS	501,994
LEASE INTANGIBLES	43,268
PERSONAL PROPERTY	610
Total real estate investments	622,570
ACCUMULATED DEPRECIATION	$ (94,906)
Medical office/outpatient | Charlotte, NC
Summary of Company's investment
NUMBER OF PROPERTIES | property	32
LAND	$ 35,465
BUILDINGS AND IMPROVEMENTS	463,461
LEASE INTANGIBLES	26,971
PERSONAL PROPERTY	110
Total real estate investments	526,007
ACCUMULATED DEPRECIATION	$ (116,578)
Medical office/outpatient | Phoenix, AZ
Summary of Company's investment
NUMBER OF PROPERTIES | property	35
LAND	$ 20,262
BUILDINGS AND IMPROVEMENTS	437,804
LEASE INTANGIBLES	36,384
PERSONAL PROPERTY	425
Total real estate investments	494,875
ACCUMULATED DEPRECIATION	$ (59,449)
Medical office/outpatient | Atlanta, GA
Summary of Company's investment
NUMBER OF PROPERTIES | property	27
LAND	$ 49,095
BUILDINGS AND IMPROVEMENTS	417,112
LEASE INTANGIBLES	28,204
PERSONAL PROPERTY	100
Total real estate investments	494,511
ACCUMULATED DEPRECIATION	$ (79,569)
Medical office/outpatient | Boston, MA
Summary of Company's investment
NUMBER OF PROPERTIES | property	17
LAND	$ 127,447
BUILDINGS AND IMPROVEMENTS	299,742
LEASE INTANGIBLES	41,183
PERSONAL PROPERTY	14
Total real estate investments	468,386
ACCUMULATED DEPRECIATION	$ (37,569)
Medical office/outpatient | Raleigh, NC
Summary of Company's investment
NUMBER OF PROPERTIES | property	28
LAND	$ 56,620
BUILDINGS AND IMPROVEMENTS	371,932
LEASE INTANGIBLES	36,411
PERSONAL PROPERTY	9
Total real estate investments	464,972
ACCUMULATED DEPRECIATION	$ (38,879)
Medical office/outpatient | Nashville, TN
Summary of Company's investment
NUMBER OF PROPERTIES | property	13
LAND	$ 43,347
BUILDINGS AND IMPROVEMENTS	397,192
LEASE INTANGIBLES	10,206
PERSONAL PROPERTY	7,427
Total real estate investments	458,172
ACCUMULATED DEPRECIATION	$ (115,979)
Medical office/outpatient | Los Angeles, CA
Summary of Company's investment
NUMBER OF PROPERTIES | property	20
LAND	$ 72,086
BUILDINGS AND IMPROVEMENTS	360,330
LEASE INTANGIBLES	16,481
PERSONAL PROPERTY	453
Total real estate investments	449,350
ACCUMULATED DEPRECIATION	$ (145,875)
Medical office/outpatient | Miami, FL
Summary of Company's investment
NUMBER OF PROPERTIES | property	19
LAND	$ 53,994
BUILDINGS AND IMPROVEMENTS	326,343
LEASE INTANGIBLES	35,014
PERSONAL PROPERTY	178
Total real estate investments	415,529
ACCUMULATED DEPRECIATION	$ (74,470)
Medical office/outpatient | Tampa, FL
Summary of Company's investment
NUMBER OF PROPERTIES | property	19
LAND	$ 31,121
BUILDINGS AND IMPROVEMENTS	351,879
LEASE INTANGIBLES	27,438
PERSONAL PROPERTY	33
Total real estate investments	410,471
ACCUMULATED DEPRECIATION	$ (36,726)
Medical office/outpatient | Indianapolis, IN
Summary of Company's investment
NUMBER OF PROPERTIES | property	36
LAND	$ 54,899
BUILDINGS AND IMPROVEMENTS	285,806
LEASE INTANGIBLES	32,780
PERSONAL PROPERTY	13
Total real estate investments	373,498
ACCUMULATED DEPRECIATION	$ (42,273)
Medical office/outpatient | Austin, TX
Summary of Company's investment
NUMBER OF PROPERTIES | property	13
LAND	$ 27,063
BUILDINGS AND IMPROVEMENTS	274,229
LEASE INTANGIBLES	18,568
PERSONAL PROPERTY	142
Total real estate investments	320,002
ACCUMULATED DEPRECIATION	$ (55,891)
Medical office/outpatient | New York, NY
Summary of Company's investment
NUMBER OF PROPERTIES | property	14
LAND	$ 64,402
BUILDINGS AND IMPROVEMENTS	170,304
LEASE INTANGIBLES	26,430
PERSONAL PROPERTY	0
Total real estate investments	261,136
ACCUMULATED DEPRECIATION	$ (15,887)
Medical office/outpatient | Chicago, IL
Summary of Company's investment
NUMBER OF PROPERTIES | property	6
LAND	$ 13,804
BUILDINGS AND IMPROVEMENTS	216,473
LEASE INTANGIBLES	13,011
PERSONAL PROPERTY	81
Total real estate investments	243,369
ACCUMULATED DEPRECIATION	$ (39,671)
Medical office/outpatient | Memphis, TN
Summary of Company's investment
NUMBER OF PROPERTIES | property	11
LAND	$ 13,901
BUILDINGS AND IMPROVEMENTS	189,941
LEASE INTANGIBLES	4,211
PERSONAL PROPERTY	322
Total real estate investments	208,375
ACCUMULATED DEPRECIATION	$ (71,813)
Medical office/outpatient | Honolulu, HI
Summary of Company's investment
NUMBER OF PROPERTIES | property	6
LAND	$ 9,527
BUILDINGS AND IMPROVEMENTS	188,772
LEASE INTANGIBLES	6,319
PERSONAL PROPERTY	169
Total real estate investments	204,787
ACCUMULATED DEPRECIATION	$ (61,575)
Medical office/outpatient | Hartford, CT
Summary of Company's investment
NUMBER OF PROPERTIES | property	30
LAND	$ 29,381
BUILDINGS AND IMPROVEMENTS	138,713
LEASE INTANGIBLES	21,848
PERSONAL PROPERTY	0
Total real estate investments	189,942
ACCUMULATED DEPRECIATION	$ (15,883)
Medical office/outpatient | Other (49 markets)
Summary of Company's investment
NUMBER OF PROPERTIES | property	193
LAND	$ 332,731
BUILDINGS AND IMPROVEMENTS	3,238,567
LEASE INTANGIBLES	272,864
PERSONAL PROPERTY	1,310
Total real estate investments	3,845,472
ACCUMULATED DEPRECIATION	$ (617,789)

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) renewal_option	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Leases [Abstract]
Rental income	$ 1,309,184	$ 907,451	$ 520,334
Approximate Investment in real estate properties subject to outstanding contractual option to purchase	$ 111,100
Number of exercisable purchase options | renewal_option	6

Leases - Non-cancelable Operati

Leases - Non-cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Leases [Abstract]
2024	$ 894,442
2025	801,973
2026	701,615
2027	582,028
2028	469,549
2029 and thereafter	1,579,010
Lease payments receivable	$ 5,028,617

Leases - Ground Leases (Details

Leases - Ground Leases (Details) ft² in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) ft² lease property	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Real Estate [Line Items]
Number of properties subject to ground leases | property	232
Square feet subject to ground leases | ft²	16.9
Number of ground leases prepaid	75
Amortization of prepaid rent | $	$ 1.3	$ 1.1	$ 0.6
Number of ground leases, excluding prepaid leases	157
Minimum
Real Estate [Line Items]
Ground leases, initial term	40 years
Maximum
Real Estate [Line Items]
Ground leases, initial term	99 years

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
OPERATING
2024	$ 12,263
2025	12,428
2026	12,516
2027	12,703
2028	12,822
2029 and thereafter	698,905
Total undiscounted lease payments	761,637
Discount	(531,923)
Lease liabilities	229,714	$ 279,895
FINANCING
2024	2,182
2025	2,218
2026	2,254
2027	2,294
2028	2,326
2029 and thereafter	394,072
Total undiscounted lease payments	405,346
Discount	(330,843)
Lease liabilities	$ 74,503	$ 72,939

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating lease cost
Operating lease expense	$ 20,623	$ 12,699
Variable lease expense	8,979	4,529
Finance lease cost
Amortization of right-of-use assets	1,564	1,288
Interest on lease liabilities	3,718	2,876
Total lease expense	34,884	21,392
Other information
Operating cash flows outflows related to operating leases	19,222	12,816
Operating cash flows outflows related to financing leases	2,122	1,838
Financing cash flows outflows related to financing leases	17	0	$ 9,182
Right-of-use assets obtained in exchange for new finance lease liabilities	0	53,765
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 1,758	$ 216,047
Weighted-average remaining lease term (excluding renewal options) - operating leases	45 years 9 months 18 days	47 years 6 months
Weighted-average remaining lease term (excluding renewal options) - finance leases	57 years 10 months 24 days	58 years 10 months 24 days
Weighted-average discount rate - operating leases	5.70%	5.80%
Weighted-average discount rate - finance leases	5%	5%

Acquisitions, Dispositions an_3

Acquisitions, Dispositions and Mortgage Repayments - Real Estate Acquisitions (Details) $ in Thousands				12 Months Ended
	Jul. 28, 2023 USD ($) ft²	Mar. 10, 2023 USD ($) ft²	Jun. 09, 2022 USD ($) ft²	Dec. 31, 2023 USD ($) ft²	Dec. 31, 2022 USD ($) ft²
Business Acquisition [Line Items]
PURCHASE PRICE				$ 5,576,463
MORTGAGE NOTES PAYABLE, NET				(5,300)
Total real estate acquisitions
Business Acquisition [Line Items]
PURCHASE PRICE				42,950
MORTGAGE NOTES PAYABLE, NET				(5,284)
CASH CONSIDERATION				36,523
REAL ESTATE				42,012
OTHER				$ (205)
SQUARE FOOTAGE | ft²				158,637
Medical Office Building
Business Acquisition [Line Items]
PURCHASE PRICE					$ 403,578
CASH CONSIDERATION					399,189
REAL ESTATE					386,818
OTHER					$ 12,371
SQUARE FOOTAGE | ft²					863,184
Tampa, FL | Medical Office Building
Business Acquisition [Line Items]
PURCHASE PRICE		$ 31,500	$ 18,650
MORTGAGE NOTES PAYABLE, NET		0
CASH CONSIDERATION		30,499	18,619
REAL ESTATE		30,596	18,212
OTHER		$ (97)	$ 407
SQUARE FOOTAGE | ft²		115,867	55,788
Colorado Springs, CO | Medical Office Building
Business Acquisition [Line Items]
PURCHASE PRICE	$ 11,450
MORTGAGE NOTES PAYABLE, NET	(5,284)
CASH CONSIDERATION	6,024
REAL ESTATE	11,416
OTHER	$ (108)
SQUARE FOOTAGE | ft²	42,770

Acquisitions, Dispositions an_4

Acquisitions, Dispositions and Mortgage Repayments - Narrative (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2023 property
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Payments to acquired a parcel of land	$ 800
Payments to acquire additional interest in an operating property	$ 600
Number of properties | property				33
Real Estate Properties Held In Joint Ventures Member
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Weighted average ownership interest (percent)				43%
Number of properties | property				33
Medical Office Building
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Cash consideration			$ 399,189
Medical Office Building | Scottsdale, Arizona
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Joint venture, ownership (in percentage)		90%
Payments to acquired a parcel of land		$ 8,800
Cash consideration		$ 8,300

Acquisitions, Dispositions an_5

Acquisitions, Dispositions and Mortgage Repayments - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jul. 20, 2022
Business Acquisition [Line Items]
Building			$ 6,841,283
Land			1,004,285
MORTGAGE NOTES PAYABLE, NET	$ (5,300)
Other assets acquired	100	$ 400	205,323
Accounts payable, accrued liabilities and other liabilities assumed	(300)	(2,900)
Total cash paid	36,500	399,200	$ 5,440,122
At-market lease intangibles
Business Acquisition [Line Items]
Intangibles	4,500	28,100
Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangibles	200	15,900
Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Below-market lease intangibles (lessor)	(200)	(2,200)
Below-market lease intangibles (lessee)
Business Acquisition [Line Items]
Intangibles		$ 1,200
Intangible asset useful life		13 years 1 month 6 days
Building
Business Acquisition [Line Items]
Building	27,500	$ 250,700
Tenant Improvements
Business Acquisition [Line Items]
Tenant Improvements	3,400	20,700
Land
Business Acquisition [Line Items]
Land	5,500	76,100
Land Improvements
Business Acquisition [Line Items]
Land Improvements	$ 1,100	$ 11,200
Minimum | At-market lease intangibles
Business Acquisition [Line Items]
Intangible asset useful life	5 years 1 month 6 days	1 year 6 months
Minimum | Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life	1 year 9 months 18 days	1 year 3 months 18 days
Minimum | Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life	6 years 4 months 24 days	1 year 3 months 18 days
Minimum | Building
Business Acquisition [Line Items]
Asset estimated useful life	17 years	14 years
Minimum | Tenant Improvements
Business Acquisition [Line Items]
Asset estimated useful life	5 years 1 month 6 days	1 year 6 months
Minimum | Land Improvements
Business Acquisition [Line Items]
Asset estimated useful life	6 years	5 years
Maximum | At-market lease intangibles
Business Acquisition [Line Items]
Intangible asset useful life	5 years 10 months 24 days	13 years 4 months 24 days
Maximum | Above-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life	4 years 10 months 24 days	15 years 7 months 6 days
Maximum | Below-market lease intangibles (lessor)
Business Acquisition [Line Items]
Intangible asset useful life	13 years 10 months 24 days	19 years 3 months 18 days
Maximum | Building
Business Acquisition [Line Items]
Asset estimated useful life	30 years	38 years
Maximum | Tenant Improvements
Business Acquisition [Line Items]
Asset estimated useful life	5 years 10 months 24 days	13 years 4 months 24 days
Maximum | Land Improvements
Business Acquisition [Line Items]
Asset estimated useful life	10 years	14 years

Acquisitions, Dispositions an_6

Acquisitions, Dispositions and Mortgage Repayments - Joint Ventures (Details) $ in Thousands		12 Months Ended
	Mar. 07, 2022 USD ($) ft² property	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) ft² property	Dec. 31, 2021 USD ($)
Equity Method Investments [Roll Forward]
Equity loss recognized during the period		$ (1,682)	$ (687)	$ (795)
PURCHASE PRICE			100,975
CASH CONSIDERATION			99,173
REAL ESTATE			97,569
OTHER			$ 1,604
SQUARE FOOTAGE unaudited | ft²			214,124
San Francisco, CA
Equity Method Investments [Roll Forward]
PURCHASE PRICE	$ 67,175
CASH CONSIDERATION	66,789
REAL ESTATE	65,179
OTHER	$ 1,610
SQUARE FOOTAGE unaudited | ft²	110,865
Number of buildings acquired | property	3		3
Los Angeles, CA
Equity Method Investments [Roll Forward]
PURCHASE PRICE	$ 33,800
CASH CONSIDERATION	32,384
REAL ESTATE	32,390
OTHER	$ (6)
SQUARE FOOTAGE unaudited | ft²	103,259
Number of buildings acquired | property			2
Parking Garages
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period		327,200	$ 161,900
New investments during the period		3,800	167,900
Equity loss recognized during the period		(1,700)	(700)
Owner distributions		(17,800)	(1,900)
Investments in unconsolidated joint ventures, end of period		$ 311,500	$ 327,200	$ 161,900

Acquisitions, Dispositions an_7

Acquisitions, Dispositions and Mortgage Repayments - Acquisitions (Details) $ in Thousands																				12 Months Ended
	Mar. 10, 2023 USD ($) ft²	Dec. 28, 2022 USD ($) ft²	Nov. 21, 2022 USD ($) ft²	Oct. 12, 2022 USD ($) ft²	Sep. 29, 2022 USD ($) ft²	Sep. 15, 2022 USD ($) ft²	Aug. 18, 2022 USD ($) ft²	Aug. 11, 2022 USD ($) ft²	Aug. 10, 2022 USD ($) ft²	Aug. 09, 2022 USD ($) ft²	Aug. 01, 2022 USD ($) ft²	Jun. 09, 2022 USD ($) ft² property	May 31, 2022 USD ($) ft² property	Apr. 29, 2022 USD ($) ft²	Apr. 28, 2022 USD ($) ft²	Apr. 13, 2022 USD ($) ft² property	Apr. 07, 2022 USD ($) ft²	Mar. 07, 2022 USD ($) ft² property	Feb. 11, 2022 USD ($) ft²	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) ft² property
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																				$ 5,576,463
San Francisco, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																		3			3
Colorado Springs, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property																2
Charlotte, NC
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property													3
Tampa, FL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Number of properties acquired | property												2
Austin, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
Additional of ownership existing		71.40%
Medical Office Building
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																					$ 403,578
CASH CONSIDERATION																					399,189
REAL ESTATE																					386,818
OTHER																					$ 12,371
SQUARE FOOTAGE | ft²																					863,184
Medical Office Building | Dallas, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																			$ 8,175
CASH CONSIDERATION																			8,185
REAL ESTATE																			8,202
OTHER																			$ (17)
SQUARE FOOTAGE | ft²																			18,000
Medical Office Building | San Francisco, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																		$ 114,000
CASH CONSIDERATION																		112,986
REAL ESTATE																		108,687
OTHER																		$ 4,299
SQUARE FOOTAGE | ft²																		166,396
Medical Office Building | Atlanta, GA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE									$ 11,800								$ 6,912
CASH CONSIDERATION									11,525								7,054
REAL ESTATE									12,038								7,178
OTHER									$ (513)								$ (124)
SQUARE FOOTAGE | ft²									43,496								21,535
Medical Office Building | Denver, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE		$ 16,400						$ 14,800								$ 6,320
CASH CONSIDERATION		16,170						13,902								5,254
REAL ESTATE		16,467						13,918								5,269
OTHER		$ (297)						$ (16)								$ (15)
SQUARE FOOTAGE | ft²		39,692						34,785								12,207
Medical Office Building | Colorado Springs, CO
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE																$ 13,680
CASH CONSIDERATION																13,686
REAL ESTATE																13,701
OTHER																$ (15)
SQUARE FOOTAGE | ft²																25,800
Medical Office Building | Seattle, WA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE											$ 4,850				$ 8,350
CASH CONSIDERATION											4,806				8,334
REAL ESTATE											4,882				8,370
OTHER											$ (76)				$ (36)
SQUARE FOOTAGE | ft²											10,593				13,256
Medical Office Building | Houston, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE			$ 5,500												$ 36,250
CASH CONSIDERATION			5,469												36,299
REAL ESTATE			5,513												36,816
OTHER			$ (44)												$ (517)
SQUARE FOOTAGE | ft²			28,369												76,781
Medical Office Building | Los Angeles, CA
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE														$ 35,000
CASH CONSIDERATION														35,242
REAL ESTATE														25,400
OTHER														$ 9,842
SQUARE FOOTAGE | ft²														34,282
Medical Office Building | Oklahoma City, OK
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE														$ 11,100
CASH CONSIDERATION														11,259
REAL ESTATE														11,334
OTHER														$ (75)
SQUARE FOOTAGE | ft²														34,944
Medical Office Building | Charlotte, NC
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE							$ 11,375			$ 3,783			$ 27,500
CASH CONSIDERATION							10,670			3,878			26,710
REAL ESTATE							10,547			3,932			27,127
OTHER							$ 123			$ (54)			$ (417)
SQUARE FOOTAGE | ft²							31,318			11,345			85,113
Medical Office Building | Tampa, FL
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE	$ 31,500											$ 18,650
CASH CONSIDERATION	30,499											18,619
REAL ESTATE	30,596											18,212
OTHER	$ (97)											$ 407
SQUARE FOOTAGE | ft²	115,867											55,788
Medical Office Building | Florida
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE				$ 3,600						$ 18,195
CASH CONSIDERATION				3,530						18,508
REAL ESTATE				3,609						18,583
OTHER				$ (79)						$ (75)
SQUARE FOOTAGE | ft²				6,200						34,133
Medical Office Building | Nashville, TN
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE						$ 21,000
CASH CONSIDERATION						20,764
REAL ESTATE						20,572
OTHER						$ 192
SQUARE FOOTAGE | ft²						61,932
Medical Office Building | Austin, TX
Real Estate Acquisitions and Mortgage Note Financing [Line Items]
PURCHASE PRICE		$ 888			$ 5,450
CASH CONSIDERATION		890			5,449
REAL ESTATE		889			5,572
OTHER		$ 1			$ (123)
SQUARE FOOTAGE | ft²		2,219			15,000

Acquisitions, Dispositions an_8

Acquisitions, Dispositions and Mortgage Repayments - Dispositions (Details) $ in Thousands																																		12 Months Ended
	Dec. 29, 2023 USD ($) ft² disposition_transaction property	Dec. 28, 2023 USD ($) ft²	Dec. 27, 2023 USD ($) ft²	Dec. 22, 2023 USD ($) ft² property disposition_transaction	Dec. 21, 2023 USD ($) ft²	Dec. 20, 2023 USD ($) ft²	Dec. 15, 2023 USD ($) ft²	Dec. 01, 2023 USD ($) ft²	Nov. 13, 2023 USD ($) ft² disposition_transaction property	Sep. 27, 2023 USD ($) ft²	Sep. 18, 2023 USD ($) ft²	Sep. 15, 2023 USD ($) ft²	Aug. 22, 2023 USD ($) ft²	Aug. 02, 2023 USD ($) ft²	Jun. 30, 2023 USD ($) ft²	May 12, 2023 USD ($) ft² a	Mar. 30, 2023 USD ($) ft²	Mar. 23, 2023 USD ($) ft²	Feb. 10, 2023 USD ($) ft²	Jan. 30, 2023 USD ($) ft²	Jan. 12, 2023 USD ($) ft² property disposition_transaction	Dec. 28, 2022 USD ($) ft²	Dec. 22, 2022 USD ($) ft² property	Nov. 10, 2022 USD ($) ft²	Oct. 21, 2022 USD ($) ft²	Oct. 04, 2022 USD ($) ft² property	Aug. 31, 2022 USD ($) ft² property	Aug. 30, 2022 USD ($) ft² property	Aug. 05, 2022 USD ($) ft² property	Aug. 04, 2022 USD ($) ft² property	Jul. 29, 2022 USD ($) ft² property	Apr. 15, 2022 USD ($) ft² property	Feb. 24, 2022 USD ($) ft² property	Dec. 31, 2023 USD ($) ft² property	Dec. 31, 2022 USD ($) ft²
Real Estate Dispositions [Line Items]
SALES PRICE																																			$ 1,242,218
CLOSING ADJUSTMENTS																																			(45,666)
NET PROCEEDS																																			1,196,552
NET REAL ESTATE INVESTMENT																																			939,363
OTHER (INCLUDING RECEIVABLES)																																			14,225
GAIN/ (IMPAIRMENT)																																			$ 242,964
SQUARE FOOTAGE unaudited | ft²																																			3,069,124
Number of owned real estate properties | property																																		655
Tampa FL & Miami FL
Real Estate Dispositions [Line Items]
SALES PRICE																					$ 93,250
CLOSING ADJUSTMENTS																					(5,875)
COMPANY-FINANCED NOTES																					0
NET PROCEEDS																					87,375
NET REAL ESTATE INVESTMENT																					87,302
OTHER (INCLUDING RECEIVABLES)																					(888)
GAIN/ (IMPAIRMENT)																					$ 961
SQUARE FOOTAGE unaudited | ft²																					224,037
Number of owned real estate properties | property																					2
Number of Property Dispositions | disposition_transaction																					2
Dallas, TX
Real Estate Dispositions [Line Items]
SALES PRICE						$ 43,295						$ 115,000								$ 19,210						$ 104,025		$ 114,290
CLOSING ADJUSTMENTS						(764)						(1,504)								(141)						(5,883)		(682)
COMPANY-FINANCED NOTES						0						0								0
NET PROCEEDS						42,531						113,496								19,069						98,142		113,608
NET REAL ESTATE INVESTMENT						33,882						64,183								18,986						38,872		113,608
OTHER (INCLUDING RECEIVABLES)						(3,782)						6,094								43						6,436		0
GAIN/ (IMPAIRMENT)						$ 12,431						$ 43,219								$ 40						$ 52,834		$ 0
SQUARE FOOTAGE unaudited | ft²						77,827						161,264								36,691						291,328		189,385
Joint venture, ownership (in percentage)																				40%								40%
Number of buildings acquired | property																										2		6
Values and square feet, represented percentage (in percent)																												100%
St. Louis, MO
Real Estate Dispositions [Line Items]
SALES PRICE																			$ 350			$ 18,000
CLOSING ADJUSTMENTS																			(18)			(1,471)
COMPANY-FINANCED NOTES																			0
NET PROCEEDS																			332			16,529
NET REAL ESTATE INVESTMENT																			398			18,340
OTHER (INCLUDING RECEIVABLES)																			0			4
GAIN/ (IMPAIRMENT)																			$ (66)			$ (1,815)
SQUARE FOOTAGE unaudited | ft²																			6,500			69,394
Los Angeles, CA
Real Estate Dispositions [Line Items]
SALES PRICE					$ 19,000											$ 3,300	$ 75,000	$ 21,000											$ 134,845
CLOSING ADJUSTMENTS					(1,311)											(334)	(8,079)	(526)											(3,102)
COMPANY-FINANCED NOTES					0											0	(45,000)	0
NET PROCEEDS					17,689											2,966	21,921	20,474											131,743
NET REAL ESTATE INVESTMENT					17,787											3,268	88,624	20,610											131,332
OTHER (INCLUDING RECEIVABLES)					0											0	(803)	52											411
GAIN/ (IMPAIRMENT)					$ (98)											$ (302)	$ (20,900)	$ (188)											$ 0
SQUARE FOOTAGE unaudited | ft²					104,377											0	147,078	37,165											283,780
Joint venture, ownership (in percentage)																													20%
Mortgage Note																	$ 45,000
Area of land | a																0.34
Number of buildings acquired | property																													4
Values and square feet, represented percentage (in percent)																													100%
Albany, NY
Real Estate Dispositions [Line Items]
SALES PRICE															$ 10,000
CLOSING ADJUSTMENTS															(1,229)
COMPANY-FINANCED NOTES															0
NET PROCEEDS															8,771
NET REAL ESTATE INVESTMENT															2,613
OTHER (INCLUDING RECEIVABLES)															(1,040)
GAIN/ (IMPAIRMENT)															$ 7,198
SQUARE FOOTAGE unaudited | ft²															40,870
Houston, TX
Real Estate Dispositions [Line Items]
SALES PRICE								$ 4,100			$ 250			$ 8,320											$ 32,000
CLOSING ADJUSTMENTS								(6)			(24)			(285)											(280)
COMPANY-FINANCED NOTES								0			0			0
NET PROCEEDS								4,094			226			8,035											31,720
NET REAL ESTATE INVESTMENT								3,486			1,998			4,567											10,762
OTHER (INCLUDING RECEIVABLES)								0			0			194											744
GAIN/ (IMPAIRMENT)								$ 608			$ (1,772)			$ 3,274											$ 20,214
SQUARE FOOTAGE unaudited | ft²								83,223			52,040			57,170											134,910
Atlanta, GA
Real Estate Dispositions [Line Items]
SALES PRICE													$ 25,140										$ 91,243
CLOSING ADJUSTMENTS													(66)										(4,326)
COMPANY-FINANCED NOTES													0
NET PROCEEDS													25,074										86,917
NET REAL ESTATE INVESTMENT													23,226										109,051
OTHER (INCLUDING RECEIVABLES)													(536)										235
GAIN/ (IMPAIRMENT)													$ 2,386										$ (22,369)
SQUARE FOOTAGE unaudited | ft²													55,195										348,416
Number of buildings acquired | property																							9
Chicago, IL
Real Estate Dispositions [Line Items]
SALES PRICE										$ 59,950
CLOSING ADJUSTMENTS										(870)
COMPANY-FINANCED NOTES										0
NET PROCEEDS										59,080
NET REAL ESTATE INVESTMENT										74,710
OTHER (INCLUDING RECEIVABLES)										(380)
GAIN/ (IMPAIRMENT)										$ (15,250)
SQUARE FOOTAGE unaudited | ft²										104,912
Evansville, IN
Real Estate Dispositions [Line Items]
SALES PRICE									$ 18,500
CLOSING ADJUSTMENTS									(63)
COMPANY-FINANCED NOTES									0
NET PROCEEDS									18,437
NET REAL ESTATE INVESTMENT									17,807
OTHER (INCLUDING RECEIVABLES)									(149)
GAIN/ (IMPAIRMENT)									$ 779
SQUARE FOOTAGE unaudited | ft²									260,520
Number of owned real estate properties | property									5
Number of Property Dispositions | disposition_transaction									3
Charleston, SC
Real Estate Dispositions [Line Items]
SALES PRICE							$ 6,200
CLOSING ADJUSTMENTS							(401)
COMPANY-FINANCED NOTES							0
NET PROCEEDS							5,799
NET REAL ESTATE INVESTMENT							3,415
OTHER (INCLUDING RECEIVABLES)							0
GAIN/ (IMPAIRMENT)							$ 2,384
SQUARE FOOTAGE unaudited | ft²							15,014
Joint venture, ownership (in percentage)							100%
Tucson, AZ
Real Estate Dispositions [Line Items]
SALES PRICE				$ 43,230
CLOSING ADJUSTMENTS				(3,770)
COMPANY-FINANCED NOTES				(6,000)
NET PROCEEDS				33,460
NET REAL ESTATE INVESTMENT				39,786
OTHER (INCLUDING RECEIVABLES)				(26)
GAIN/ (IMPAIRMENT)				$ (300)
SQUARE FOOTAGE unaudited | ft²				215,471
Number of owned real estate properties | property				12
Number of Property Dispositions | disposition_transaction				1
Mortgage Note				$ 6,000
Miami, FL
Real Estate Dispositions [Line Items]
SALES PRICE				18,250
CLOSING ADJUSTMENTS				(756)
COMPANY-FINANCED NOTES				0
NET PROCEEDS				17,494
NET REAL ESTATE INVESTMENT				17,354
OTHER (INCLUDING RECEIVABLES)				643
GAIN/ (IMPAIRMENT)				$ (503)
SQUARE FOOTAGE unaudited | ft²				48,000
Sebring, FL
Real Estate Dispositions [Line Items]
SALES PRICE			$ 9,500
CLOSING ADJUSTMENTS			(81)
COMPANY-FINANCED NOTES			0
NET PROCEEDS			9,419
NET REAL ESTATE INVESTMENT			10,438
OTHER (INCLUDING RECEIVABLES)			(512)
GAIN/ (IMPAIRMENT)			$ (507)
SQUARE FOOTAGE unaudited | ft²			38,949
Boston, MA
Real Estate Dispositions [Line Items]
SALES PRICE		$ 117,197
CLOSING ADJUSTMENTS		(2,079)
COMPANY-FINANCED NOTES		0
NET PROCEEDS		115,118
NET REAL ESTATE INVESTMENT		107,803
OTHER (INCLUDING RECEIVABLES)		9,828
GAIN/ (IMPAIRMENT)		$ (2,513)
SQUARE FOOTAGE unaudited | ft²		161,254
Jacksonville/Orlando/Miami, FL
Real Estate Dispositions [Line Items]
SALES PRICE	$ 77,000
CLOSING ADJUSTMENTS	(8,678)
COMPANY-FINANCED NOTES	(7,700)
NET PROCEEDS	60,622
NET REAL ESTATE INVESTMENT	65,839
OTHER (INCLUDING RECEIVABLES)	(294)
GAIN/ (IMPAIRMENT)	$ 2,777
SQUARE FOOTAGE unaudited | ft²	354,500
Number of owned real estate properties | property	3
Number of Property Dispositions | disposition_transaction	1
Mortgage Note	$ 7,700
Loveland, CO
Real Estate Dispositions [Line Items]
SALES PRICE																																	$ 84,950
CLOSING ADJUSTMENTS																																	(45)
NET PROCEEDS																																	84,905
NET REAL ESTATE INVESTMENT																																	40,095
OTHER (INCLUDING RECEIVABLES)																																	4
GAIN/ (IMPAIRMENT)																																	$ 44,806
SQUARE FOOTAGE unaudited | ft²																																	150,291
Number of buildings acquired | property																																	2
San Antonio, TX
Real Estate Dispositions [Line Items]
SALES PRICE																																$ 25,500
CLOSING ADJUSTMENTS																																(2,272)
NET PROCEEDS																																23,228
NET REAL ESTATE INVESTMENT																																14,381
OTHER (INCLUDING RECEIVABLES)																																284
GAIN/ (IMPAIRMENT)																																$ 8,563
SQUARE FOOTAGE unaudited | ft²																																201,523
Number of buildings acquired | property																																2
GA, FL, PA
Real Estate Dispositions [Line Items]
SALES PRICE																															$ 133,100
CLOSING ADJUSTMENTS																															(8,109)
NET PROCEEDS																															124,991
NET REAL ESTATE INVESTMENT																															124,991
OTHER (INCLUDING RECEIVABLES)																															0
GAIN/ (IMPAIRMENT)																															$ 0
SQUARE FOOTAGE unaudited | ft²																															316,739
Number of buildings acquired | property																															4
GA, FL, TX
Real Estate Dispositions [Line Items]
SALES PRICE																														$ 160,917
CLOSING ADJUSTMENTS																														(5,893)
NET PROCEEDS																														155,024
NET REAL ESTATE INVESTMENT																														151,819
OTHER (INCLUDING RECEIVABLES)																														3,205
GAIN/ (IMPAIRMENT)																														$ 0
SQUARE FOOTAGE unaudited | ft²																														343,545
Number of buildings acquired | property																														6
Indianapolis, IN
Real Estate Dispositions [Line Items]
SALES PRICE																											$ 238,845
CLOSING ADJUSTMENTS																											(5,846)
NET PROCEEDS																											232,999
NET REAL ESTATE INVESTMENT																											84,767
OTHER (INCLUDING RECEIVABLES)																											4,324
GAIN/ (IMPAIRMENT)																											$ 143,908
SQUARE FOOTAGE unaudited | ft²																											506,406
Number of buildings acquired | property																											5
Number of properties acquired in the merger | property																											2
College Station, TX
Real Estate Dispositions [Line Items]
SALES PRICE																								$ 49,177
CLOSING ADJUSTMENTS																								(3,755)
NET PROCEEDS																								45,422
NET REAL ESTATE INVESTMENT																								44,918
OTHER (INCLUDING RECEIVABLES)																								475
GAIN/ (IMPAIRMENT)																								$ 28
SQUARE FOOTAGE unaudited | ft²																								122,942
El Paso, TX
Real Estate Dispositions [Line Items]
SALES PRICE																							$ 55,326
CLOSING ADJUSTMENTS																							(4,002)
NET PROCEEDS																							51,324
NET REAL ESTATE INVESTMENT																							56,427
OTHER (INCLUDING RECEIVABLES)																							(1,897)
GAIN/ (IMPAIRMENT)																							$ (3,205)
SQUARE FOOTAGE unaudited | ft²																							110,465
Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALES PRICE																																		$ 787,042
CLOSING ADJUSTMENTS																																		(36,860)
COMPANY-FINANCED NOTES																																		(58,700)
NET PROCEEDS																																		691,482
NET REAL ESTATE INVESTMENT																																		708,082
OTHER (INCLUDING RECEIVABLES)																																		8,444
GAIN/ (IMPAIRMENT)																																		$ 33,658
SQUARE FOOTAGE unaudited | ft²																																		2,282,057

Held for Sale - Narrative (Deta

Held for Sale - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 property
Discontinued Operations and Disposal Groups [Abstract]
Number of properties classified as held for sale | property	1	1
Impairment charges on net real estate assets held for sale | $	$ 5.9

Held for - Sale Assets Held for

Held for - Sale Assets Held for Sale (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet data
Land	$ 1,343,265	$ 1,439,798
Buildings and improvements	10,881,373	11,332,037
Total real estate investments	13,399,067	14,057,625
Less accumulated depreciation	(2,226,853)	(1,645,271)
Total real estate investments, net	11,172,214	12,412,354
Assets held for sale, net	8,834	18,893
Liabilities of properties held for sale	295	437
Disposal Group, Held-for-sale, Not Discontinued Operations
Balance Sheet data
Land	1,850	1,700
Buildings and improvements	6,779	15,164
Lease intangibles	1,017	1,986
Total real estate investments	9,646	18,850
Less accumulated depreciation	(913)	0
Total real estate investments, net	8,733	18,850
Other assets, net	101	43
Assets held for sale, net	8,834	18,893
Accounts payable and accrued liabilities	23	282
Other liabilities	272	155
Liabilities of properties held for sale	$ 295	$ 437

Impairment Charges (Details)

Impairment Charges (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($) property
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of properties sold	31	12
Number of properties redeveloped	6	3
Impairment charges | $	$ 149.7	$ 54.4
Number of owned real estate properties	655
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of owned real estate properties	6
Fair value | $	$ 53.6

Other Assets - Other Assets (De

Other Assets - Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Real estate notes receivable, net	$ 173,614	$ 99,643
Straight-line rent receivables	116,866	88,868
Prepaid assets	116,455	81,900
Above-market intangible assets, net	66,695	80,720
Accounts receivable, net	63,203	54,667
Additional long-lived assets, net	20,717	21,446
Interest rate swap assets	4,634	14,512
Investment in securities	6,011	6,011
Debt issuance costs, net	3,867	5,977
Project costs	6,187	4,337
Net investment in lease	2,112	1,828
Customer relationship intangible assets, net	1,066	1,120
Other	10,941	8,961
Other assets	592,368	469,990
Allowance for doubtful accounts	$ 8,400	4,000
Other receivables, net		$ 7,169

Intangible Assets and Liabili_3

Intangible Assets and Liabilities - Components of intangible assets and liabilities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of finite lived intangible assets and liabilities
Intangible assets and liabilities, gross	$ 1,082.3	$ 1,278.6
Intangible assets and liabilities, accumulated amortization	$ 301.5	186.3
Assets and liabilities, weighted avg. life (years)	4 years 3 months 18 days
Below-market lease intangibles (lessor) | Other liabilities
Schedule of finite lived intangible assets and liabilities
Liabilities gross balance	$ (112.5)	(112.5)
Liabilities accumulated amortization	$ (35.7)	(14.6)
Liabilities, weighted avg. life (years)	5 years 9 months 18 days
Goodwill | Other Assets
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 250.5	223.2
Assets accumulated amortization	0	0
Credit facility debt issuance costs | Other Assets
Schedule of finite lived intangible assets and liabilities
Assets gross balance	6.9	6.9
Assets accumulated amortization	$ 3.1	0.9
Assets, weighted avg. life (years)	1 year 10 months 24 days
Above-market lease intangibles (lessor) | Other Assets
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 98	91.5
Assets accumulated amortization	$ 31.3	10.7
Assets, weighted avg. life (years)	5 years 3 months 18 days
Customer relationship intangibles (lessor) | Other Assets
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 2.1	2.1
Assets accumulated amortization	$ 1.1	1
Assets, weighted avg. life (years)	19 years 7 months 6 days
At-market lease intangibles | At-market lease intangibles
Schedule of finite lived intangible assets and liabilities
Assets gross balance	$ 837.3	1,067.4
Assets accumulated amortization	$ 301.7	$ 188.3
Assets, weighted avg. life (years)	4 years

Intangible Assets and Liabili_4

Intangible Assets and Liabilities - Expected future amortization expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible amortization expense	$ 214.8	$ 133.6
Future Amortization of Intangibles, Net [Abstract]
2024	206.7
2025	109.1
2026	84.3
2027	53
2028	$ 31.9

Notes and Bonds Payable (Detail

Notes and Bonds Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Senior notes carrying amount	$ 4,994,859,000	$ 5,351,827,000
Line of Credit | $1.5B Unsecured Credit Facility
Debt Instrument [Line Items]
Credit facility	1,500,000,000
Senior notes carrying amount	$ 0	385,000,000
EFFECTIVE INTEREST RATES	6.24%
Line of Credit | $1.5B Unsecured Credit Facility | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	0.95%
Medium-term Notes | $350 million Unsecured Term Loan due 2023, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 350,000,000
Senior notes carrying amount	$ 349,798,000	349,114,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $350 million Unsecured Term Loan due 2023, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $200 million Unsecured Term Loan due 2024, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 200,000,000
Senior notes carrying amount	$ 199,903,000	199,670,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $200 million Unsecured Term Loan due 2024, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $150 million Unsecured Term Loan due 2026, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 150,000,000
Senior notes carrying amount	$ 149,643,000	149,495,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $150 million Unsecured Term Loan due 2026, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $300 million Unsecured Term Loan due 2025, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 300,000,000
Senior notes carrying amount	$ 299,958,000	299,936,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $300 million Unsecured Term Loan due 2025, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $200 million Unsecured Term Loan due 2027, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 200,000,000
Senior notes carrying amount	$ 199,502,000	199,362,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $200 million Unsecured Term Loan due 2027, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Medium-term Notes | $300 million Unsecured Term Loan due 2028, net of issuance costs
Debt Instrument [Line Items]
Face value	$ 300,000,000
Senior notes carrying amount	$ 298,288,000	297,869,000
EFFECTIVE INTEREST RATES	6.30%
Medium-term Notes | $300 million Unsecured Term Loan due 2028, net of issuance costs | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Contractual interest rates, basis spread on variable rate	1.05%
Senior Notes | Senior Notes due 2025
Debt Instrument [Line Items]
Senior notes carrying amount	$ 249,484,000	249,115,000
Contractual interest rates	3.88%
EFFECTIVE INTEREST RATES	4.12%
Senior Notes | Senior Notes due 2026
Debt Instrument [Line Items]
Senior notes carrying amount	$ 579,017,000	571,587,000
Contractual interest rates	3.50%
EFFECTIVE INTEREST RATES	4.94%
Senior Notes | Senior Notes Due 2027
Debt Instrument [Line Items]
Senior notes carrying amount	$ 483,727,000	479,553,000
Contractual interest rates	3.75%
EFFECTIVE INTEREST RATES	4.76%
Senior Notes | Senior Notes due 2028
Debt Instrument [Line Items]
Senior notes carrying amount	$ 297,429,000	296,852,000
Contractual interest rates	3.63%
EFFECTIVE INTEREST RATES	3.85%
Senior Notes | Senior Notes Due 2030 One
Debt Instrument [Line Items]
Senior notes carrying amount	$ 575,443,000	565,402,000
Contractual interest rates	3.10%
EFFECTIVE INTEREST RATES	5.30%
Senior Notes | Senior Notes Due 2030 Two
Debt Instrument [Line Items]
Senior notes carrying amount	$ 296,780,000	296,385,000
Contractual interest rates	2.40%
EFFECTIVE INTEREST RATES	2.72%
Senior Notes | Senior Notes Due 2031 One
Debt Instrument [Line Items]
Senior notes carrying amount	$ 295,832,000	295,547,000
Contractual interest rates	2.05%
EFFECTIVE INTEREST RATES	2.25%
Senior Notes | Senior Notes Due 2031 Two
Debt Instrument [Line Items]
Senior notes carrying amount	$ 649,521,000	632,693,000
Contractual interest rates	2%
EFFECTIVE INTEREST RATES	5.13%
Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Face value	$ 70,752,000	84,122,000
Senior notes carrying amount	$ 70,534,000	$ 84,247,000
Minimum | Mortgage Notes
Debt Instrument [Line Items]
Contractual interest rates	3.60%
Minimum | Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Contractual interest rates	3.60%
EFFECTIVE INTEREST RATES	3.57%
Maximum | Mortgage Notes
Debt Instrument [Line Items]
Contractual interest rates	4.80%
Maximum | Mortgage Notes | Mortgage Notes Payable
Debt Instrument [Line Items]
Contractual interest rates	4.77%
EFFECTIVE INTEREST RATES	6.88%

Notes and Bonds Payable - Senio

Notes and Bonds Payable - Senior and Term Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Debt issuance costs	$ (3,867)	$ (5,977)
Senior notes carrying amount	4,994,859	5,351,827
Healthcare Trust Of America, Inc
Debt Instrument [Line Items]
Principal balance	3,699,285	3,699,500
Unaccreted discount	(265,852)	(304,919)
Debt issuance costs	(6,200)	(7,447)
Senior notes carrying amount	$ 3,427,233	$ 3,387,134

Notes and Bonds Payable - Mortg

Notes and Bonds Payable - Mortgage Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Debt issuance costs	$ (3,867,000)	$ (5,977,000)
NOTES AND BONDS PAYABLE	4,994,859,000	5,351,827,000
Term Loan Net | Term Loan
Debt Instrument [Line Items]
Face value	1,500,000,000	1,500,000,000
Debt issuance costs	(2,908,000)	(4,554,000)
NOTES AND BONDS PAYABLE	1,497,092,000	1,495,446,000
Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Face value	70,752,000	84,122,000
Unamortized premium	285,000	486,000
Unaccreted discount	(237,000)	(38,000)
Debt issuance costs	(266,000)	(323,000)
NOTES AND BONDS PAYABLE	$ 70,534,000	$ 84,247,000

Notes and Bonds Payable - Narra

Notes and Bonds Payable - Narrative (Details) $ in Thousands	Feb. 01, 2024 USD ($) ft²	Jan. 06, 2024 USD ($) ft²	Dec. 01, 2023 USD ($) ft²	Aug. 01, 2023 USD ($) ft²	Dec. 31, 2023 USD ($)	Jul. 28, 2023 USD ($) ft²	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Senior notes carrying amount | $					$ 4,994,859		$ 5,351,827
Mortgage Notes
Debt Instrument [Line Items]
EFFECTIVE INTEREST RATES			4.51%	3.31%
Amount of debt repaid | $			$ 6,600	$ 9,800
Mortgage Notes | Subsequent Event
Debt Instrument [Line Items]
EFFECTIVE INTEREST RATES	4.12%	4.77%
Amount of debt repaid | $	$ 5,600	$ 11,300
Mortgage Notes Payable
Debt Instrument [Line Items]
Percentage of interest-bearing in mortgage notes payable						4.50%
Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Senior notes carrying amount | $					$ 70,534		$ 84,247
Colorado Springs, CO | Mortgage Notes
Debt Instrument [Line Items]
Encumbered square footage | ft²			93,992
Colorado Springs, CO | Mortgage Notes Payable | Mortgage Notes
Debt Instrument [Line Items]
Senior notes carrying amount | $						$ 5,600
Square feet subject to mortgage notes payable | ft²						42,770
Atlanta, GA | Mortgage Notes
Debt Instrument [Line Items]
Encumbered square footage | ft²				66,984
Atlanta, GA | Mortgage Notes | Subsequent Event
Debt Instrument [Line Items]
Encumbered square footage | ft²	40,324
California | Mortgage Notes | Subsequent Event
Debt Instrument [Line Items]
Encumbered square footage | ft²		63,012

Notes and Bonds Payable - Detai

Notes and Bonds Payable - Details of Mortgage Notes (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) mortage_note_payable	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Number of outstanding mortgage notes | mortage_note_payable	4
Mortgage Notes
Debt Instrument [Line Items]
Investment in collateral	$ 202,100,000
Mortgage notes payable carrying amount	$ 70,500,000	$ 84,200,000
Number of outstanding mortgage notes | mortage_note_payable	7
Mortgage Notes | Minimum
Debt Instrument [Line Items]
Contractual interest rates	3.60%
Mortgage Notes | Maximum
Debt Instrument [Line Items]
Contractual interest rates	4.80%
Mortgage Notes | Mortgage Notes 3.86% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 12,300,000
Effective interest rate	3.86%
Collateral	MOB
Principal and interest amortization period	7 years
Investment in collateral	$ 0
Mortgage notes payable carrying amount	0	10,000,000
Unencumbered gross investment	26,000,000
Mortgage Notes | Mortgage Notes 4.84% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 9,000,000
Effective interest rate	4.84%
Collateral	MOB,OFC
Principal and interest amortization period	10 years
Investment in collateral	$ 0
Mortgage notes payable carrying amount	0	6,800,000
Unencumbered gross investment	24,500,000
Mortgage Notes | Mortgage Notes 4.13% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 13,300,000
Effective interest rate	4.13%
Collateral	MOB
Principal and interest amortization period	10 years
Investment in collateral	$ 24,400,000
Mortgage notes payable carrying amount	11,300,000	11,700,000
Unamortized premium	800,000
Mortgage Notes | Mortgage Notes 3.96% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 6,800,000
Effective interest rate	3.96%
Collateral	MOB
Principal and interest amortization period	7 years
Investment in collateral	$ 12,600,000
Mortgage notes payable carrying amount	5,600,000	5,800,000
Unamortized premium	200,000
Mortgage Notes | Mortgage Notes 4.32% | Life Insurance Co.
Debt Instrument [Line Items]
Mortgage notes payable carrying amount		7,500,000
Mortgage Notes | Mortgage Notes 4.32% | Financial Services
Debt Instrument [Line Items]
Principal balance	$ 9,700,000
Effective interest rate	4.32%
Collateral	MOB
Principal and interest amortization period	10 years
Investment in collateral	$ 16,900,000
Mortgage notes payable carrying amount	7,200,000
Unamortized premium	100,000
Mortgage Notes | Mortgage Notes 3.43% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 16,500,000
Effective interest rate	3.43%
Collateral	MOB,OFC
Principal and interest amortization period	7 years
Investment in collateral	$ 49,200,000
Mortgage notes payable carrying amount	15,900,000	16,200,000
Unamortized premium	700,000
Mortgage Notes | Mortgage Notes 3.71% | Financial Services
Debt Instrument [Line Items]
Principal balance	$ 11,500,000
Effective interest rate	3.71%
Collateral	MOB
Principal and interest amortization period	10 years
Investment in collateral	$ 41,700,000
Mortgage notes payable carrying amount	7,800,000	8,300,000
Mortgage Notes | Mortgage Notes 6.883% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 6,000,000
Effective interest rate	6.88%
Principal and interest amortization period	7 years
Unaccreted discount	$ 300,000
Mortgage Notes | Mortgage Notes 6.883% | Financial Services
Debt Instrument [Line Items]
Investment in collateral	11,600,000
Mortgage notes payable carrying amount	5,200,000	0
Mortgage Notes | Mortgage Notes 4.08% | Life Insurance Co.
Debt Instrument [Line Items]
Principal balance	$ 19,200,000
Effective interest rate	4.08%
Collateral	MOB
Principal and interest amortization period	10 years
Investment in collateral	$ 45,700,000
Mortgage notes payable carrying amount	$ 17,500,000	$ 17,900,000

Notes and Bonds Payable - Futur

Notes and Bonds Payable - Future Maturities (Details) $ in Thousands	Dec. 31, 2023 USD ($) mortage_note_payable	Dec. 31, 2022 USD ($)
Long Term Debt Maturities [Line Items]
Number of outstanding mortgage notes | mortage_note_payable	4
Excluded debt issuance costs	$ 3,900
Future contractual maturities of the Company's notes and bonds payable
Debt issuance costs	(3,867)	$ (5,977)
NOTES AND BONDS PAYABLE	4,994,859	$ 5,351,827
2024
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	575,473
Net Accretion/Amortization	(41,050)
Debt issuance costs	(2,438)
NOTES AND BONDS PAYABLE	$ 531,985
%	10.70%
2025
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 566,375
Net Accretion/Amortization	(43,163)
Debt issuance costs	(1,916)
NOTES AND BONDS PAYABLE	$ 521,296
%	10.40%
2026
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 778,904
Net Accretion/Amortization	(41,837)
Debt issuance costs	(1,650)
NOTES AND BONDS PAYABLE	$ 735,417
%	14.70%
2027
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 700,000
Net Accretion/Amortization	(36,192)
Debt issuance costs	(1,519)
NOTES AND BONDS PAYABLE	$ 662,289
%	13.30%
2028
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 600,000
Net Accretion/Amortization	(35,179)
Debt issuance costs	(707)
NOTES AND BONDS PAYABLE	$ 564,114
%	11.30%
2029 and thereafter
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 2,049,285
Net Accretion/Amortization	(68,382)
Debt issuance costs	(1,145)
NOTES AND BONDS PAYABLE	$ 1,979,758
%	39.60%
Net of Unsecured Credit Facility
Future contractual maturities of the Company's notes and bonds payable
PRINCIPAL MATURITIES	$ 5,270,037
Net Accretion/Amortization	(265,803)
Debt issuance costs	(9,375)
NOTES AND BONDS PAYABLE	$ 4,994,859
%	100%

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) $ in Millions	Dec. 31, 2023 USD ($)	Nov. 09, 2023 USD ($)	Oct. 23, 2023 USD ($) transaction	Oct. 19, 2023 USD ($) transaction	Mar. 28, 2023 USD ($)	Feb. 16, 2023 USD ($)
Derivative [Line Items]
Reclassified from accumulated other comprehensive loss	$ 7.3
Fair value of derivatives in a net liability position	$ 11
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, Expiring June 1, 2026
Derivative [Line Items]
Derivative notional amount					$ 100	$ 50
Derivative, fixed interest rate					3.67%	4.16%
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, Effective November 1, 2023
Derivative [Line Items]
Derivative notional amount				$ 100
Number of swap transactions | transaction				2
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, Expiring June 1, 2027
Derivative [Line Items]
Derivative notional amount				$ 50
Derivative, fixed interest rate				4.71%
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, Expiring December 1, 2027
Derivative [Line Items]
Derivative notional amount				$ 50
Derivative, fixed interest rate				4.67%
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, Expiring May 31, 2026
Derivative [Line Items]
Derivative notional amount		$ 75	$ 100
Derivative, fixed interest rate		4.54%	4.73%
Number of swap transactions | transaction			2

Derivative Financial Instrume_4

Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Interest Rate Swap
Derivative [Line Items]
Derivative notional amount	$ 1,275,000	$ 1,150,000
Derivative, fixed interest rate	3.49%	2.63%
Interest Rate Swap, Expiring January 2023
Derivative [Line Items]
Derivative notional amount		$ 300,000
Derivative, fixed interest rate		1.42%
Interest Rate Swap, Expiring January 2024
Derivative [Line Items]
Derivative notional amount	$ 200,000	$ 200,000
Derivative, fixed interest rate	1.21%	1.21%
Interest Rate Swap, Expiring May 2026
Derivative [Line Items]
Derivative notional amount	$ 275,000	$ 100,000
Derivative, fixed interest rate	3.74%	2.15%
Interest Rate Swap, Expiring June 2026
Derivative [Line Items]
Derivative notional amount	$ 150,000
Derivative, fixed interest rate	3.83%
Interest Rate Swap, Expiring December 2026
Derivative [Line Items]
Derivative notional amount	$ 150,000	$ 150,000
Derivative, fixed interest rate	3.84%	3.84%
Interest Rate Swap, Expiring June 2027
Derivative [Line Items]
Derivative notional amount	$ 200,000	$ 150,000
Derivative, fixed interest rate	4.27%	4.13%
Interest Rate Swap, Expiring December 2027
Derivative [Line Items]
Derivative notional amount	$ 300,000	$ 250,000
Derivative, fixed interest rate	3.93%	3.79%

Derivative Financial Instrume_5

Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets	$ 4,625
GROSS AMOUNTS of recognized liabilities	(12,424)
Interest rate swaps 2019 | Designated as Hedging Instrument | Other Assets
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets	4,214	$ 13,603
Interest rate swaps 2022 | Designated as Hedging Instrument | Other Assets
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets		909
Interest rate swaps 2022 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized liabilities	(5,067)	(4,269)
Interest rate swaps 2023 | Designated as Hedging Instrument | Other Assets
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets	411
Interest rate swaps 2023 | Designated as Hedging Instrument | Other liabilities
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized liabilities	(7,357)
Interest Rate Swap | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
GROSS AMOUNTS of recognized assets		$ 10,243
GROSS AMOUNTS of recognized liabilities	$ (7,799)

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	$ 1,463	$ 10,630	$ 3,379
Amount of (gain)/loss reclassified from AOCI into income	14,488	(1,527)	$ (4,472)
Interest rate swaps 2017
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	0	302
Interest rate swaps 2018
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	0	616
Interest rate swaps 2019
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	1,995	12,964
Interest rate swaps 2022
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	4,583	(3,252)
Interest rate swaps 2023
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	(5,115)	0
Settled treasury hedges
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	0	0
Settled interest rate swaps
Derivative [Line Items]
Amount of gain/(loss) recognized in AOCI on derivative	0	0
Interest expense
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	(14,488)	1,527
Interest expense | Interest rate swaps 2017
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	0	118
Interest expense | Interest rate swaps 2018
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	0	361
Interest expense | Interest rate swaps 2019
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	(6,964)	563
Interest expense | Interest rate swaps 2022
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	(6,289)	(109)
Interest expense | Interest rate swaps 2023
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	(1,829)	0
Interest expense | Settled treasury hedges
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	426	426
Interest expense | Settled interest rate swaps
Derivative [Line Items]
Amount of (gain)/loss reclassified from AOCI into income	$ 168	$ 168

Derivative Financial Instrume_7

Derivative Financial Instruments - Offsetting Derivatives (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Offsetting of Derivative Assets
GROSS AMOUNTS of recognized assets	$ 4,625
GROSS AMOUNTS OFFSET in the Consolidated Balance Sheets	0
NET AMOUNTS OF ASSETS presented in the Consolidated Balance Sheets	4,625
FINANCIAL INSTRUMENTS	(4,625)
CASH COLLATERAL	0
NET AMOUNT	$ 0
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets
Offsetting of Derivative Liabilities
GROSS AMOUNTS of recognized liabilities	$ (12,424)
GROSS AMOUNTS OFFSET in the Consolidated Balance Sheets	0
NET AMOUNTS OF LIABILITIES presented in the Consolidated Balance Sheets	(12,424)
FINANCIAL INSTRUMENTS	4,625
CASH COLLATERAL	0
NET AMOUNT	$ (7,799)
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities

Stockholders' Equity - Common s

Stockholders' Equity - Common shares (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock, outstanding (in shares)	0	0
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of year (in shares)	380,590,000
Balance, end of year (in shares)	380,964,000	380,590,000
Common Stock
Class of Stock [Line Items]
Preferred stock, outstanding (in shares)	0	0	0
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of year (in shares)	380,589,894	150,457,433	139,487,375
Issuance of common stock (in shares)	8,627	229,618,304	10,899,301
Conversion of OP units to common stock (in shares)	190,544	0	0
Non-vested share-based awards, net of withheld shares and forfeitures (in shares)	175,368	514,157	70,757
Balance, end of year (in shares)	380,964,433	380,589,894	150,457,433

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) - USD ($)		12 Months Ended
	Feb. 13, 2024	Dec. 31, 2023	May 31, 2023
Class of Stock [Line Items]
Dividends per share to common stockholders, paid per quarter (in USD per share)		$ 0.31
Stock repurchase, amount authorized			$ 500,000,000
Subsequent Event
Class of Stock [Line Items]
Dividends per share to common stockholders, declared (in USD per share)	$ 0.31
Dividend Declared
Class of Stock [Line Items]
Dividends per share to common stockholders, declared (in USD per share)		$ 1.24
Common Stock
Class of Stock [Line Items]
Equity offering program of common stock		$ 750,000,000

Stockholders' Equity - Accumula

Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Net current-period other comprehensive (loss) income	$ (13,025)	$ 12,157	$ 7,851
Forward Starting Swaps | Reclassification out of Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	2,140	(9,981)
Other comprehensive income (loss) before reclassifications	1,434	1,531
Amounts reclassified from accumulated other comprehensive (loss) income	(14,315)	10,590
Net current-period other comprehensive (loss) income	(12,881)	12,121
Balance, end of period	$ (10,741)	$ 2,140	$ (9,981)

Stockholders' Equity - Reclassi

Stockholders' Equity - Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	$ 258,584	$ 146,691	$ 53,124
Net (loss) income	282,083	$ (40,693)	$ (66,659)
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net (loss) income	(14,488)
Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income (Loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	594
Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income (Loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest Expense	$ (15,082)

Stock and Other Incentive Pla_3

Stock and Other Incentive Plans - Stock Incentive Plan Narrative (Details) - Restricted Stock - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jul. 20, 2022
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	8,102,861	9,432,388		9,647,839
Accelerated stock compensation expense	$ 14.6	$ 13.9	$ 10.4
Legacy HR Incentive Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Legacy HR Incentive Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	8 years

Stock and Other Incentive Pla_4

Stock and Other Incentive Plans - Amortization of Compensation for Nonvested Shares (Details) $ in Millions	Dec. 31, 2023 USD ($)
Share-Based Payment Arrangement [Abstract]
2024	$ 12.2
2025	9.7
2026	6.9
2027	2.1
2028 and thereafter	0.5
Total	$ 31.4

Stock and Other Incentive Pla_5

Stock and Other Incentive Plans - Executive Incentive Plan Narrative (Details) - Executive Incentive Plan - USD ($) $ / shares in Units, $ in Millions						12 Months Ended
	Jan. 04, 2027	Jan. 04, 2026	Jan. 04, 2025	Jan. 04, 2024	Jan. 04, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested grant date fair value (in dollars per share)					$ 22.55
At the Market Equity Offering Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of RSUnits					43%
Market Condition 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, fair value (in dollars per share)					$ 24.23
Market Condition 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, fair value (in dollars per share)					$ 27.84
Performance Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of RSUnits					57%
Vested grant date fair value (in dollars per share)					$ 20.21
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense						$ 9	$ 9.8	$ 6.6
Performance Shares | Share-Based Payment Arrangement, Nonemployee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period					3 years
Non Vested Stock Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted in period					$ 4.1
Shares issued under the plan (in shares)					205,264
Award vesting period					5 years
Non Vested Stock Award | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense				$ 0.8
Non Vested Stock Award | Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense	$ 0.8	$ 0.8	$ 0.8
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period					5 years
Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Nonemployee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued under the plan (in shares)					165,174
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage					50%
Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage					50%

Stock and Other Incentive Pla_6

Stock and Other Incentive Plans - Schedule of Stock Options, Valuation Assumptions (Details) - $ / shares		1 Months Ended
	Jan. 04, 2023	Jan. 31, 2023
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Volatility	34%
Expected term in years	3 years
Risk-free rate	4.42%
Stock price (in dollar per share)	$ 20.21
Operating Partnership Performance Units
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Volatility		34%
Expected term in years		3 years
Risk-free rate		4.42%
Stock price (in dollar per share)		$ 20.21

Stock and Other Incentive Pla_7

Stock and Other Incentive Plans - LTIP Series C Units Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Jan. 31, 2023	Dec. 31, 2023
Operating Partnership Performance Units | Market Condition 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, fair value (in dollars per share)	$ 12.24
Operating Partnership Performance Units | Market Condition 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, fair value (in dollars per share)	$ 13.98
LTIP Series C Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award performance period	3 years
LTIP Series C Units | Operating Partnership Performance Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of RSUnits	43%
Granted, fair value (in dollars per share)	$ 15.85
LTIP Series C Units | Operating Partnership Performance Units | Performance Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of RSUnits	57%
Granted, fair value (in dollars per share)	$ 20.21
LTIP Series C Units | Share-Based Payment Arrangement, Employee | Operating Partnership Performance Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted in period (in shares)	627,547
Award vesting period	5 years
LTIP Series C Units | Directors | Share-Based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value	$ 7.1
LTIP Series C Units | Officer | LTIP-C Unit Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense		$ 1.2

Stock and Other Incentive Pla_8

Stock and Other Incentive Plans - Officer Incentive Program Narrative (Details) - Officer Incentive Program $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($) shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Non-Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of performance based awards released	$ 0.7
Number of executive officers granted awards (in shares) | shares	33,438
Non-Executive Officers | Minimum | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Non-Executive Officers | Maximum | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	8 years
Non-Executive Officers | Weighted Average | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense		$ 0.6	$ 0.9	$ 1

Stock and Other Incentive Pla_9

Stock and Other Incentive Plans - Salary Deferral Plan Narrative (Details) - Salary Deferral Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum salary deferral for officers under the plan, percent	50%
Shares issued under the plan (in shares)	31,792	17,381	21,396
Accelerated stock compensation expense	$ 0.9	$ 0.9	$ 0.9
Deferral Option One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Employer matching contribution, percent	30%
Deferral Option Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
Employer matching contribution, percent	50%
Deferral Option Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	8 years
Employer matching contribution, percent	100%

Stock and Other Incentive Pl_10

Stock and Other Incentive Plans - Non-employee Directors Incentive Plan Narrative (Details) - Non-Employee Directors Incentive Plan $ in Millions			12 Months Ended
	Jun. 05, 2023 USD ($) director shares	May 13, 2022	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares
Non Vested Stock Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Granted in period | $	$ 0.7
Granted in period (in shares) | shares	42,768
LTIP-D units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Granted in period | $	$ 1.1
Granted in period (in shares) | shares	57,868
Restricted Stock and Performance Based Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			1 year
Restricted Stock and Performance Based Awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			8 years
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining contractual terms			4 years 9 months 18 days
Withheld of common stock (in shares) | shares			126,085	137,892	129,987
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		1 year
Accelerated stock compensation expense | $			$ 2.1	$ 1.5	$ 1.2
Director | Non Vested Stock Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of directors | director	6
Director | LTIP-D units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of directors | director	6

Stock and Other Incentive Pl_11

Stock and Other Incentive Plans - 2015 Incentive Plan and related information (Details) - Stock Incentive Plan - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Summary of the activity under the incentive plans
Share-based awards, beginning of year (in shares)	2,090,060	1,562,028	1,766,061
Granted (in shares)	1,164,359	952,407	203,701
Vested (in shares)	(403,266)	(418,949)	(404,777)
Change in awards based on performance assessment (in shares)	(205,668)	0	0
Forfeited (in shares)	(29,923)	(5,426)	(2,957)
Share-based awards, end of year (in shares)	2,615,562	2,090,060	1,562,028
Weighted-average grant date fair value of:
Share-based awards, beginning of year (in dollars per share)	$ 30.35	$ 31.10	$ 30.51
Share-based awards granted during the year (in dollars per share)	18.70	29.64	30.86
Share-based awards vested during the years (in dollars per share)	28.38	31.52	28.38
Share-based awards change in performance assessment during the year (in dollars per share)	29.05	0	0
Share-based awards forfeitures during the year (in dollars per share)	31.16	31.48	33.04
Share-based awards, end of year (in dollars per share)	$ 25.56	$ 30.35	$ 31.10
Grant date fair value of shares granted during the year	$ 22,171	$ 28,225	$ 6,286

Stock and Other Incentive Pl_12

Stock and Other Incentive Plans - 401(k) Plan/Employee Stock Purchase Plan Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
401(k) Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined contribution plan, employer matching contribution, amount of employees gross pay	$ 2,800
Value of matching contribution	1,500,000	$ 1,200,000	$ 700,000
Employee Stock Purchase Plan | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash received from employees upon exercising options	$ 200,000	400,000	800,000
Employee Stock Purchase Plan | Employee Stock Purchase Plan | General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated stock compensation expense		$ 400,000	$ 400,000

Stock and Other Incentive Pl_13

Stock and Other Incentive Plans - Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Stock Options Outstanding:
Options outstanding, beginning of year (in shares)	340,976	348,514	341,647
Granted (in shares)	0	255,960	253,200
Exercised (in shares)	(8,627)	(20,246)	(30,281)
Forfeited (in shares)	(43,737)	(102,619)	(71,630)
Expired (in shares)	(132,999)	(140,633)	(144,422)
Outstanding, end of period (in shares)	155,613	340,976	348,514
Weighted-average exercise price:
Options outstanding, beginning of year (in dollars per share)	$ 16.38	$ 25.38	$ 24.70
Options granted during the year (in dollars per share)	0	26.89	25.16
Options exercised during the year (in dollars per share)	15.07	20.97	25.03
Options forfeited during the year (in dollars per share)	15.50	21.88	25.45
Options expired during the year (in dollars per share)	16.43	23.36	24.17
Options outstanding, end of year (in dollars per share)	12.98	16.38	25.38
Weighted-average fair value of options granted during the year (calculated as of the grant date) (in dollars per share)	$ 0	$ 9.91	$ 9.05
Intrinsic value of options exercised during the year	$ 23	$ 75	$ 165
Intrinsic value of options outstanding (calculated as of December 31)	$ 401	$ 985	$ 1,997
Exercise prices of options outstanding (calculated as of December 31) (in dollars per share)	$ 14.65	$ 16.38	$ 25.91
Weighted-average contractual life of outstanding options (calculated as of December 31, in years)	3 months 18 days	9 months 18 days	9 months 18 days

Stock and Other Incentive Pl_14

Stock and Other Incentive Plans - Black-Scholes Options Pricing Model (Details) - Employee Stock Purchase Plan	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair value of options issued based on weighted-average assumptions
Risk-free interest rates	0%	0.73%	0.13%
Expected dividend yields	0%	3.97%	4.11%
Expected life (in years)		1 year 5 months 8 days	1 year 5 months 4 days
Expected volatility	0%	49%	48.20%
Expected forfeiture rates	0%	85%	85%

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Dilutive effect of forward equity (in shares)	0	0	0
Proceeds from issuance of common stock, adjusted for costs to borrow			$ 23.1
Weighted-average incremental shares of common stock excluded from the computation (in shares)			1,682
Employee Stock Option
Class of Stock [Line Items]
Weighted-average incremental shares of common stock excluded from the computation (in shares)	31,997
Employee Stock Option | Operating Partnership Performance Units
Class of Stock [Line Items]
Nonvested shares (in shares)	4,023,679
At the Market Equity Offering Program
Class of Stock [Line Items]
Dilutive effect of forward equity (in shares)			700,000

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Earnings per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Weighted average common shares outstanding
Weighted average common shares outstanding (in shares)	380,850,967	254,296,810	144,411,835
Non-vested shares (in shares)	(1,923,096)	(1,940,607)	(1,774,669)
Weighted average common shares outstanding - Basic (in shares)	378,927,871	252,356,203	142,637,166
Dilutive effect of forward equity (in shares)	0	0	0
Dilutive effect of OP Units (in shares)	0	1,451,599	0
Dilutive effect of employee stock purchase plan (in shares)	0	65,519	73,062
Weighted average common shares outstanding - diluted (in shares)	378,927,871	253,873,321	142,710,228
Net (loss) income	$ (282,083)	$ 40,693	$ 66,659
Net loss attributable to non-controlling interest	3,822	204	0
Net (loss) income attributable to common stockholders	(278,261)	40,897	66,659
Income allocated to participating securities	(2,504)	(2,437)	(2,154)
Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units	(851)	0	0
Net (loss) income applicable to common stockholders - basic	(281,616)	38,460	64,505
Net income attributable to OP Units	0	81	0
Net income applicable to common stockholders - diluted	$ (281,616)	$ 38,541	$ 64,505
Basic earnings per common share - net income (in dollars per share)	$ (0.74)	$ 0.15	$ 0.45
Diluted earnings per common share- net income (in dollars per share)	$ (0.74)	$ 0.15	$ 0.45

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($) property
Property, Plant and Equipment [Line Items]
Number of land parcels held for development | property	17	20
Investment in land held for development	$ 59.9	$ 74.3
Letter of Credit
Property, Plant and Equipment [Line Items]
Deposits	38.5
Active Development Properties
Property, Plant and Equipment [Line Items]
Construction activity and development properties	69.1
Redevelopment Properties
Property, Plant and Equipment [Line Items]
Construction activity and development properties	20.5
Completed Develpoment and Redevelopment Properties
Property, Plant and Equipment [Line Items]
Construction activity and development properties	22.6
First and Second Generation Leases | Tenant Improvement Allowances
Property, Plant and Equipment [Line Items]
Anticipated amount of investment	$ 222.4

Other Data - Narrative (Details

Other Data - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Tax Credit Carryforward [Line Items]
Number of preferred shares outstanding (in shares)	0	0
Dividends distributed to preferred shares	$ 0
Legacy HR
Tax Credit Carryforward [Line Items]
Estimated aggregate total cost of total assets for federal income tax purposes	$ 12,600,000,000	$ 13,000,000,000	$ 5,000,000,000
Legacy HTA
Tax Credit Carryforward [Line Items]
Estimated aggregate total cost of total assets for federal income tax purposes			$ 8,200,000,000

Other Data - Characterization o

Other Data - Characterization of Distributions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Tax Treatment of Dividends Pre-Merger Healthcare Trust of America
Characterization of distributions on common stock
Ordinary income (in dollars per share)	$ 0	$ 0.5862	$ 0.7920
Return of capital (in dollars per share)	0	4.0162	0.4930
Capital gain (in dollars per share)	0	1.2216	0
Common stock distributions (in dollars per share)	0	5.8240	1.2850
Tax Treatment of Dividends Pre-Merger Healthcare Realty
Characterization of distributions on common stock
Ordinary income (in dollars per share)	0	0.2655	0.7500
Return of capital (in dollars per share)	0	0.5555	0.3600
Capital gain (in dollars per share)	0	0	0.0964
Common stock distributions (in dollars per share)	0	0.8210	1.2064
Tax Treatment of Dividends Post-Merger Healthcare Realty
Characterization of distributions on common stock
Ordinary income (in dollars per share)	0.5482	0.0422	0
Return of capital (in dollars per share)	0.5031	0.2889	0
Capital gain (in dollars per share)	0.1887	0.0879	0
Common stock distributions (in dollars per share)	$ 1.2400	$ 0.4190	$ 0

Other Data - State Income Taxes

Other Data - State Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
State income tax expense
Texas gross margins tax	$ 1,206	$ 1,693	$ 564
Other	133	151	8
Total state income tax expense	1,339	1,844	572
State income tax payments, net of refunds and collections	$ 1,324	$ 1,834	$ 560

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
CARRYING VALUE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes and bonds payable	$ 4,994.9	$ 5,351.8
Real estate notes receivable	173.6	99.6
FAIR VALUE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes and bonds payable	4,872.7	5,149.6
Real estate notes receivable	$ 172.5	$ 99.6

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts (Details) - Accounts receivable allowance - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 3,954	$ 654	$ 604
Charged/(Credited) to costs and expenses, additions and deductions	5,119	3,306	72
Charged to other accounts, additions and deductions	0	0	0
Uncollectible accounts written-off	669	6	22
Balance at end of period	$ 8,404	$ 3,954	$ 654

Schedule III - Real Estate an_2

Schedule III - Real Estate and Accumulated Depreciation (Details) $ in Thousands	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Summary of real estate properties
NUMBER OF PROPERTIES | property	655
Buildings, Improvements, Lease Intangibles, and CIP
Gross real estate asset, Total	$ 13,408,713	$ 14,076,475	$ 5,104,942	$ 4,670,226
Accumulated depreciation	$ 2,227,766	$ 1,645,271	$ 1,338,743	$ 1,249,679
Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	656
Land
INITIAL INVESTMENT	$ 1,136,297
COST CAPITALIZED subsequent to acquisition	208,818
TOTAL	1,345,115
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	10,677,434
COST CAPITALIZED subsequent to acquisition	1,048,037
TOTAL	11,725,471
PERSONAL PROPERTY	12,718
Gross real estate asset, Total	13,083,304
Accumulated depreciation	2,227,766
Encumbrances	$ 70,534
Land held for develop.
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
Land
INITIAL INVESTMENT	$ 59,871
COST CAPITALIZED subsequent to acquisition	0
TOTAL	59,871
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	59,871
Accumulated depreciation
Encumbrances	$ 0
Construction in progress
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
Land
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	60,727
COST CAPITALIZED subsequent to acquisition	0
TOTAL	60,727
PERSONAL PROPERTY	0
Gross real estate asset, Total	60,727
Accumulated depreciation	0
Encumbrances	$ 0
Financing lease right-of-use assets
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
Land
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	82,209
Accumulated depreciation	0
Encumbrances	$ 0
Investment in financing receivables, net
Summary of real estate properties
NUMBER OF PROPERTIES | property	0
Land
INITIAL INVESTMENT	$ 0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	0
COST CAPITALIZED subsequent to acquisition	0
TOTAL	0
PERSONAL PROPERTY	0
Gross real estate asset, Total	122,602
Accumulated depreciation	0
Encumbrances	$ 0
Total properties
Summary of real estate properties
NUMBER OF PROPERTIES | property	656
Land
INITIAL INVESTMENT	$ 1,196,168
COST CAPITALIZED subsequent to acquisition	208,818
TOTAL	1,404,986
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	10,738,161
COST CAPITALIZED subsequent to acquisition	1,048,037
TOTAL	11,786,198
PERSONAL PROPERTY	12,718
Gross real estate asset, Total	13,408,713
Accumulated depreciation	2,227,766
Encumbrances	$ 70,534
Dallas, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	43
Land
INITIAL INVESTMENT	$ 72,772
COST CAPITALIZED subsequent to acquisition	17,396
TOTAL	90,168
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	925,170
COST CAPITALIZED subsequent to acquisition	147,779
TOTAL	1,072,949
PERSONAL PROPERTY	550
Gross real estate asset, Total	1,163,667
Accumulated depreciation	221,375
Encumbrances	$ 0
Houston, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	31
Land
INITIAL INVESTMENT	$ 63,942
COST CAPITALIZED subsequent to acquisition	13,018
TOTAL	76,960
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	642,626
COST CAPITALIZED subsequent to acquisition	32,557
TOTAL	675,183
PERSONAL PROPERTY	57
Gross real estate asset, Total	752,200
Accumulated depreciation	97,793
Encumbrances	$ 0
Seattle, WA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	29
Land
INITIAL INVESTMENT	$ 59,412
COST CAPITALIZED subsequent to acquisition	4,883
TOTAL	64,295
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	551,328
COST CAPITALIZED subsequent to acquisition	90,031
TOTAL	641,359
PERSONAL PROPERTY	715
Gross real estate asset, Total	706,369
Accumulated depreciation	186,903
Encumbrances	$ 0
Denver, CO | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	33
Land
INITIAL INVESTMENT	$ 62,172
COST CAPITALIZED subsequent to acquisition	14,526
TOTAL	76,698
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	488,764
COST CAPITALIZED subsequent to acquisition	56,499
TOTAL	545,263
PERSONAL PROPERTY	610
Gross real estate asset, Total	622,571
Accumulated depreciation	94,906
Encumbrances	$ 0
Charlotte, NC | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	32
Land
INITIAL INVESTMENT	$ 28,119
COST CAPITALIZED subsequent to acquisition	7,345
TOTAL	35,464
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	451,251
COST CAPITALIZED subsequent to acquisition	39,182
TOTAL	490,433
PERSONAL PROPERTY	110
Gross real estate asset, Total	526,007
Accumulated depreciation	116,578
Encumbrances	$ 0
Phoenix, AZ | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	35
Land
INITIAL INVESTMENT	$ 12,205
COST CAPITALIZED subsequent to acquisition	8,057
TOTAL	20,262
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	447,753
COST CAPITALIZED subsequent to acquisition	26,436
TOTAL	474,189
PERSONAL PROPERTY	425
Gross real estate asset, Total	494,876
Accumulated depreciation	59,449
Encumbrances	$ 0
Atlanta, GA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	27
Land
INITIAL INVESTMENT	$ 40,227
COST CAPITALIZED subsequent to acquisition	8,868
TOTAL	49,095
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	429,729
COST CAPITALIZED subsequent to acquisition	15,587
TOTAL	445,316
PERSONAL PROPERTY	100
Gross real estate asset, Total	494,511
Accumulated depreciation	79,569
Encumbrances	$ 5,572
Boston, MA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	17
Land
INITIAL INVESTMENT	$ 117,857
COST CAPITALIZED subsequent to acquisition	9,590
TOTAL	127,447
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	336,670
COST CAPITALIZED subsequent to acquisition	4,255
TOTAL	340,925
PERSONAL PROPERTY	14
Gross real estate asset, Total	468,386
Accumulated depreciation	37,569
Encumbrances	$ 0
Raleigh, NC | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	28
Land
INITIAL INVESTMENT	$ 44,530
COST CAPITALIZED subsequent to acquisition	12,090
TOTAL	56,620
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	393,245
COST CAPITALIZED subsequent to acquisition	15,098
TOTAL	408,343
PERSONAL PROPERTY	9
Gross real estate asset, Total	464,972
Accumulated depreciation	38,879
Encumbrances	$ 0
Nashville, TN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	13
Land
INITIAL INVESTMENT	$ 40,673
COST CAPITALIZED subsequent to acquisition	2,674
TOTAL	43,347
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	309,400
COST CAPITALIZED subsequent to acquisition	97,997
TOTAL	407,397
PERSONAL PROPERTY	7,427
Gross real estate asset, Total	458,171
Accumulated depreciation	115,979
Encumbrances	$ 7,841
Los Angeles, CA | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	20
Land
INITIAL INVESTMENT	$ 68,225
COST CAPITALIZED subsequent to acquisition	3,861
TOTAL	72,086
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	305,221
COST CAPITALIZED subsequent to acquisition	71,590
TOTAL	376,811
PERSONAL PROPERTY	453
Gross real estate asset, Total	449,350
Accumulated depreciation	145,875
Encumbrances	$ 28,870
Miami, FL | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	19
Land
INITIAL INVESTMENT	$ 47,092
COST CAPITALIZED subsequent to acquisition	6,902
TOTAL	53,994
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	325,814
COST CAPITALIZED subsequent to acquisition	35,543
TOTAL	361,357
PERSONAL PROPERTY	178
Gross real estate asset, Total	415,529
Accumulated depreciation	74,470
Encumbrances	$ 0
Tampa, FL | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	19
Land
INITIAL INVESTMENT	$ 23,491
COST CAPITALIZED subsequent to acquisition	7,631
TOTAL	31,122
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	363,588
COST CAPITALIZED subsequent to acquisition	15,729
TOTAL	379,317
PERSONAL PROPERTY	33
Gross real estate asset, Total	410,472
Accumulated depreciation	36,726
Encumbrances	$ 0
Indianapolis, IN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	36
Land
INITIAL INVESTMENT	$ 45,914
COST CAPITALIZED subsequent to acquisition	8,985
TOTAL	54,899
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	308,044
COST CAPITALIZED subsequent to acquisition	10,542
TOTAL	318,586
PERSONAL PROPERTY	13
Gross real estate asset, Total	373,498
Accumulated depreciation	42,273
Encumbrances	$ 0
Austin, TX | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	13
Land
INITIAL INVESTMENT	$ 22,178
COST CAPITALIZED subsequent to acquisition	4,885
TOTAL	27,063
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	261,585
COST CAPITALIZED subsequent to acquisition	31,211
TOTAL	292,796
PERSONAL PROPERTY	142
Gross real estate asset, Total	320,001
Accumulated depreciation	55,891
Encumbrances	$ 0
New York, NY | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	14
Land
INITIAL INVESTMENT	$ 58,719
COST CAPITALIZED subsequent to acquisition	5,683
TOTAL	64,402
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	192,029
COST CAPITALIZED subsequent to acquisition	4,705
TOTAL	196,734
PERSONAL PROPERTY	0
Gross real estate asset, Total	261,136
Accumulated depreciation	15,887
Encumbrances	$ 0
Chicago, IL | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	6
Land
INITIAL INVESTMENT	$ 11,250
COST CAPITALIZED subsequent to acquisition	2,554
TOTAL	13,804
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	212,170
COST CAPITALIZED subsequent to acquisition	17,314
TOTAL	229,484
PERSONAL PROPERTY	81
Gross real estate asset, Total	243,369
Accumulated depreciation	39,671
Encumbrances	$ 0
Memphis, TN | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	11
Land
INITIAL INVESTMENT	$ 12,253
COST CAPITALIZED subsequent to acquisition	1,648
TOTAL	13,901
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	118,427
COST CAPITALIZED subsequent to acquisition	75,725
TOTAL	194,152
PERSONAL PROPERTY	322
Gross real estate asset, Total	208,375
Accumulated depreciation	71,813
Encumbrances	$ 0
Honolulu, HI | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	6
Land
INITIAL INVESTMENT	$ 8,314
COST CAPITALIZED subsequent to acquisition	1,213
TOTAL	9,527
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	147,422
COST CAPITALIZED subsequent to acquisition	47,669
TOTAL	195,091
PERSONAL PROPERTY	169
Gross real estate asset, Total	204,787
Accumulated depreciation	61,575
Encumbrances	$ 0
Hartford, CT | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	30
Land
INITIAL INVESTMENT	$ 24,167
COST CAPITALIZED subsequent to acquisition	5,214
TOTAL	29,381
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	159,178
COST CAPITALIZED subsequent to acquisition	1,383
TOTAL	160,561
PERSONAL PROPERTY	0
Gross real estate asset, Total	189,942
Accumulated depreciation	15,883
Encumbrances	$ 0
Other (49 markets) | Real estate acquired
Summary of real estate properties
NUMBER OF PROPERTIES | property	194
Land
INITIAL INVESTMENT	$ 272,785
COST CAPITALIZED subsequent to acquisition	61,795
TOTAL	334,580
Buildings, Improvements, Lease Intangibles, and CIP
INITIAL INVESTMENT	3,308,020
COST CAPITALIZED subsequent to acquisition	211,205
TOTAL	3,519,225
PERSONAL PROPERTY	1,310
Gross real estate asset, Total	3,855,115
Accumulated depreciation	618,702
Encumbrances	$ 28,251

Schedule III - Real Estate an_3

Schedule III - Real Estate and Accumulated Depreciation - Narrative (Details) $ in Thousands	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($)
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Federal income tax purposes	$ 12,600,000
Issuance costs	3,867	$ 5,977
Mortgage Notes Payable | Mortgage Notes
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Unamortized premium	285	486
Unaccreted discount	237	38
Issuance costs	$ 266	$ 323
Minimum | Buildings and improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	3 years 3 months 18 days
Minimum | Lease intangibles
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	1 year
Minimum | Personal Property
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	3 years
Minimum | Land improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	2 years
Maximum | Buildings and improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	49 years
Maximum | Lease intangibles
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	99 years
Maximum | Personal Property
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	20 years
Maximum | Land improvements
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Asset estimated useful life	39 years
Asset Held-for-sale
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Number of real estate assets held for sale | property	1
Amount of ​assets ​held for ​sale	$ 9,600

Schedule III - Real Estate an_4

Schedule III - Real Estate and Accumulated Depreciation - Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward]
Beginning Balance, Total Property	$ 14,076,475	$ 5,104,942	$ 4,670,226
Retirement/dispositions
Ending Balance, Total Property	13,408,713	14,076,475	5,104,942
Reconciliation of Real Estate Accumulated Depreciation [Roll Forward]
Beginning Balance, Accumulated Depreciation	1,645,271	1,338,743	1,249,679
Retirement/dispositions
Ending Balance, Accumulated Depreciation	2,227,766	1,645,271	1,338,743
Real estate acquired
Additions during the period
Total Property	54,024	9,780,070	374,912
Retirement/dispositions
TOTAL PROPERTY	(800,958)	(1,098,702)	(247,880)
Ending Balance, Total Property	13,083,304
Additions during the period
ACCUMULATED DEPRECIATION	2,322	241,285	7,668
Retirement/dispositions
Accumulated Depreciation	(87,896)	(140,696)	(110,479)
Ending Balance, Accumulated Depreciation	2,227,766
Other improvements
Additions during the period
Total Property	28,521	219,783	103,035
Additions during the period
ACCUMULATED DEPRECIATION	668,069	205,703	191,875
Land held for development
Additions during the period
Total Property		49,416	2,021
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Construction in progress
Additions during the period
Total Property	49,901	31,586	3,974
Retirement/dispositions
Ending Balance, Total Property	60,727
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Retirement/dispositions
Ending Balance, Accumulated Depreciation	0
Investment in financing receivables, net
Additions during the period
Total Property	2,366		186,745
Total Property Reclassified		(66,509)
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Financing lease right-of-use assets
Additions during the period
Total Property		52,249	11,909
Total Property Reclassified	(1,616)
Retirement/dispositions
Ending Balance, Total Property	82,209
Additions during the period
ACCUMULATED DEPRECIATION	0	0	0
Retirement/dispositions
Ending Balance, Accumulated Depreciation	0
Corporate Properties
Additions during the period
Total Property	0	3,640	0
Additions during the period
ACCUMULATED DEPRECIATION	$ 0	$ 236	$ 0

Schedule IV - Mortgage Loans _2

Schedule IV - Mortgage Loans on Real Estate Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Prior Liens	$ 0
Face Amount	182,125,000
Carrying Amount	173,614,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	54,119,000
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance as of the beginning of the year	99,643,000	$ 0	$ 0
Additions:
Fair value real estate notes assumed	0	74,819,000	0
New real estate notes	58,700,000	23,325,000	0
Draws on existing real estate notes	19,103,000
Capitalized interest	0	1,499,000	0
Accretion of fees and other items	1,364,000	0	0
Deductions:
Collection of real estate loans	0	0	0
Deferred fees and other items	0	0	0
Allowance for credit loss	(5,196,000)
Balance as of the end of the year	$ 173,614,000	$ 99,643,000	$ 0
Texas | Medical Real Estate, Maturing in July 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	7%
Prior Liens	$ 0
Face Amount	31,150,000
Carrying Amount	31,150,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Texas | Property 1
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	8%
Prior Liens	$ 0
Face Amount	54,119,000
Carrying Amount	45,856,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 54,119,000
North Carolina | Medical Real Estate, Maturing in December 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	8%
Prior Liens	$ 0
Face Amount	6,000,000
Carrying Amount	5,796,000
Principal Amount of Loans Subject to Delinquent Principal or Interest
Florida | Medical Real Estate Maturing in February 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	6%
Prior Liens	$ 0
Face Amount	32,156,000
Carrying Amount	32,112,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	0
Construction loan, maximum	$ 65,000,000
Florida | Medical Real Estate, Maturing in December 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	9%
Prior Liens	$ 0
Face Amount	7,700,000
Carrying Amount	7,700,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	0
Monthly installment payments of principal and interest amount	$ 152,069
California | Medical Real Estate, Maturing in March 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	6%
Prior Liens	$ 0
Face Amount	45,000,000
Carrying Amount	45,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Arizona | Property 2
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Interest rate	9%
Prior Liens	$ 0
Face Amount	6,000,000
Carrying Amount	6,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0